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Skeletal muscle mass and function deteriorates with advancing age (sarcopenia). 
Physical inactivity and obesity are associated with advancing age and exacerbate inherent 
age-related decrements in physiological function, skeletal muscle mass and morphology. 
The study of older individuals that have chronically undertaken structured exercise 
training (Master Athletes; MA) provide an opportunity to elucidate the contribution of 
inherent ageing and biological ageing factors to age-related physiological deterioration. 
Chapter 2 describes the first systematic review to quantitatively and qualitatively 
summarise the literature surrounding MA. We established that, at present, there are few 
high-quality studies, utilising sophisticated measurement tools to comprehensively assess 
whether, and to what extent, physiological function and muscle morphology are 
enhanced/preserved in MA compared with trained and untrained older and younger 
individuals. Accordingly, in Chapter 3, we conducted a detailed mechanistic study to 
compare physical function, cardiorespiratory fitness, body composition, muscle strength, 
architecture and fibre-type morphology in MA, with healthy untrained younger and age-
matched older individuals. We shed light on the morphological mechanisms through 
which chronic exercise training enhances skeletal muscle function and body composition, 
with implications for sarcopenia diagnosis. Based on the superior phenotype observed in 
MA, the final experimental in this thesis, Chapter 4, describes an investigation of in vivo 
skeletal muscle remodelling responsiveness in MA. This work demonstrates that basal and 
exercise-induced rates of muscle protein synthesis are equivalent between older untrained 
individuals and MA. As such, untrained older individuals retain a capacity to adapt to 
exercise and that it may never be too late to benefit from exercise training.  











“I think science has begun to demonstrate that ageing is a disease. 
If it is, it can be cured.” 
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1.1. Challenges of Global Ageing 
 
1.1.1. Ageing Population 
The demographic of the UK population is rapidly shifting towards that of an 
ageing one (2015). Since 1960 the life expectancy of all countries in the EU has 
significantly increased and it is predicted that by 2060 average life expectancies of men 
and women will have increased to 84.7 and 89.1 years, respectively (2015). In the UK 
alone, the population is anticipated to increase by 25% between 2013-2060 from 64.1 
million to 80.1 million (2015). The number of individuals over the age of 65 years is 
predicted to increase from 11.1 to 19.9 million, of which 7.6 million will be over the age 
of 80 years, signifying a 78.9% increase in the ‘oldest old’ in our society. Advancements 
in preventative and therapeutic medicine, lifestyle modifications have led to falling 
mortality rates and increasing longevity which, alongside declining fertility rates, have 
largely driven this demographic population shift (Harper, 2014). An ageing population 
presents a significant global socio-economic challenge to individuals and healthcare 
providers. However, the predicament is not that individuals are living longer; it is that 
individuals are spending an ever-expanding portion of their later years with a number of 
age-related diseases and poor quality of life (Seals et al., 2016).  
 
1.1.2. Primary vs. Secondary Ageing 
“Ageing is commonly characterized as a progressive, generalized impairment of 
function, resulting in an increasing vulnerability to environmental challenge and a 
growing risk of disease and death (Kirkwood, 2005)”. The complexities of ageing can be 
broadly subdivided into two contributing categories, the first of which is primary/inherent 
 3 
ageing, previously described by Holloszy as “the inevitable deterioration of cellular 
structure and function independent of disease and environment” (Holloszy, 2000). 
Primary ageing is largely determined by genetics. A large number of genes that contribute 
to the inherent ageing process and longevity have been identified, and are described in 
detail elsewhere (Sinclair and Guarente, 2006). Based on large-scale studies of identical 
twins, it has been estimated that genetic factors account for ~20-30% of lifespan 
(Hjelmborg et al., 2006, Finch and Tanzi, 1997, Herskind et al., 1996, Ljungquist et al., 
1998). The remaining determinants of lifespan are disease factors and environmental 
influences (Holloszy, 2000); referred to as secondary or biological ageing. Secondary 
ageing is predominantly influenced by factors including, exercise, nutrition, smoking and 
ultraviolet radiation (Holloszy, 2000). These environmental factors, most notably physical 
activity and exercise, can impact the likelihood of progressing into older age with/without 
disease and physical impairments (Booth et al., 2012).  
 
1.1.3. Lifespan vs. Healthspan  
Originally, James Fries (1980) posited that geriatric medicine should focus on 
compressing the period of time individuals spend with disease and disability (Fries, 1980). 
This would result in a reduced total time of incurred illness, much closer to a natural end 
of life (Seals et al., 2016), often expressed as compression of the ‘area under the morbidity 
curve’.  Until recently, the primary focus has been the extension of lifespan. The lifespan 
of individuals around the world has increased and is projected to continue increasing 
(Kontis et al., 2017). However, healthspan is distinct from lifespan in that it represents the 
period of time individuals are able to maintain good health, unburdened by disease and 
ailment (Seals et al., 2016). Minimising the gap between healthspan and lifespan is 
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challenging. Ageing is complex and proposed as the foremost risk factor for the 
development of a number of diseases and conditions. Cardiac pathologies, cancer, stroke, 
diabetes, and neurodegenerative conditions are amongst the most prevalent diseases of 
older age (Niccoli and Partridge, 2012). These common diseases associated with older age 
can severely impact functional independence and quality of life, which is reflected in the 
numbers of older individuals reliant on health services (Sousa et al., 2016). Therefore, the 
challenge facing healthcare professionals, and researchers, is to determine whether it is 
possible to extend the number of ‘healthy years’ that individuals experience by preventing, 
or slowing the progression of, these age-associated health decrements. 
 
1.2. Musculoskeletal Ageing  
Skeletal muscle makes up ~40% of total body mass and is critical for a variety of 
mechanical and metabolic functions; including locomotion, basal metabolism, energy 
storage and nutrient deposition (Frontera and Ochala, 2015). Skeletal muscle mass is an 
independent predictor of all-cause mortality (Srikanthan and Karlamangla, 2014), 
emphasising the significance of maintaining this tissue mass. In young, healthy adults 
consuming adequate dietary protein and not engaged in regular structured exercise, muscle 
mass remains relatively constant throughout adulthood until ~40-50 y, following which it 
declines at a rate of ~0.5-1% each year (Hughes et al., 2002). The trajectory at which 
muscle mass loss occurs in older age is highly variable. Specifically, muscle atrophy can 
be  drastically hastened when individuals experience major alterations to activity status 
such as periods of disuse/immobilisation (Wall et al., 2016) or the development of 
diseases (Morley et al., 2006).  
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1.2.1. Sarcopenia: Definition, Diagnosis and Prevalence 
The loss of skeletal muscle mass with ageing is termed ‘sarcopenia’, proposed by 
Rosenberg in 1989, which the literal translation in Greek refers to ‘poverty of the flesh’ 
(Rosenberg, 1989). Since inception, the definition of sarcopenia has been repeatedly 
modified to accommodate the progressive complexities of the syndrome. Cruz-Jentoft and 
colleagues, of The European Working Group on Sarcopenia in Older People (EWGSOP), 
proposed that the appropriate definition incorporate low muscle mass, muscular strength 
and/or physical performance (Cruz-Jentoft et al., 2010). Resulting in the definition most 
commonly used today “Sarcopenia is a syndrome characterised by progressive and 
generalised loss of skeletal muscle mass and strength with a risk of adverse outcomes such 
as physical disability, poor quality of life and death” (Cruz-Jentoft et al., 2010). In 2018, 
ten years following the original EWGSOP meeting, the working definition of sarcopenia 
has been revised to include (i) low muscle strength (ii) low muscle quantity or quality and 
(iii) low physical performance: where probable sarcopenia is identified by criterion 1, 
diagnosis is confirmed by the addition of criterion 2, and severe sarcopenia is indicated by 
the addition of criterion 3 (Cruz-Jentoft et al., 2018). To obtain an estimate of the number 
of individuals suffering from sarcopenia with any degree of accuracy is problematic, as the 
prevalence of sarcopenia is highly dependent on the specific diagnostic tool that is used 
(Beaudart et al., 2015). Previous reports suggest that sarcopenia prevalence increases with 
age (Janssen et al., 2002), with ~5-13% of individuals between 60-70 y and ~11-50% of 
individuals >80 y diagnosed with sarcopenia (Morley, 2008, von Haehling et al., 2010); 
with small differences between men and women, feasibly due to the disparity in absolute 
peak muscle mass at the onset of muscle mass decline in the 4th-5th decade of life (Janssen 
et al., 2002). Sarcopenia presents a significant health concern for individuals, in particular 
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due to the negative impact on physical and metabolic function, which are tightly linked to 
disease development and mortality (Kodama et al., 2009, Li et al., 2017). The designation 
of an International classification of Diseases (ICD-10) code to sarcopenia, in September 
2016, represents a significant step towards recognising age-related muscle loss as an 
independent disease requiring healthcare intervention (Cao and Morley, 2016, Anker et al., 
2016).  
 
1.2.2. Effects of Ageing on Skeletal Muscle 
Sarcopenia is a syndrome resulting from the interaction of numerous physiological and 
lifestyle factors (i.e. primary and secondary ageing) (Narici and Maffulli, 2010). 
Mechanistically, neuromuscular changes, hormonal and immunological alterations, 
alongside reductions in physical activity and changes to nutritional habits with advancing 
age, contribute to the development of sarcopenia, and the rate at which this disease 
progresses (Narici and Maffulli, 2010). Neuropathies including a-motor neuron death 
coupled with continuous cycles of denervation and re-innervation underpin a decrease in 
the number of motor units and, hence, an increase in size of surviving motor units as 
sprouting axons re-innervate denervated muscle fibres  (Campbell et al., 1973). 
Mitochondrial dysfunction and heightened inflammatory status (elevated interlukin-6 (IL-
6), Interlukin-1 (IL-1), tumour necrosis factor alpha (TNF-a)) contribute to sarcopenia 
through muscle cell apoptosis (Narici and Maffulli, 2010). In addition, age-related muscle 
fibre loss occurs through a reduction in mechanical loading of muscle contractile 
components (physical inactivity), modifications to the hormonal environment (i.e., 
reductions in diurnal testosterone, growth hormone, IGF-1, oestrogen and other 
 7 
androgens) which manifest as a shift towards muscle catabolism, resulting in a net loss of 
muscle protein mass (Narici and Maffulli, 2010). Moreover, impairments in satellite cell 
activation and proliferation likely reduce skeletal muscle regenerative capacity over the 
life-course (Narici and Maffulli, 2010). Taken together, these underlying age-associated 
physiological alterations potentially have serious consequences for the preservation of 
muscle mass and functional capacity in older age.  
1.2.2.1. Skeletal Muscle Morphology and Architecture 
Architecture 
Ageing deleteriously impacts skeletal muscle architectural organisation (i.e. the 
macroscopic arrangement of muscle fibres) (Narici et al., 2003). It is well established that 
muscle architecture is one of the principal determinants of muscle function; primarily 
force generation and contraction velocity (Lieber and Friden, 2000). The main 
architectural features that determine skeletal muscle function include muscle length, 
fibre/fascicle length, fibre pennation angle and physiological cross sectional area (PCSA) 
(Figure 1). Specifically, muscle length describes the linear distance between the origin and 
insertion of the muscle. Fibre/fascicle length describes the distance between the 
intersection composed of the superficial aponeurosis and fascicle and the intersection 
composed of the deep aponeurosis and the fascicle. Pennation angle was defined as the 
internal angle composed of the fascicle and deep aponeurosis. Muscle thickness describes 
the vertical line from the superficial aponeurosis to deep aponeurosis (Fukutani and 
Kurihara, 2015). Lastly, the PCSA describes muscle volume relative to the arrangement of 
muscle fibres/fascicles (i.e., Muscle volume/fascicle length) (McPhee et al., 2018). 
Skeletal muscle architecture is of particular importance as the force produced by the 
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muscle is proportional to PCSA, and the force decreases in proportion to the cosine of the 
fibre pennation angle (McPhee et al., 2018).  
Previously, it has been shown that PCSA was reduced in older compared with young 
individuals (Narici et al., 2003). A reduction in muscle thickness, fascicle length and 
pennation angle has also been demonstrated in old (60-85 years) compared with young 
(20-39 years) individuals (Kubo et al., 2003). In addition, young (~24 years) had greater 
muscle thickness and pennation angle of the quadriceps than older (~68 years) individuals, 
and muscle thickness was reported to be closely associated with maximal voluntary 
contraction (MVC) torque (Strasser et al., 2013). Clearly, alterations to skeletal muscle 
architecture with advancing age are relatively well characterised and may, in part, explain 
some of the functional decrements commonly observed in older individuals.  
 
Figure 1. The main architectural features shown in situ (A) and as an ultrasound image 
(B) that determine skeletal muscle function include muscle length, fibre/fascicle length, 
fibre pennation angle and physiological cross sectional area (PCSA, Indicated by the 
dotted circler on diagram A). Lf and FL, Fibre/Fascicle length; ML, Muscle length; MT, 








Muscle Cross-Sectional Area 
The advancement of imaging techniques has enabled investigation into myocellular 
alterations and skeletal muscle morphology (i.e., muscle fibre cross sectional area (CSA) 
and fibre type distribution). A frequently observed characteristic of ageing muscle is the 
reduction in muscle CSA between 50 and 80 y (Goodpaster et al., 2006); driven by a 
decline in the size of individual muscle fibres (Lexell, 1995) and a reduction in fibre 
number (Lexell et al., 1988). It has been consistently observed that predominantly myosin 
heavy chain (MHC) II fibre size is reduced with advancing age. In an early cadaveric 
study, Lexell and colleagues discovered that MHC II fibre CSA was ~26% smaller in 80 y 
old individuals when compared with that of a 20 y old, whereas the reduction in MHC I 
fibre CSA was not as readily apparent (Lexell, 1995).  Later work suggested that 
reductions in muscle CSA with ageing are predominantly driven by a significant reduction 
in the size of the Type II muscle fibres (Nilwik et al., 2013). However, the larger muscles 
and fibre CSA in these individuals may preclude the identification of fibre number losses. 
More recently, in a study that set out to determine the contributors to age-related muscle 
weakness and voluntary activation, it was shown that reductions in muscle mass and CSA 
are the result of equal contributions of fibre loss and atrophy (McPhee et al., 2018). Taken 
together, it is apparent that reductions in muscle fibre CSA and fibre number are a 
commonly observed hallmark of sarcopenia (Lexell et al., 1986) and may play a role in the 




Skeletal muscle stem cells, termed ‘satellite cells’, are proposed to play a key role in 
regeneration and repair processes (Snijders et al., 2015). Located between the sarcolemma 
and basal lamina, satellite cells remain in a quiescent state until stimulation, upon which 
the cells are activated, proliferate and differentiate (Snijders et al., 2015). Differentiation 
allows satellite cells to form new myofibres, which can repair or replace damaged fibres, 
or fuse to existing myofibres to donate their nucleus and enable hypertrophy. Satellite cell 
activity and progression through the cell cycle is regulated by a number of transcription 
factors (i.e., Pax7) and myogenic regulatory factors (Myf5, MyoD, MRF4, and 
Myogenin). Additional factors including; hepatocyte growth factor (HGF), myostatin 
(Mstn), Notch/Delta1, interleukin-6 (IL-6), mechano-growth factor (MGF), and insulin 
like growth factor-1 (IGF1) contribute to the regulation of satellite cells during differing 
stages of their myogenic program (Snijders et al., 2015). Ageing appears to exert a 
deleterious impact on skeletal muscle satellite cell number, predominantly in Type II 
muscle fibres (Verdijk et al., 2014). Satellite cells have been shown to decrease between 
25-70% in the vastus lateralis, biceps brachii and tibialis anterior in old vs. young 
individuals. However, studies have also reported no change in the satellite cell pool with 
ageing (Roth et al., 2000, Dreyer et al., 2006). Much of the discrepancy between studies 
could be the result of a scarcity of fibre-type specific satellite cell data (Verdijk et al., 
2007). A reduction in the intramuscular satellite cell pool and/or impairments in satellite 
cell activation and proliferation in response to exercise stimuli, may adversely affect 
muscle remodelling and long-term maintenance (Snijders et al., 2009). Others have 
suggested that a reduction in the satellite cell pool in aged skeletal muscle may not be 
limiting for skeletal muscle remodelling, and that diminution of the satellite cell pool is 
unlikely to prevent repair of aged skeletal muscle following damage as a result of chronic 
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exercise training (Thornell et al., 2003). Therefore, the role satellite cells perform in 
skeletal muscle repair and remodelling with ageing is somewhat contentious. Further 
investigation is necessary to fully characterise the influence of ageing on satellite cells 
content and responsiveness, and whether chronic exercise training, over many years, is a 
viable strategy to preserve satellite cell integrity. Such investigations could ultimately 
yield new treatment methods for sarcopenia. 
 
Myonuclei 
Skeletal muscle fibres are one of only a few multinucleated cells in the human body. 
Each myonucleus is responsible for the gene transcription and protein synthetic activity of 
a finite region of skeletal muscle cytoplasm; termed the myonuclear domain (Cheek, 
1985). It is plausible to consider that increases, or decreases, in skeletal muscle CSA in 
response to chronic exercise or ageing would be mirrored by alterations to the total 
number of myonuclei. Upon stimulation, satellite cells eventually form new myonuclei or 
return to a state of quiescence (Verdijk et al., 2014). Similar to satellite cells, the role of 
the myonuclear domain in skeletal muscle maintenance and adaptation is debatable. It has 
been shown that myonuclear domain is decreased in older adults (50-69 years) compared 
with younger adults (18-49 years), expressly in Type II muscle fibres (Verdijk et al., 
2014). Single fibre analysis of immobilized rodent muscle (i.e. a model of accelerated 
ageing), suggests that myonuclei are not lost, but that the domain size does decrease with 
fibre atrophy (Wada et al., 2002). Regardless, the dynamic between satellite cells and 
myonuclei in the maintenance and repair of skeletal muscle is poorly understood, and it 
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remains to be determined whether satellite cells and myonuclear domain are integral to the 
maintenance of muscle mass and function with advancing age.  
 
Capillarisation 
Sufficient delivery of oxygen and nutrients to skeletal muscle is critical to increase and 
maintain skeletal muscle mass and function. Therefore, adequate muscle perfusion from 
the surrounding capillary network is vital. Previously, it has been shown that ageing 
adversely impacts skeletal muscle microvasculature (Parizkova et al., 1971, Groen et al., 
2014) and total limb blood flow (Donato et al., 2006, Skilton et al., 2005). This is clearly 
demonstrated by substantial alterations to the capillary network, with reported reductions 
in (i) capillary contacts per myofibre, (ii) individual capillary-to-fibre ratio (C:Fi) and (iii) 
capillary fibre perimeter exchange (CFPE) index (Hepple et al., 1997b). Conversely, 
exercise training, specifically endurance type, elicits significant adaptations to the skeletal 
muscle capillary network. Previously, it has been shown that 8 weeks of cycle training led 
to a 20% increase in capillary density in young men (Andersen and Henriksson, 1977). 
Furthermore, older individuals can also increase skeletal muscle capillarisation in response 
to endurance training (Gavin et al., 2007). The difference in basal capillarisation between 
young and old reflects an age-related decline, which can potentially be offset as both 
groups demonstrate the same capacity to increase capillarisation following endurance 
exercise training (~20%) (Gavin et al., 2007). Reductions in capillarisation with ageing 
may contribute to an accelerated loss of muscle mass and insulin resistance, due to poor 
delivery of nutrients (i.e., amino acids, glucose, insulin), which may have significant 
consequences for an individual’s functional capacity and metabolic health. Importantly, 
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impairments in this skeletal muscle perfusion may be overcome with exercise training, the 
extent to which this is possible with chronic endurance training, over many years, warrants 
further investigation.  
 
1.2.2.2. Neuromuscular Properties 
Ageing skeletal muscle characteristically undergoes neuromuscular alterations. In 
ageing muscle, muscle fibre denervation occurs, predominantly in Type II fibres, due to a 
progressive loss of motor neurons (Degens, 2007). Previous studies in cadavers have 
revealed that individuals aged 75 y have ~30% fewer motor neurons supplying the 
muscles of the lower limbs (Tomlinson and Irving, 1977). In some cases, the neural drive 
to denervated fibres can be salvaged through re-innervation by sprouting axons of nearby 
motor neurons. This leads to an increased size of the surviving motor units, which may 
have significant consequences for muscle function; as larger motor units require much 
greater stimulation for force generation. In addition to this, ageing skeletal muscle 
undergoes extensive neuromuscular remodelling, specifically older individuals (~71 years) 
demonstrate ~44% fewer motor units (assessed by motor unit number estimates (MUNE)), 
less stable neuromuscular junction transmission and slower discharge rates when 
compared with young individuals (~25 years) (Piasecki et al., 2016c). When coupled with 
the reduction in muscle CSA, this had notable consequences for motor function as shown 
by a reduction in MVC by ~32% when compared with younger individuals.  
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1.2.3. Consequences for Function and Health 
Physiological function and performance typically deteriorates with advancing age, 
particularly maximal aerobic capacity and muscular strength. The cardiovascular and 
respiratory systems, which play a critical role in delivering oxygen and nutrients to the rest 
of the body whilst concurrently removing metabolic waste products, are adversely affected 
by ageing (Harridge and Lazarus, 2017). Maximal aerobic capacity (VO2max), a product of 
both cardiac output (Q) and maximal arterio-venous difference (A-VO2diff), decreases at a 
rate of ~1% per year after the age of 25 years in untrained individuals (Astrand et al., 
1973, Buskirk and Hodgson, 1987). Young healthy men and women aged 20-29 y 
typically display a VO2max of 54.4 and 43.0 ml.kg-1.min-1, respectively (Loe et al., 2013). 
By age 60-69 y, VO2max is significantly reduced to 39.2 and 31.1 ml.kg-1.min-1 for men and 
women, respectively (Loe et al., 2013). The reduction in VO2max with advancing age is 
predominantly caused by a decline in cardiac output (Lambert and Evans, 2005), 
impairments in skeletal muscle oxidative capacity (Betik and Hepple, 2008), a reduction in 
fat-free mass and increased fat mass (Kuk et al., 2009); all of which are typically 
exacerbated with advancing age. Due to a close association of VO2max with morbidity and 
mortality, the development and maintenance of high levels of aerobic fitness should be a 
primary consideration for healthy ageing. 
Ageing exerts a significant influence on the musculoskeletal system, with reductions in 
muscular strength and power. Muscular strength declines at a rate of ~3-4% and 2.5-3% 
annually in men and women, respectively (Manini and Clark, 2012). Similar declines in 
muscular power have been observed (Izquierdo et al., 1999), with dire consequences for 
functional capacity in older individuals. Specifically, a reduced ability to carry out basic 
functional tasks required for independent living such as ambulation, rising from a 
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chair/bath, or opening a jar (Skelton et al., 1994). Previously, it has been shown that 
individuals over 60 y in the lowest tertile of strength(i.e., the weakest old), were almost 
50% more likely to die due to all-cause mortality when compared with the upper tertile 
(i.e., the strongest old) (Ruiz et al., 2008), clearly demonstrating the importance of 
maintaining muscle strength and power in older age. The underlying mechanisms 
responsible for the decline in muscular strength observed with ageing are contentious. 
There are two key contributory elements that have been suggested to drive the reduction in 
muscular strength and power; neurological and musculoskeletal factors (Clark and Manini, 
2010). Neurological alterations include the reduction of motor unit recruitment and α-
motoneuron discharge rate alongside neuromuscular junction transmission failure (Clark 
and Manini, 2010). Conversely, the muscular factors that contribute to the reduction in 
voluntary force output are alterations to the muscle contractile machinery (i.e., excitation-
contraction uncoupling, fibre-type shifts and infiltrations) and the decline in fat-free mass 
due to fibre atrophy (Clark and Manini, 2010). Although there is still some debate of the 
contribution of neural and muscular factors to sarcopenia, it has recently been 
demonstrated that reductions in muscle mass appear to be the dominant driving force 
behind strength reductions with advancing age (McPhee et al., 2018).  
Greater levels of physical function are associated with lower risk of all-cause mortality 
(Kodama et al., 2009, Blair et al., 1989). Aerobic capacity and muscular strength are 
examples of bodily functions that require the successful integration of the cardiovascular, 
respiratory and neuromuscular systems. As a result, targeted strategies to combat declines 
in physiological function are imperative to extend the healthspan, and improve the quality 
of later life for individuals. It is well established that endurance exercise training improves 
endurance performance, mitochondrial function, capillarisation, glucose/insulin 
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metabolism and drastically reduces cardiovascular risk profile (Egan and Zierath, 2013). 
Resistance exercise has a more substantial effect on the development/maintenance of 
muscular strength and power, basal metabolic rate and locomotor activities (Egan and 
Zierath, 2013). As a result, a combination of the two types of exercise in promoting a 
‘healthy lifestyle’ has been reflected in physical activity guidelines for older adults (Piercy 
et al., 2018). Unfortunately, a significant number of older individuals fail to meet the 
current recommended physical activity guidelines (Jefferis et al., 2014). The importance of 
skeletal muscle function to an individual’s ability to age ‘healthily’ and independently, 
necessitates continued research into the mechanisms underlying age-related physiological 
deterioration in aerobic capacity and muscle strength and to develop strategies that offset, 
and perhaps prevent, this deterioration.   
 
1.3. Regulation of Muscle Plasticity 
Skeletal muscle is a highly plastic tissue, capable of momentous change in response to 
the environmental demands placed upon it. This is best illustrated in extreme situations, 
for example, following 6 months of spaceflight skeletal muscle volume is reduced by ~4-
20% in the lower limbs despite counter-measures focussed on skeletal muscle maintenance 
(Gopalakrishnan et al., 2010). Conversely, chronic resistance training elicits substantial 
skeletal muscle hypertrophy (i.e., ~7-10% following 10 weeks of resistance training 
(Damas et al., 2018). A reduction in the body’s most abundant tissue, skeletal muscle, 
unavoidably leads to an increased risk for disability and disease (Visser et al., 2005). 
Exercise and nutrition are key determinants in the regulation of skeletal muscle, and may 
play an important role in mitigating the negative effects of ageing. The change in skeletal 
muscle tissue abundance is brought about by changes in the synthesis and degradation of 
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muscle proteins, tightly controlled by a cascade of intracellular signalling proteins (Figure 
2) and satellite cells which alter protein expression and drive alterations in skeletal muscle 
phenotype. Much of what has been learned so far is the result of the development and 
integration of sophisticated analytical tools to investigate the mechanistic control of 
skeletal muscle. It is essential to continue to progress understanding of the complexities of 
ageing and how it impacts musculoskeletal health.  
1.3.1. Skeletal Muscle Protein Turnover 
Skeletal muscle mass is regulated by diurnal oscillations in muscle protein synthesis 
(MPS) and muscle protein breakdown (MPB), both of which are dynamic in nature and act 
to constantly turn over skeletal muscle protein mass (Kim et al., 2016a). These processes 
are radically influenced by ageing, physical activity and nutrition. The balance between 
these two opposing processes determines whether muscle protein mass is gained or lost. In 
young healthy adults consuming adequate dietary protein, MPS and MPB are in net 
protein balance (NPB), thus maintaining skeletal muscle mass (Phillips et al., 1997). MPS 
occurs at a rate of ~1-2% per day (Carraro et al., 1990), such that the entirety of skeletal 
muscle an individual has will have undergone complete renewal every ~3-4 months. It is 
thought that the primary role of MPB is to maintain adequate concentrations of 
intramuscular amino acids for the synthesis of new proteins and the removal of 
dysfunctional/damaged proteins (Tipton et al., 2018). However, due to methodological 
difficulties inaccurately measuring rates of MPB (i.e., contributions of amino acids from 
non-muscle tissues, catheterization of an artery/deep vein, and the necessity of 
physiological steady state), little is known about the role of proteolysis in overall NPB 
(Tipton et al., 2018). It is generally accepted that changes in skeletal muscle mass are 
primarily driven by alterations in MPS, with MPB playing a lesser (but potentially 
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important) role (Phillips et al., 1997). In the postabsorptive state, rates of MPB exceed 
MPS resulting in an overall negative NPB which results in the gradual loss of muscle 
protein mass (i.e. catabolism). Specifically, young men and women (~23 years) during the 
postabsorptive state demonstrate MPS rates of ~0.06 %.h-1 whereas MPB rates were 
estimated to be ~0.12 %.h-1 (Phillips et al., 1997). Furthermore, when exposed to a 
resistance exercise stimulus, both MPS and MPB increased simultaneously; though overall 
NPB was less negative due to a greater relative rise in MPS (Phillips et al., 1997). 
However, the intake of dietary protein, in particular the amino acid leucine, stimulates a 
robust increase in MPS (Biolo et al., 1995) and is critical for the generating a positive 
NPB (i.e. anabolism). Indeed, the stimulation of MPS is synergistically enhanced by 
combined protein nutrition and resistance exercise stimuli (Pennings et al., 2011) and this 
response is influenced by protein dose (Moore et al., 2009a), Source (Tang et al., 2009), 
Quality (Churchward-Venne et al., 2014) and timing (Areta et al., 2013). Thus, repeated 
stimulation of this anabolic response (i.e. high protein diet and frequent resistance 
exercise) leads to an increase in skeletal muscle mass over time (Morton et al., 2018, 
Hoffman et al., 2009).  
1.3.2. Translational Regulation of Muscle Protein Turnover 
Central to the regulation of MPS and skeletal protein mass, is the highly conserved 
serine/threonine kinase, the mammalian target of rapamycin (mTOR). In humans, this 
protein complex is present in two forms, mTORC1 and mTORC2 both of which consist of 
a number of protein sub-units (Laplante and Sabatini, 2012). Primarily mTORC1 regulates 
a number of growth and metabolic pathways, whereas mTORC2 is largely responsible for 
cell proliferation and survival (Laplante and Sabatini, 2012). Both complexes are large, 
and contain some similar protein sub-units (mTOR, mLST8, DEPTOR and the Tti1/Tel2 
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complex). However, the proteins differ structurally in that mTORC1 contains Raptor and 
PRAS40, and mTORC2 contains Rictor, mSin1 and Protor1/2. This thesis will focus on 
mTORC1, as the upstream and downstream targets are the better characterised of the two 
complexes with mTORC1 implicated in age-related skeletal muscle deterioration. 
mTORC1 integrates a number of critical upstream signals, including mechanical stress, 
growth factors, amino acids, energy status and oxygen levels and controls several 
downstream pathways with divergent cellular processes including macromolecule 
synthesis, autophagy, cell cycle, growth and metabolism (Laplante and Sabatini, 2012). 
This array of biological functions has led to mTOR frequently being referred to as a 
‘master regulator’ of cell plasticity (Hsieh, 2012).   
The upstream regulation of mTORC1 has been the topic of intense study, although 
regulatory factors remain to be fully elucidated. First the heterodimer tuberous sclerosis 1 
(TSC1) and tuberous sclerosis 2 (TSC2), serves to activate the GTPase-activating protein 
(GAP) Ras homolog enriched in brain (Rheb). GTPase has been shown to modulate 
mTORC1 activity (Laplante and Sabatini, 2012). The GTP-bound form of Rheb strongly 
activates mTORC1 kinase activity. TCS1/2 negatively regulates mTORC1 by converting 
Rheb to its GDP bound state, this regulator of mTORC1 activity integrates signals from a 
number of upstream stimuli (i.e., growth factors/insulin) (Laplante and Sabatini, 2012). 
Protein kinase B (akt/PKB) also acts directly by invoking dissociation of PRAS40 from 
mTORC1 (Laplante and Sabatini, 2012); stimulating its kinase activity. Amino acids 
activate mTORC1 activity through a TSC2 independent mechanism involving Rag-
GTPases. Conversely, Adenosine monophosphate-activated protein kinase (AMPK) acts 
as a negative regulator of mTORC1 activity, both directly and through activation of TSC2 
(Laplante and Sabatini, 2012). Finally, mitogen-activated protein kinase (MAP4k3), 
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mammalian vacuolar protein sorting 34 homolog (hVPS34), inositol polyphosphate 
monokinase (IPMK) and phosphatidic acid (PA) have all been implicated in mTORC1 
activity.  
Downstream of mTORC1 lie a number of relatively well characterised key cellular 
processes, responsible for maintenance and growth of skeletal muscle mass (Laplante and 
Sabatini, 2012).  mTORC1 is thought to regulate MPS via two primary mechanisms. First, 
the phosphorylation and inhibition of eukaryotic translation initiation factor 4E-binding 
protein 1 (4E-BP1), which prevents association with cap dependent protein eIF4E and 
enables formation of the eIF4F complex, thereby promoting cap dependent translation. 
Second, the phosphorylation and activation of ribosomal protein S6 kinase (p70S6K), 
which upregulates ribosomal biogenesis, mRNA translation initiation and elongation for 
MPS (Laplante and Sabatini, 2012). Thus, mTORC1-mediated signalling events play a 
critical role in the regulation of MPS (Wackerhage and Ratkevicius, 2008). A simplified 
schematic detailing the intracellular signalling mechanisms controlling skeletal muscle 
protein synthesis are illustrated in Figure 2.  
The translational regulation of MPS in response to exercise and nutritional stimuli is 
an important focus for integrative physiology researchers. It is typically demonstrated that 
mTORC1 and its downstream targets (i.e., 4E-BP1 and p70S6K) are rapidly 
phosphorylated and remains so for hours following, resistance, exercise (Burd et al., 
2010a, Mitchell et al., 2014). The activation of these proteins and their upstream signalling 
proteins are included in the analysis of acute exercise studies to gain mechanistic insight 
into the regulatory control of MPS in response to exercise. The impact that ageing exerts 




Figure  2. A simplified schematic representation of the intracellular signalling 





























1.3.3. Exercise, Nutrition and Muscle Anabolism 
Exercise, in particular resistance exercise, significantly modulates muscle 
(myofibrillar) protein turnover. The complexity involved in measuring MPS and MPB 
during an exercise bout means very few studies have attempted to do so (Carraro et al., 
1990). As a result, most studies have investigated the effect of exercise on MPS and MPB 
in the post-exercise recovery period (early- and late-phase). It has been consistently shown 
that resistance exercise is a potent stimulus for elevating MPS following exercise (Burd et 
al., 2010b). Typically, during acute substrate-specific stable isotope infusion trials, 
exercise increases MPS by ~100-220% over several hours post-exercise (Phillips et al., 
1997, Moore et al., 2009b), which remain elevated above basal rates for up to 48 h 
(Phillips et al., 1997). Exercise and feeding appear to work synergistically to maximally 
stimulate MPS and promote skeletal muscle remodelling (Moore et al., 2009b, Dreyer et 
al., 2008, Witard et al., 2014). The extent to which MPS is stimulated, and duration of this 
anabolic response, can be modulated by altering the training variables of the resistance 
exercise bout (i.e., load (Burd et al., 2010b), volume (Burd et al., 2010a), rest-interval 
(McKendry et al., 2016)) and is the subject of intense study.  
Frequent stimulation of MPS and net protein accretion through resistance exercise 
loading and amino acid provision, is thought to underpin increases in muscle mass 
(Phillips, 2004). However, there appears to be a large degree of incongruence between the 
acute increases in MPS, markers of anabolic signalling and the degree of muscular 
hypertrophy and strength development (Hubal et al., 2005). For example, Baar and Esser 
have shown, in rodents, that upregulation of signalling 6 hours following an acute bout of 
exercise is a good marker of muscle mass gain over time (Baar and Esser, 1999). Despite 
the lack of sufficient human data it has become all too common to extrapolate findings 
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from acute investigations of MPS as predictive of chronic changes in muscle mass 
(Murton and Greenhaff, 2013). The acute rise in MPS following a bout of resistance 
exercise was not related to the subsequent increase in muscle mass over a 16 week training 
period (Mitchell et al., 2014). The authors postulated that the lack of relationship between 
acute MPS and chronic muscle hypertrophy could be due to a number of factors, namely; 
the specificity of the muscle protein fraction measured (i.e., myofibrillar vs non-
myofibrillar), the inclusion of measures at later time points (i.e. >4 h post-exercise), or 
alterations to MPB throughout the training programme (Mitchell et al., 2014). It has 
recently been shown that elevated MPS at the beginning of a training programme are 
directed towards the repair of damaged muscle protein, with the continuation of the 
exercise stimulus for 10 weeks leading to a greater proportion of MPS being directed 
towards muscular hypertrophy (Damas et al., 2016). Nevertheless, the lack of a clear 
relationship precludes the use of acute MPS as a predictive tool for quantitative estimates 
in responsiveness to a resistance exercise training programme. Alternatively, it is apparent 
that stable isotopic tracer approaches such as D2O, that permit measurement of muscle 
protein turnover over longer periods, offer a logical step to characterise an individual’s 
muscle hypertrophic/remodelling responsiveness. 
The introduction of stable isotopic tracer methodologies has enabled exercise 
physiologists to study the complex mechanisms that govern muscle mass regulation (for  
comprehensive resources on stable isotopic tracer methodology see (Wolfe and Chinkes, 
2005) (Kim et al., 2016a) and (Wilkinson, 2018)). Administered orally, D2O rapidly 
equilibrates in body water and is incorporated into multiple metabolic pathways (lipid, 
glycogen, protein and RNA/DNA synthesis). D2O confers many benefits when compared 
with traditional tracer methodologies (Brook et al., 2017). The ease of administration and 
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maintenance of steady-state make measurements of bound product and precursor-labelling 
in saliva, over periods of hours-days-weeks-months (i.e., integrated MPS (iMPS)) feasible. 
In addition, study participants are able to continue their habitual daily activity, which 
enables the investigation of an individual’s muscle protein turnover in a ‘free-living’ 
environment without the confounding influence of the restrictive laboratory setting. 
Whereas, conducting an acute isotope infusion investigation within a strictly controlled 
laboratory setting is problematic when attempting to translate the study findings to chronic 
changes in muscle mass under free-living conditions (Mitchell et al., 2013). The 
advantages previously highlighted make D2O an ideal candidate to study human muscle 
protein metabolism. 
Chronic exercise training and individual training status, influences the MPS response 
to exercise. Previously, it has been shown that 8 weeks of unilateral resistance exercise 
alters the temporal pattern of MPS to acute exercise in young individuals (Tang et al., 
2008). In the untrained leg, mixed muscle FSR was elevated at 4 h post-exercise, and 
remained elevated above baseline for 28 h post exercise. In the trained leg, the amplitude 
of the mixed muscle MPS response was greater, and the duration of the MPS response 
shorter, compared with the untrained leg, returning to basal values by 28 h post-exercise. 
However, no change in myofibrillar MPS was evident following 8 weeks of leg resistance 
exercise training in another study (Kim et al., 2005).  The apparent difference between 
these studies is likely the specific protein fractions measured in which MPS was measured 
(i.e., mixed vs. myofibrillar protein). Alterations to acute MPS responsiveness are not 
limited to temporal changes, Wilkinson et al. (2008) demonstrated that the acute MPS 
response becomes exercise mode-specific following a period of endurance or resistance 
training, such that resistance training elicited an increase in the synthesis of myofibrillar 
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proteins (i.e. contractile) whereas endurance exercise stimulated an increase in 
mitochondrial protein synthesis (Wilkinson et al., 2008b). The individuals recruited in the 
studies previously highlighted were considered ‘trained’ following ~8-16 weeks of 
exercise training; whether or not the observed alterations to acute MPS would hold true in 
individuals who had been training for many years is unknown.  
Exercise is an effective treatment for the unfavourable shifts in body composition that 
occur with ageing. Both exercise modalities, resistance and endurance, have been shown 
to reduce visceral and subcutaneous body fat by ~4-10% with 16-32 weeks of training 
(Slentz et al., 2004, Ibanez et al., 2005). Additionally, it has been repeatedly shown that 
chronic resistance exercise increases skeletal muscle mass in both young (Mitchell et al., 
2012a, West and Phillips, 2012) and older individuals (Peterson et al., 2011). Thus, it has 
been effectively shown that both resistance and endurance exercise modalities may be 
effective tools to help slow the deterioration of body composition with advancing age 
(Harber et al., 2012, Harber et al., 2009, Peterson et al., 2011). As outlined earlier, the 
importance of increasing, or preserving, skeletal muscle mass is crucial for maintenance of 
physical function, independence and quality of life during later years. Thus, studies 
focussed on exercise interventions to maintain skeletal muscle mass, and the investigation 
of mechanisms responsible for its regulation, are vital.  
Exercise training induces significant alterations to skeletal muscle morphology. 
Changes in skeletal muscle morphology underpin the augmentation of muscle mass and 
subsequently physical function (Snijders et al., 2009), which is often compromised in 
older individuals. In young individuals, in response to chronic exercise training, studies 
have repeatedly demonstrated changes in architectural arrangement of skeletal muscle 
fibres (Brook et al., 2015, Kim et al., 2015) and muscle fibre hypertrophy (in particular 
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Type II) (McCall et al., 1996, Mitchell et al., 2013, Staron et al., 1990, Staron et al., 1994). 
Moreover, it has been shown in a number of studies that in response to an acute exercise 
stimulus, skeletal muscle robustly upregulates satellite cell number in the subsequent days 
(McKay et al., 2009, Snijders et al., 2014). Thus, when exposed to a chronic resistance 
exercise stimulus, it is thought that the satellite cell pool undergoes notable expansion 
(Kadi et al., 2005). However, the effect of exercise on other muscle morphological 
features is less clear. Studies investigating changes in skeletal muscle capillarisation 
(Hepple et al., 1997b, Hagerman et al., 2000) and myonuclei (Verdijk et al., 2014, Snijders 
et al., 2016) have yielded conflicting findings. Significant increases in myonuclei content 
have been reported (Verdijk et al., 2014) in response to exercise training whereas other 
studies have demonstrated no changes to the myonuclear content of human skeletal muscle 
(Snijders et al., 2016). This may indicate that with chronic exercise training, the age-
associated changes to skeletal muscle morphological features (i.e., reductions in fibre 
CSA, capillarisation, satellite cell no., myonuclei) may be preventable, however very few 
chronic training studies have been undertaken making this difficult to reconcile.  
For a long time, it was assumed that older individuals were unable to adapt to an 
exercise stimulus. This appears not to be the case, and with exercise training it has been 
shown that older individuals can successfully improve physical function (i.e., aerobic 
capacity and muscular strength) (Coggan et al., 1992, Schoenfeld et al., 2015). However, 
studies investigating whether exercise training in older adults can facilitate shifts in body 
composition and facilitate skeletal muscle morphological alterations yield conflicting 
findings. Previously, exercise training in older individuals has demonstrated that 
improvements in body composition are achievable (i.e., lower body fat and greater muscle 
mass) (Willis et al., 2012). Whereas, others have shown that with 6 weeks of resistance 
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training older individuals failed to increase muscle mass when compared with young 
(Brook et al., 2016), suggestive of a blunting to exercise adaptation. Therefore, with 
advancing age the idea that older individuals retain the capacity to adapt to exercise 
similarly to young individuals (Harber et al., 2012) remains contentious and warrants 
further investigation. 
1.3.4. Dysregulated Muscle Protein Turnover in Ageing 
An impairment in the capacity to upregulate MPS in response to anabolic stimuli 
in older individuals has been termed age-related muscle ‘anabolic resistance’ and is 
considered a primary contributor to the loss of skeletal muscle mass with advancing age. 
Early studies investigating differences in protein turnover between young and older adults 
concluded that reductions in the basal rates of MPS were the fundamental drivers of age 
related loss of muscle mass (Yarasheski et al., 1993, Welle et al., 1993). In addition, it has 
been suggested that elevations in basal MPB contribute to the loss of muscle protein in 
older individuals (Trappe et al., 2004). However, if reductions in basal MPS and 
elevations in basal MPB were responsible for muscle protein loss, it would likely occur at 
a much greater rate than is characteristically observed in older individuals (~1-1.5% per 
decade) (Hughes et al., 2001). It has been demonstrated that differences in the basal rates 
of MPS were imperceptible between younger and older individuals (Volpi et al., 2001), 
however the inability to upregulate MPS in response to the ingestion of essential amino 
acids (EAA) (Cuthbertson et al., 2004) and resistance exercise (Kumar et al., 2009) was 
evident in old compared with young individuals. This finding has been supported by data 
from a number of subsequent studies, and summarised in a recent systematic review (Shad 
et al., 2016). Conversely, a number of studies have shown no evidence of anabolic 
resistance in response to protein feeding and resistance exercise (Koopman et al., 2009, 
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Paddon-Jones et al., 2004, Symons et al., 2011). The discrepancies observed between 
those that identified anabolic resistance and those that did not, are most likely the result of 
experimental methodology differences used to investigate the MPS response. For example, 
i) manipulating exercise volume ii) the dose/source/matrix of protein provided iii) the 
specific subfractions of muscle protein measured iv) time frame of the MPS assessment as 
previously highlighted (Shad et al., 2016). Regardless, it is evident that throughout the 
ageing process a multitude of alterations occurs at various stages, impairing the ability of 
older muscle to upregulate MPS in response to typically anabolic stimuli and ultimately 
driving the progression of sarcopenia. Conceivably, the amount of habitual physical 
activity may also play a role in modifying the responsiveness of older muscles. Thus, it is 
imperative that investigations to delineate the relative contribution of ageing and 
increasing physical inactivity to the observed anabolic resistance, are pursued.  
 
1.3.5. Mechanisms of Age-related Muscle Anabolic Resistance 
The mechanisms regulating the impaired responsiveness of older muscle to 
anabolic stimuli (i.e., protein feeding and exercise) remain to be fully elucidated. Multiple 
theses for the development of anabolic resistance with ageing have been proposed (i.e., 
dysregulation of amino acid availability, delivery and perfusion, inflammation, alterations 
to anabolic signalling and reductions in physical activity) (Burd et al., 2013, Breen and 
Phillips, 2011). The complex mechanisms underpinning anabolic resistance is illustrated 
in Figure 3.  
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1.3.5.1. Protein Digestion, Absorption and Muscle Perfusion  
Protein digestion and absorption kinetics are modified with advancing age (Fujita and 
Volpi, 2004). Reduced protein (amino acid) availability may have significant 
consequences for skeletal muscle remodelling. Manipulating the dose, source and pattern 
of protein intake may be strategies employed to mitigate these impairments. It has been 
demonstrated that older individuals require significantly larger doses of protein in order to 
achieve the same degree of stimulation of MPS compared with young adults (Moore et al., 
2014). Perhaps a result of a greater degree of splanchnic extraction of the amino acid 
leucine in older individuals (Boirie et al., 1997). This would lead to a lower systemic 
availability of leucine, and likely other amino acids, for the upregulation of MPS and 
skeletal muscle remodelling. In addition, a reduction in skeletal muscle perfusion may be a 
significant contributor to the purported insensitivity of older muscle to anabolic stimuli. 
Impaired delivery and perfusion, thus nutritive blood-flow, of skeletal muscle has also 
been observed in older individuals (Fujita et al., 2009, Meneilly et al., 1995, Rasmussen et 
al., 2006) and when blood flow is restored pharmacologically, rates of MPS are restored 
(Timmerman et al., 2010). Conversely, resistance exercise training can enhance leg muscle 
microvascular blood flow, however this did not result in an augmented MPS response in 
older men (Phillips et al., 2015), making it difficult to draw firm conclusions regarding the 
effect of muscle perfusion on MPS. Furthermore, an increase in EAA availability in older 
muscle was not sufficient to stimulate an increase in the expression of amino acid 
transporters, L amino acid transporter (LAT1)/solute-linked carrier (SLC)7A5 and system 
amino acid transporter (SNAT2)/ solute-linked carrier (SLC)38A2, beyond that of 
resistance exercise (Dickinson et al., 2013). Taken together, this suggests that older 
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individuals require a considerably greater anabolic stimulus in order to stimulate MPS to 
the same extent as younger individuals.  
 
1.3.5.2. Inflammation and Obesity 
It is generally accepted that body fat increases with advancing age, and ageing 
promotes the redistribution of fat to ectopic regions; both of which are a significant health 
concern (Ortega et al., 2016). Computed tomography (CT) and immunohistochemistry 
have shown that adipose tissue accumulates in older muscle (Goodpaster et al., 2000a, 
Smeuninx et al., 2017, Goodpaster et al., 2000b). Increases in intramyocellular lipid 
(IMCL) content, may play a role in the observed reduction in anabolic sensitivity (Rivas et 
al., 2012, Pan et al., 1997). Ostensibly, this may occur through the activation of pro-
inflammatory cytokines (toll-like receptor 4, tumour necrosis factor alpha (TNFα), and 
nuclear factor kappa-light-chain enhancer of activated B cells (NFκB)) (Holland et al., 
2011) and lipid-induced insulin resistance (Stephens et al., 2015). Non-steroidal anti-
inflammatory drug (NSAID) have been shown to reduce the low grade inflammatory 
status experienced with ageing, postprandial MPS was significantly augmented compared 
to a control group (Rieu et al., 2009).  It should be noted that this study was conducted in 
largely heterogeneous rats which may explain some inconsistent findings. Moreover, a 
mechanistic link between C-Reactive Protein (CRP), a well-established biomarker of 
systemic inflammation, and the decline in muscle mass has been established (Wåhlin-
Larsson et al., 2017). Indicating that CRP may, in part, be responsible for deleterious 
changes with muscle mass and its regulation with advancing age. This effect may be 
mediated through activation of markers of stress and energy status (i.e., AMPK) and a 
reduction of in the phosphorylation of Akt and rpS6, both of which are implicated in 
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upregulating MPS in the mTORC1 Pathway. As a result, the prevention of ectopic fat 
accumulation and a reduction in the chronic low-grade inflammation with ageing should 
be a key concern. The continuation of exercise throughout life may act as a suitable 
countermeasure by promoting a healthy body composition.  
 
1.3.5.3. Sex Hormones 
Sex hormones play a major role in regulation MPS and MPB, and hormonal 
modifications are one of the many contributing factors towards the progression of 
sarcopenia (Narici and Maffulli, 2010). An optimal hormonal milieu provides the best 
systemic conditions in which to maintain skeletal muscle mass with advancing age. 
However, a decline in hormones responsible for skeletal muscle anabolism (i.e., growth 
hormone (GH), insulin-like Growth Factor 1 (IGF-1), testosterone along with other 
androgens) and an elevation in catabolic factors (i.e., IL-1, IL-6, TNF-⍺ and myostatin) 
shifts the stimulus towards catabolism (Narici and Maffulli, 2010). Beginning in the third 
decade, total testosterone concentrations decline at a rate of ~1% per year, simultaneously 
with a decrease in free testosterone and albumin-bound testosterone at ~2% year (Feldman 
et al., 2002). During menopause women undergo significant hormonal alterations, of 
which the decline in oestrogen is thought to have substantial consequences for women’s 
health; specifically, the accelerated loss of bone mineral density and subcutaneous fat 
accumulation (Messier et al., 2011). The canonical hormonal alterations observed with 
ageing have consequences for skeletal muscle. Reduced levels of free testosterone are 
associated with muscle mass loss (Yuki et al., 2013) and higher levels of total testosterone 
are associated with less muscle mass loss (LeBlanc et al., 2011), which may have 
significant consequences for the maintenance of physical function in older adults. It is well 
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documented that supraphysiological exogenous testosterone supplementation can enhance 
skeletal muscle mass and strength in young (Bhasin et al., 1996)  and older men (Ferrando 
et al., 2002, Neto et al., 2015). Even restoring testosterone in men aged 65 years to the 
mid-normal range of values for a young individual resulted in significant improvements in 
muscle mass (Snyder et al., 1999). Thus, hormonal modifications with advancing age may 
be an important intervention point for preventing declines muscle mass and physical 
function and promoting the extension of the healthspan.  
 
1.3.5.4. Intramuscular Anabolic Signalling 
It has been repeatedly demonstrated that ageing induces a dysregulation of 
intramuscular anabolic signalling (Guillet et al., 2004, Cuthbertson et al., 2004, Kumar et 
al., 2009, Fry et al., 2011). Guillet and colleagues were the first group to demonstrate that 
rates of mixed muscle and mitochondrial protein synthetic rates were lower in older 
individuals in a fasted state and in response to a hyperinsulinemic, euglycemic, 
hyperaminoacidemic clamp compared with younger individuals (Guillet et al., 2004). The 
observed deficit in MPS response occurred in association with a reduction in the degree of 
activation, by phosphorylation, of p70S6K. However, other signalling proteins (i.e., 4E-
BP1, mTORC1 and Akt) responded normally. In an attempt to undertake a more 
physiologically applicable investigation, insulin was clamped at basal levels and 10g of 
EAA were provided to establish whether the previously observed differences in MPS 
persisted between young and old. A blunted myofibrillar and sarcoplasmic MPS response 
was found in older individuals, concomitant with deficits in mTORC1 and p70S6K 
phosphorylation (Cuthbertson et al., 2004). Moreover, the acute MPS and intramuscular 
signalling response to resistance exercise across a spectrum of resistance exercise 
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intensities, showed that basal rates of MPS did not differ between young and old, however 
a sigmoidal dose-response relationship was noted with the overall MPS response being 
30% greater in the young compared with the old (Kumar et al., 2009). In addition, the FSR 
peak at 1-2 hours’ post-exercise was significantly greater in the young, and this was 
supported by significantly greater levels p70S6K and 4E-BP1 phosphorylation at 1-hour 
post-exercise. An acute bout of resistance exercise upregulated mixed muscle FSR in 
young, but not old, individuals and this occurred concurrently with enhanced 
phosphorylation of anabolic signalling markers implicated in skeletal muscle translational 
regulation (ribosomal protein S6 (rpS6), extracellular-regulated signal kinase 1/2 
(ERK1/2), mTORC1, p70S6K, 4E-BP1) (Fry et al., 2011). Thus, altered intramuscular 
signalling occurs concomitantly with age-associated blunting in MPS.  
 
1.3.5.5. Physical (In)activity and Disuse 
Reductions in physical activity are commonplace amongst the ageing community. 
It is recommended that older adults should undertake multicomponent physical activity 
that includes balance training as well as aerobic and muscle-strengthening activities 
(chronic conditions permitting) (Piercy et al., 2018). Recent estimates suggest that ~80% 
of adults in America are insufficiently active (Piercy et al., 2018). Similarly, 15% of older 
men and 10% of older females achieved the recommended physical activity guidelines 
when measured objectively by accelerometry (Jefferis et al., 2014). The lack of people 
meeting the recommended physical activity guidelines has dire consequences for the risk 
of developing disabling health conditions and premature mortality (Lee et al., 2012). The 
gradual declining physical activity levels punctuated by protracted periods of disuse in 
older populations are fundamental drivers of accelerated skeletal muscle atrophy (Alkner 
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and Tesch, 2004). As little as two weeks of reduced activity (undertaking ~1400 steps per 
day) was enough to induce anabolic resistance to feeding, of 25 egg white protein, and 
reduce leg lean mass by ~4% (Breen et al., 2013). Similar observations occur when 
physical activity is reduced by disuse (Wall et al., 2013) and immobilisation (Glover et al., 
2008). A reduction of muscle mass with immobilisation has been demonstrated in both 
young (Glover et al., 2008), and older (Breen et al., 2013) populations, and seems to be 
driven by reductions in postprandial MPS. The loss of muscle mass does not seem to be 
determined by alterations to basal postabsorptive MPS (Breen et al., 2013), and current 
evidence indicates older individuals demonstrate a blunted response to anabolic stimuli 
(i.e., exercise or feeding). Periods of immobilisation (i.e., bed rest, limb casting) and 
reductions in physical activity (i.e., sedentariness, reduced step-count), characteristics 
commonly observed in ageing populations, have devastating consequences for skeletal 
muscle (Dirks et al., 2016). One week of bed rest is enough to induce whole-body insulin 
resistance, reductions in muscle oxidative capacity and significantly decrease skeletal 
muscle mass and strength by 4 and 9 %, respectively (Dirks et al., 2016). During these 
periods MPB exceeds MPS, due to an increase in MPB or a decrease in MPS, or both and 
the problem is exacerbated by the inability to recover the responsiveness to anabolic 
stimuli following relatively short periods of disuse. When the daily activity of a group of 
older men and women was reduced to ~1000 steps per day (McGlory et al., 2018), the 
change in activity status was sufficient to induce a significant reduction in MPS. Which 
upon re-ambulation did not recover, following two weeks of returning to normal activity, 
demonstrating how damaging periods of disuse are for muscle mass maintenance.  
Physical activity may play an important role in preventing anabolic resistance, 
augmenting the MPS response and potentially slowing the progression of sarcopenia. 
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Acutely, when performing combined aerobic and resistance exercise prior to the ingestion 
of 20g protein the MPS response increased significantly compared with resting rates; 
importantly, this occurred irrespective of age (Pennings et al., 2011). However, it is yet to 
be determined whether older individuals that have continuously performed extremely high 
levels of physical activity for prolonged periods (i.e., years) are able to offset declines in 
anabolic sensitivity and MPS. The study of individuals that have done so would enable 
researchers to determine whether the observed deterioration is purely an effect of ageing 
or the consequence of physical inactivity.  
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Figure  3. Anabolic resistance is considered an important driver of skeletal muscle mass loss with ageing (sarcopenia). This figure illustrates 
























1.4. The Master Athlete: A Model for Healthy Musculoskeletal Ageing? 
The study of mechanisms of skeletal muscle ageing in a human population is 
problematic. Advances in technology and improvements in infrastructure have led to 
reductions in physical activity gradually since the 1900s (Booth and Lees, 2006). 
Presently, the strain placed on global healthcare systems necessitates interventions that 
promote extension of the healthspan. Primary ageing is often confounded by 
environmental influences which can accelerate the erosion of physiological function and 
health (Lazarus and Harridge, 2007). Frank Booth elegantly stated that “Being physically 
active is the body’s biological default position to maintain physiological function 
throughout the life course” (Harridge and Lazarus, 2017). Thus, in order to unravel the 
impact that primary ageing and alterations to physical activity status elicit on skeletal 
muscle function, mass, and morphology, it is imperative that an appropriate model is 
implemented. However, an important consideration in the study of MA is the selection 
bias that may limit the translatability of research findings to the wider populations. 
Specifically, not only are MA highly active, MA often demonstrate superior nutritional 
habits, a higher socioeconomic background, better education and may be genetically 
predisposed to superior physical function (Hannam et al., 2017). The recruitment of MA in 
older age also selectively employs those that have avoided serious injury or illness. 
Nevertheless, MA offer an exciting opportunity to investigate proposed ‘optimal ageing’, 
distinct from canonical increases in physical inactivity.  
 
1.4.1. Definition and Performance Characteristics of Master Athletes 
Individuals, typically ~35-80 y, that have continued to undertake structured 
exercise training and competition, are commonly referred to as ‘Master Athletes’ (MA) 
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(sometimes ‘veteran or senior athletes’). As physical activity is known to have a profound 
effect of physiological function, skeletal muscle mass and morphology, intuitively, older 
individuals that have maintained high levels of exercise throughout life are likely to 
display a superior range of physiological function and health parameters compared with 
older non-exercising individuals (Lazarus and Harridge, 2010). This poses the question of 
whether the continuation of exercise training throughout the life-course can offset age-
related impairments in skeletal muscle function, mass and morphology and subsequently 
extend the healthspan. The proposed decline in physiological function with increasing age 
and levels of physical activity (i.e., in sedentary and habitually active older individuals and 
MA) is depicted in Figure 4.  
The inclusion of MA in physiology research is not a novel idea. Some of the first 
work to incorporate physically well trained older athletes dates back to 1966, when it was 
shown that VO2max, along with other measures of cardiovascular physiology, declined with 
advancing age, despite continuous endurance training (Grimby and Saltin, 1966). A key 
focus of MA research studies since has been to examine world record performances across 
the age spectrum in these well-trained older individuals, to provide insight into the 
maximal capacity for successful integration of all bodily systems (Harridge and Lazarus, 
2017). As a result, there are substantial data illustrating that world record performances 
decline linearly with age until approximately the 8th decade, following which the rate of 
decline is greatly accelerated (Baker et al., 2003, Baker and Tang, 2010, Rittweger et al., 
2009, Tanaka and Seals, 2003). Nevertheless, world record performances in older athletes 
are astounding. For example, the current world record for i) 100 m sprint time for a 75-
year-old is 13.49 and 15.03 s for men and women, respectively, ii) 10,000 m for an 80-
year-old is 42:39 and 51:46 for men and women, respectively. It appears that chronic 
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training in MA does not necessarily help these individuals escape the decline in 
physiological function and health associated with inherent ageing. Nevertheless, 
advancements in experimental methodology and analytical techniques has enabled 
researchers to better understand the extent to which chronic exercise training offsets 
decrements in physiological function and performance in old age, and shed light on the 
mechanisms responsible for these alterations.  
1.4.2. Muscle Morphology and Function in Master Athletes 
Individuals that have continued to exercise throughout their lifespan consistently 
demonstrate superior physiological function (i.e., VO2max, muscular strength, physical 
function) compared with non-exercisers. Senior sportsmen exhibit greater muscular 
strength and physical performance than their older sedentary (untrained) counterparts, 
comparable to that of young healthy individuals (Zampieri et al., 2015). Nevertheless, MA 
still demonstrate a decline in VO2max (Faulkner et al., 2008, Wilson and Tanaka, 2000, 
Fitzgerald et al., 1997, Tanaka et al., 1997) and muscular strength/power (Goodpaster et 
al., 2006, Rittweger et al., 2009, Faulkner et al., 2008). Crucially, MA have a much larger 
physiological reserve capacity, thereby allowing for greater alterations to physical function 
before independence and quality of life are compromised. Given the importance of 
physical function and skeletal muscle health during the ageing process, it can be assumed 
that MA are far more likely to advance through later years without the presence of disease 
and disability. To date, our understanding of the mechanisms that dictate the age-
associated alterations in physical function in MA are still somewhat limited.  
In addition to studying the deterioration of physiological function in MA, the effect of 
exercise training throughout the life-course may offset the decline in skeletal muscle mass. 
However, there is no clear consensus regarding the impact that chronic exercise training 
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exerts on skeletal muscle mass maintenance. Previously, differences in skeletal muscle 
mass between endurance-trained MA and age-matched sedentary individuals have been 
undetectable (Carrick-Ranson et al., 2014). It has been shown that chronic endurance 
exercise training is able to preserve skeletal muscle mass (Wroblewski et al., 2011) and 
master rowers have greater total and regional lean mass compared with age-matched 
sedentary counterparts (Sanada et al., 2009). Conversely, older endurance trained men and 
women have significantly less fat-free mass than their younger endurance trained 
comparators (Proctor and Joyner, 1997). In summary, the effect of chronic endurance 
training on muscle mass maintenance appears equivocal. Conversely, it has been 
demonstrated that strength trained MA have significantly more lean body mass and greater 
strength than untrained individuals of the same age (Sallinen et al., 2008). However, the 
cross-sectional nature of this study prevents firm conclusions being drawn as to whether 
strength training prevent muscle mass loss in MA. Which may suggest, the maintenance of 
skeletal muscle mass with advancing age is dependent on the exercise training modality 
(resistance vs. endurance). Therefore, research stratifying the effects of chronic exercise 
training mode on muscle mass maintenance is of foremost importance.  
Similar to skeletal muscle mass, there is much debate about the effect of chronic 
exercise training on skeletal muscle architecture (Korhonen et al., 2006, Ojanen et al., 
2007) and fibre morphology (Korhonen et al., 2006, Aagaard et al., 2007a) in MA. 
Skeletal muscle architecture has previously been shown to be altered with ageing (Narici 
et al., 2003, Strasser et al., 2013). Despite continuous sprint training, Vastus Lateralis 
thickness is reduced with ageing, with no effect on fascicle length (Korhonen et al., 2006). 
Further, it has been shown that, relatively young, master throwers had significantly greater 
muscle thickness than older master throwers (Ojanen et al., 2007). These data indicate that 
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although muscle thickness decreases with advancing age, continuous resistance training 
may cause an upward shift in the trajectory of decline. That said, it appears endurance 
running in older age has little effect on skeletal muscle architecture (Stenroth et al., 2016). 
Alterations to muscle architecture have significant consequences for skeletal muscle 
function. As a result, more conclusive investigations into the effect that chronic exercise 
has on skeletal muscle architecture in MA are needed.  
The muscle loss experienced during ageing can largely be attributed to a Type II fibre 
atrophy (Nilwik et al., 2013) and fibre loss (McPhee et al., 2018). Due to the generally 
well accepted relationship between muscle cross-sectional area and the force generating 
capacity of muscle (Maughan, 1984), this may have severe functional implications. 
Whether or not the continuation of exercise in MA is able to prevent or attenuate muscle 
fibre atrophy, is much less clear. Strength trained older individuals had larger Type I fibres 
than endurance trained older individuals, and larger Type IIa and IIx fibres than untrained 
and endurance trained older individuals (Aagaard et al., 2007a). In addition, the 
distribution of the fibre-type reflected the training modality, with endurance trained older 
individuals displaying a greater proportion Type 1 fibres than untrained and strength 
trained older individuals. Whereas, others have been unable to detect any difference in 
fibre CSA between young, old, untrained old and master endurance runners (Mackey et 
al., 2014). However a recent study showed that young individuals had larger fibre 
diameter than senior sportsmen, from varied training backgrounds, and the senior 
sportsmen had a greater fibre diameter compared with sedentary seniors (young > senior 
sportsmen > sedentary seniors) (Zampieri et al., 2015). Plausibly, this may suggest that the 
continuation of exercise into later years can offset some of the age-related declines in fibre 
CSA, but not prevent them; though this requires further confirmation.  
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Beyond skeletal muscle mass, architecture and fibre CSA in MA, there is a paucity of 
studies investigating skeletal muscle microscopic and neuromuscular properties in this 
population. Two studies investigating the effects of ageing and chronic exercise on 
neuromuscular structure and function report conflicting findings. Initially it was shown 
that master runners were able to maintain the estimated number of motor units (MUNE), 
despite a reduced strength output, when compared with untrained young and older 
individuals (Power et al., 2010). However more recently, others have been unable to 
replicate this and instead report that chronic exercise training in master runners was not 
preventative of the decline in MUNE (Piasecki et al., 2016a). The discrepant findings 
between these studies are difficult to reconcile as both studies investigated the same 
muscle, using similar analytical methods. It may be that chronic exercise training, in MA, 
is able to protect other muscle fibre properties (i.e., capillarisation, satellite cells) from 
deterioration with older age. For example, Coggan et al. (1990) showed that muscle fibre 
capillarisation in MA was similar when compared with competitive young runners, 
however this did not prevent a reduction in VO2max in MA (Coggan et al., 1990). More 
recently these findings have been reinforced by work demonstrating that 50+ years of 
continuous endurance training preserved skeletal muscle capillarisation (Gries et al., 
2018). Again, it was shown that the decline in physiological function, in this case VO2max, 
was offset in the highly trained older individuals (i.e., young > MA > non-exercising older 
individuals). A gradual decline in capillarisation has been demonstrated in MA between 
~55 and 80 years, which is likely reflective of an inherent age-related decline (Pollock et 
al., 2018). Furthermore, only one study has investigated satellite cells in MA, and they 
highlight no differences in satellite cell content regardless of age or training status 
(Mackey et al., 2014). Which is perhaps surprising as studies often report a reduction of 
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Type II fibre specific satellite cell content. As a result, it appears that further research is 
required to fully elucidate the effect that the continuation of chronic exercise training 
exerts on the microscopic properties of skeletal muscle fibres (i.e., fibre CSA, 
capillarisation). Likewise, a number of morphological features require further 
investigation (i.e., myonuclei, satellite cells) in this unique population. This will deepen 
our understanding on the effects of inherent ageing on muscle morphological features, and 
shed light on the extent to which exercise can protect against losses that underpin 













Figure  4. Physiological function deteriorates with ageing, the portion of life that remains above the line for ‘Functional limitations, disease 
and disability’ represents healthspan. Increasing activity levels lead to an upward and rightward shift in the decline of physiological 
function, which reflects an increased period of time individuals experience life unburdened by poor health and functional limitations 




1.4.3 Muscle Protein Turnover in Master Athletes 
The maintenance of regulatory process that govern skeletal muscle turnover is 
critical with advancing age. Previously, only one study has investigated the impact that the 
maintenance of exercise training into later years exhibits on skeletal muscle protein 
metabolism (Doering et al., 2016). This study showed that master triathletes had lower 
(1.49%·d-1) iMPS rates than young triathletes (1.7%·d-1), measured over 3 d of 
consecutive training, in response to an initial downhill running exercise stimulus. In light 
of this, despite the continuation of exercise training in older age, MA may exhibit an 
impairment in the muscle remodelling process though this is yet to be confirmed. 
However, this was also reflected in the greater attenuation of performance in MA in 
response to the initial exercise bout. Nevertheless, the incorporation of an un-trained older 
cohort for comparison against MA, would have enabled the researchers to distinguish 
whether the observed differences in MPS, were the result of inherent ageing or due to 
aspects of secondary/biological ageing.  Further, it is essential that future studies include a 
basal measurement period of iMPS and confirm whether the muscle responsiveness to a 
bout of resistance exercise to describe the net muscle anabolic effect of exercise (i.e. 
difference between rest and exercise-induced iMPS).  
 
1.5. Thesis Aims and Objectives 
It is apparent that ageing exerts deleterious effects on skeletal muscle metabolism, 
morphology and function, that appear to be underpinned, in part, by inherent ageing 
processes and aspects of secondary/biological ageing. MA are a model of inherent ageing 
free from the confounding factor of biological ageing (i.e. inactivity), and generally 




counterparts. The mechanisms underpinning the benefits of chronic exercise training with 
advancing age have been only partially explored, indicating that the ‘normal’ age-related 
deterioration of physical function, muscle mass and morphology appears to be offset 
(shifted up and to the right). However, deeper insight into the regulatory processes that 
may protect MA muscle are less clear. The overarching aim of this thesis is to identify and 
address knowledge gaps regarding the impact that chronic exercise training exerts on 
skeletal muscle metabolism, morphology and function and to improve understanding of 
the mechanisms that govern these processes in MA. The specific aim of each thesis 
chapter is described below. 
First, the absence of a narrative/systematic review highlighted the need for a 
thorough synthesis and evaluation of the current status of the literature surrounding MA, 
and the extent to which chronic exercise training may preserve indices of skeletal muscle 
mass, function and morphology. Therefore, the focus of Chapter 2 was to identify what is 
already known regarding whether MA preserve physical function, muscular strength, mass 
and fibre properties compared with untrained age-matched individuals, as well as younger 
trained and untrained individuals.  
Second, although previous cross-sectional studies have been conducted in MA, to 
date, there are very few high-quality comprehensive cross-sectional studies characterising 
the physiological function, muscle mass and morphology in chronically trained MA. Thus, 
Chapter 3 reports a cross-sectional study that investigated whether MA have superior 
functional capacity, cardiorespiratory fitness, body composition, muscle strength, 
architecture and fibre-type properties compared with untrained healthy younger and 




Third, only one previous study has investigated whether the continuation of 
exercise training into older age is able to preserve muscle anabolic sensitivity to an 
exercise stimulus. However, a primary focus of the previous investigation was recovery 
from damaging exercise (i.e., downhill running) and it was not established whether 
differences exist in basal rates of iMPS, or whether differences exist between MA and 
older untrained individuals in response to an anabolic (resistance exercise) stimulus. 
Therefore, this area of research requires significant attention, and Chapter 4 reports a 
study that investigated whether basal and resistance exercise-induced iMPS differs 
between MA and age-matched untrained individuals, and characterised the acute 
intramuscular mechanisms coordinating the response.  
Finally, Chapter 5 discusses the main findings of the preceding chapters and 
details appropriate conclusions about the impact chronic exercise training, in MA, has on 
indices of skeletal muscle metabolism, morphology and function. Finally, this chapter 








2. Muscle Morphology and 
Performance in Master Athletes: A 







Introduction:  The extent to which chronic exercise training preserves age-related 
decrements in physical function, muscle strength, mass and morphology is unclear. Our 
aim was to conduct a systematic review of the literature to determine to what extent 
chronically trained master athletes (strength/power and endurance) preserve levels of 
physical function, muscle strength, muscle mass and morphology in older age, compared 
with older and younger controls and young trained individuals.  
Methods: The systematic data search included Medline, EMBASE, SPORTDiscus, 
CINAHL and Web of Science databases. Inclusion criteria: i) master athletes mean 
exercise training duration ≥20 years ii) master athletes mean age of cohort >59 years) iii) 
at least one measurement of muscle mass/volume/fibre-type morphology and/or 
strength/physical function.  
Results: Fifty-five eligible studies were identified. Meta-analyses were carried out on 
maximal aerobic capacity, maximal voluntary contraction and body composition. Master 
endurance athletes (42.0 ± 6.6 ml·kg-1·min-1) exhibited VO2max values comparable with 
young healthy controls (43.1 ± 6.8 ml·kg-1·min-1, P=0.84), greater than older controls 
(27.1 ± 4.3 ml·kg-1·min-1, P<0.01) and master strength/power athletes (26.5 ± 2.3 ml·kg-
1·min-1, P<0.01), and lower than young endurance trained individuals (60.0 ± 5.4 ml·kg-
1·min-1, P<0.01). Master strength/power athletes (0.60 (0.28 to 0.93) P<0.01) and young 
controls (0.71 (0.06 to 1.36) P<0.05) were significantly stronger compared with the other 
groups. Body fat % was greater in master endurance athletes than young endurance trained 
(-4.44% (-8.44 to -0.43) P<0.05) but lower compared with older controls (7.11% (5.70 to 




Conclusion: Despite advancing age, this review suggests that chronic exercise training 
preserves physical function, muscular strength and body fat levels similar to that of young, 

























The UK population is projected to increase by ~25% between 2013 and 2060, from 
64.1 to 80.1 million (Mitchell et al., 2012b) which heralds a demographic shift towards an 
ageing society. This changing demographic presents a significant and overwhelming 
challenge to healthcare provision in the UK (Holloszy, 2000). Indeed, although individuals 
are living longer (i.e., lifespan), many endure a large portion of their later years with a 
number of age-related comorbidities (Seals et al., 2016). Extending the length of time 
individuals remain healthy and disease-free (i.e. health-span) with an emphasis on 
compressing morbidity is therefore an important focus (Seals et al., 2016). Physical 
function (e.g., aerobic capacity and muscular strength) typically declines with advancing 
age and this is often highlighted as a principal risk factor for the development of a number 
of degenerative chronic health conditions (Niccoli and Partridge, 2012). However, it has 
been suggested that exercise throughout the lifespan (i.e., ‘chronic’ exercise training) can 
attenuate or even prevent age-related declines in physical function. Understanding 
whether, and to what extent, chronic exercise training preserves physical function, muscle 
strength, mass and morphology is of great importance in the pursuit of appropriate 
countermeasures to age-related health deterioration. 
Reductions of aerobic capacity (VO2max) and muscular strength are major risk 
factors for all-cause mortality in older age (Ortega et al., 2012, Ruiz et al., 2008, Lee et al., 
2011). VO2max and muscular strength are often considered robust measures of physical 
function and health as they require successful integration of the cardiovascular, respiratory 
and neuromuscular systems (Harridge and Lazarus, 2017). The gradual decline of these 
bodily systems with ageing ultimately reduces the ability of older individuals to carry out 




independence and a poorer quality of life (Sonn, 1996). Delineating the relative 
contribution of primary ageing and environmental influences (or secondary ageing) to the 
age-related decline in physical function, muscle strength, mass and morphology is 
problematic. One aspect of secondary aging that is considered to be particularly influential 
is habitual physical activity. The majority of older adults reduce habitual physical activity 
with advancing age (Blair, 2009), and this is often accompanied by the presence of at least 
one chronic disease (Hung et al., 2011). However, a small sub-set of the population, 
referred to as master athletes, are unique in that they have chronically undertaken and 
continue to maintain high levels of physical activity, including structured exercise 
training. Indeed, Zampieri and colleagues (Zampieri et al., 2015) demonstrated that senior 
sportsmen from varied training backgrounds exhibited muscular strength, performance, 
myofibre properties and function comparable with young, healthy individuals. These 
findings suggest that chronic exercise training can preserve physical function and skeletal 
muscle properties in older age. As such, the study of Master athletes may allow us the 
opportunity to distinguish the contribution of primary and secondary ageing to the age-
related decline in health, function and performance (Harridge and Lazarus, 2017, Lazarus 
and Harridge, 2007). However, Mackey and colleagues observed no difference in type I or 
type II fibre size between young and old regardless of training status, despite differences 
in VO2max; making it challenging to draw firm conclusions regarding the impact ageing 
and/or chronic endurance exercise elicits on fibre area (Mackey et al., 2014). To further 
complicate the variable findings in these unique individuals, Piasecki and colleagues 
demonstrated that the loss of muscle size, strength and motor units in the Tibialis anterior 
was similar between master endurance athletes and age-matched untrained controls 




quantitative summary of the existing literature surrounding the effect of chronic exercise 
training on indices of performance and skeletal muscle properties.  
Earlier comparisons between young and older individuals and master athletes have 
typically included master athletes younger than 60 y (Gent and Norton, 2013, Kusy and 
Zielinski, 2014, Maffulli et al., 1994). Specifically, this systematic review will focus on 
master athletes 60 y or older as these individuals would typically have begun to experience 
age-related decrements in physical function, muscle strength, mass and morphology 
(Janssen et al., 2000, Doherty, 2003). Additionally, most systematic review comparisons 
between young and older individuals and master athletes have focused on single outcome 
measures, specifically body composition (Ballor and Keesey, 1991), aerobic capacity 
(Fitzgerald et al., 1997, Wilson and Tanaka, 2000), muscular strength (Peterson et al., 
2010) adaptations to training (Daskalopoulou et al., 2017) and protein supplementation 
(Doering et al., 2015). Therefore, the primary aim of this systematic review was to 
establish whether older individuals who have undertaken chronic exercise training, 
preserve physical function, muscular strength, mass and fibre properties (i.e. size and 
relative distribution) compared with untrained age-matched individuals, as well as 
younger trained and untrained individuals. A secondary aim was to determine the 






2.3. METHODS  
 
2.3.1. Information sources and literature search 
A systematic literature search of online databases was conducted in November 
2017 using selected key words, free text terms, indexed terms, and Boolean operators. The 
search strategies were applied to Medline, EMBASE, SPORTDiscus, CINAHL and Web 
of Science databases. Recursive searching of the bibliographies of eligible studies and 
relevant reviews was performed to identify additional articles. The systematic review was 
conducted in accordance with the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) report (Moher et al., 2009).  
2.3.2. Study Selection Criteria 
2.3.2.1 Inclusion Criteria 
Studies were included in the review if they met the following inclusion criteria: 1) 
Exercise training for a minimum of 20 years in the master athletes group, explicitly stated 
within the study. 2) Mean age of older cohorts older than59 years. 3) Inclusion of at least 
one measurement of muscle mass/volume/fibre type morphology (fibre type, size, area) 
and/or a measurement of strength/physical function. 4) Muscle mass measurement using 
magnetic resonance imaging (MRI), computed tomography (CT), dual x-ray 
absorptiometry (DXA), air displacement plethysmography (BodPod), hydrostatic 
weighing, bioelectrical impedance analysis (BIA) or B-Mode ultrasonography.  Physical 
function/strength/performance measurements to include one, or more, of: handgrip 
strength, isometric/isotonic strength/power/torque or aerobic capacity (VO2max). 5) 
Freedom from any neurological, neuromuscular, cardiovascular and metabolic disease. 6) 




2.3.2.2. Exclusion Criteria 
Studies were excluded from the review if: 1) The authors did not explicitly state 
the length of time that master athletes had been continuously training, or if that time was 
less than 20 years. 2) No inclusion of relevant measures of muscle mass/morphology or 
physical function. 3) Relevant data could not be obtained directly from potentially eligible 
articles or via contact with the study authors.  
 
2.3.3. Participant criteria  
Sedentary older control groups were required to be of a similar age to master 
athlete groups (mean group >59 years) and have undertaken little, to no, structured 
exercise training. Older control groups did not have to be completely sedentary compared 
with master athlete groups. Young controls were required to be younger than 40 years, and 
have undertaken little to no structured exercise training. Young controls did not have to be 
completely sedentary compared with young trained individuals, who were required to be 
younger than 40 years and undertaking either structured endurance or strength/power-
based exercise training.  
 
2.3.4. Study Selection  
Titles and abstracts were screened for relevance by 2 reviewers (J.M. and B.J.S). 
Irrelevant titles were removed. Full-text articles were obtained for potentially relevant 
studies via a combination of online databases, hardcopy sourcing and direct contact with 
the authors, and these were further evaluated to determine whether they met the inclusion 




(J.M and B.J.S.) independently assessed full-texts for eligibility; any disagreements 
between the two reviewers were settled by consensus. All records were managed using the 
reference software EndNote (Thomson Reuters, v.X7). 
 
2.3.5. Data Extraction 
Predetermined variables were extracted from each of the included studies using a 
customised data extraction form (J.M and B.J.S). Measures of interest included participant 
characteristics (number, age, and anthropometrics), training type and duration, 
measurements of muscle mass, physical function (strength, aerobic capacity) and fibre-
type characteristics along with various aspects of study design/assessment (measurement 
tool or analytical method). In situations where the necessary data could not be obtained, 
either directly from the article or by contacting the corresponding authors of the paper, the 
study (or particular outcome measure) was excluded from review and/or meta-analysis.  
Where BMI was not reported, it was calculated manually from the reported mean height 
and weight of the study groups.  
 
2.3.6. Data Syntheses & Statistical Analyses  
Statistical analyses were dependent upon the number of studies obtained and the 
associated outcomes measures in the relevant studies. If sufficient studies incorporating an 
eligible analytical protocol were identified for a single outcome measure (e.g., VO2max), a 
meta-analysis was conducted. In cases where insufficient data were available from eligible 
studies to conduct a meta-analysis for a single outcome measure (e.g., muscle mass), 




Meta-analyses were performed on studies (and variables) which included direct 
comparisons (within study) between master athletes (power/endurance) and a non-
exercising older controls (older control) or young trained/non-trained groups. Meta-
analyses were carried out with a random effects model using RevMan software (Review 
Manager (RevMan) V.5.3. Copenhagen, The Nordic Cochrane Centre, The Cochrane 
Collaboration, 2014). Data in meta-analyses were presented as mean differences 
(MD)/standardised mean differences (SMD) ± 95% confidence interval (CI). Standardised 
mean differences were presented only for outcomes reported using non-comparable scales 
(i.e. muscular strength). All data were presented as mean ± SD, along with the number of 
studies/study groups reporting that particular variable and the number of participants 



















2.4.1. Study Selection 
A total of 14,572 studies were identified by the extensive literature search and a 
further 1 study was identified by manual searching of reference lists. Following removal 
of duplicates, 393 study titles and abstracts were screened resulting in 143 articles being 
excluded from the review; leaving 250 full texts to be independently screened (J.M and 
B.J.S). Figure 5 highlights the study identification, screening process and reasons for study 
exclusion. 
 





2.4.2. Study Characteristics 
The 55 included studies demonstrated substantial heterogeneity regarding the 
outcome measures and methodology (Table 1). Further, the participant characteristics 
displayed substantial incongruity, specifically the mode and level of exercise training, and 
the number of years training experience (Table 2). Twenty-one studies included young 
untrained control groups, 43 studies included 44 older control groups, 2 studies each 
included a young strength/power trained group, 11 studies included 12 endurance trained 
young groups and all studies included at least one master endurance and/or strength/power 
training group. 
 
2.4.3. Participant Characteristics  
The 55 eligible studies included 2449 participants (2181 were Male and 268 
Female). In short, included groups were master endurance athletes (67.3 ± 5.1 years, 1.73 
± 0.04 m, 71.6 ± 5.2 kg, 56 study groups, n=958) and master power athletes (71.7 ± 4.8 
years, 1.73 ± 0.03 m, 76.2 ± 8.0 kg, 15 study groups, n=218), older controls (67.9 ± 4.5 
years, 1.73 ± 0.03 m, 78.2 ± 6.2 kg, 44 study groups, n=746), young endurance trained 
(25.4 ± 3.1 years, 1.79 ± 0.03 m, 70.1 ± 5.0 kg, 13 study groups, n=143), young power 
trained (26.0 ± 1.6 years, 1.80 ± 0.02 m, 77.0 ± 0.4 kg, 3 study groups, n=47) and young 
controls (26.6 ± 3.9 years, 1.79 ± 0.03 m, 75.9 ± 5.0 kg, 23 study groups, n=337). The 
participant characteristics and anthropometrics of the sub-groups included in the review 





2.4.4. Training characteristics  
Experience – Master athletes had been training for 31.1 ± 9.3 (56 study groups, n=958) 
and 35.6 ± 9.6 (15 study groups, n=218) years for endurance and strength/power groups, 
respectively. Young athletes had been training for 6.1 ± 2.6 (13 study groups, n =143) and 
11.2 ± 5.5 (3 study groups, n=47) years for endurance and strength/power groups, 
respectively. 
Frequency - The included groups reported similar training frequency 4.6 ± 1.4, 3.6 ± 1.1, 
5.0 ± 0.8 and 4.1 ± 2.5 times per week, for master endurance (21 study groups, n=339), 
master strength/power (7 study groups, n=111), young endurance (4 study groups, n=66) 
and young strength/power trained groups (2 study groups, n=35), respectively.  
Duration – The included groups reported a similar number of training hours per week; 
master endurance 6.8 ± 3.0 h (19 study groups, n=298), master strength/power 6.3 ± 0.7 h 
(8 study groups, n=164) young endurance 7.7 ± 3.6 h (6 study groups, n=45) and young 
strength/power 10.0 ± 2.1 h (2 study groups, n=42), respectively.   
Distance - Seventeen study groups of master endurance (44.5 ±10.8 km, n=302) and 3 
study groups of young endurance trained athletes (44.7 ± 2.9 km, n=30) completed similar 
weekly cycling distance. 
 
2.4.5. Fat-Free Mass 
A total of 12 studies (Carrick-Ranson et al., 2014, DubÉ et al., 2016, Hawkins et 
al., 2001, Hayes et al., 2015, Marcell et al., 2003, Marcell et al., 2014, Pollock et al., 2015, 




Yataco et al., 1997) reported indices of whole body fat-free mass (FFM) using DXA, 
hydrostatic weighing or bioelectrical impedance. Nineteen study groups included master 
endurance athletes (55.2 ± 6.1 kg FFM, n=366), 5 study groups included older controls 
(54.5 ± 7.7 kg FFM, n=122), 1 study group included young controls (53.8 ± 5.7 kg FFM, 
n=23) and 4 study groups included young endurance trained individuals (54.8 ± 7.3 kg 
FFM, n=56).  
 
2.4.6. Fat Mass 
Only three studies (DubÉ et al., 2016, Schmidt et al., 2015, Yataco et al., 1997) 
reported measures of whole-body fat mass (FM) measured using DXA or hydrostatic 
weighing. Three study groups included master endurance athletes (14.1 ± 3.6 kg FM, 
n=91), 2 study groups included older untrained individuals (20.1 ± 6.3 kg FM, n=65) and 
1 study group included young endurance trained individuals (12.0 ± 4.2 kg FM, n=14).  
 
2.4.7. Body Fat Percentage 
A meta-analysis was conducted for body fat % for studies that made direct 
comparisons with master endurance athletes (Figure 6); this allowed for the greatest 
number of within-study comparisons to be incorporated into the statistical analysis. 
Twenty-nine studies (Aagaard et al., 2007a, Arbab-Zadeh et al., 2004, Ari et al., 2004, 
Bjork et al., 2012, Buford et al., 2010, Buyukyazi, 2004, Carrick-Ranson et al., 2014, 
Cristea et al., 2008, DubÉ et al., 2016, Hawkins et al., 2001, Hayes et al., 2015, Katzel et 
al., 1998, Korhonen et al., 2006, Korhonen et al., 2012, Marcell et al., 2003, Marcell et al., 




Pollock et al., 2015, Proctor and Joyner, 1997, Sallinen et al., 2008, Sanada et al., 2009, 
Schmidt et al., 2015, Tarpenning et al., 2004, Trappe et al., 2013, Witkowski et al., 2010, 
Yataco et al., 1997) reported data for body fat percentage measured using bioelectrical 
impedance, DXA, hydrostatic weighing or multiple-site skinfold. Thirty study groups 
included master endurance athletes (19.7 ± 3.8 %, n=594), 11 study groups included 
master strength/power athletes (16.4 ± 4.4 %, n=136), 19 study groups older control (24.5 
± 4.6 %, n=361), 5 study groups included young endurance trained (15.4 ± 5.2 %, n=63), 2 
study groups included young strength/power trained individuals (14.1 ± 3.5 %, n=42) and 
8 study groups included young controls (17.4 ± 3.0 %, n=126). 
Master endurance athletes had a significantly lower body fat % than older control 
individuals (P<0.01), and a significantly greater body fat % than young endurance trained 
(P<0.05). No significant differences were observed in the body fat % between master 
endurance athletes when compared with young controls and master strength/power 
athletes. Young strength/power trained individuals were not included in the meta-analyses 







Figure 6.  Forest plot of the results from a random-effects meta-analyses shown and mean 
difference with 95% CI on body fat % in old control, master power athletes, endurance trained 
young and young control. The vertical dotted line represents the body fat for the master 
endurance athletes. For each study the square represents the mean difference with the 
horizontal line indicating the upper and lower limits of the 95% CI. The size of the square 
indicates the relative weighted contribution of each study to the meta-analyses. The diamond in 
each section indicates the pooled mean difference for each respective group. Master endurance 
athletes vs. old control: Heterogeneity: 7.11 (5.70, 8.52) Tau² = 5.36; Chi² = 71.00, df = 14 (P 
< 0.00001); I² = 80% Test for overall effect: Z = 9.89 (P < 0.00001). Master endurance 
athletes vs. master power athletes: -1.00 (-7.61, 5.61) Heterogeneity: Not applicable Test for 
overall effect: Z = 0.30 (P = 0.77). Master endurance athletes vs. young control: -0.22 (-3.72, 
3.28) Heterogeneity: Tau² = 13.08; Chi² = 17.30, df = 5 (P = 0.004); I² = 71% Test for overall 
effect: Z = 0.12 (P = 0.90). Master endurance athletes vs. young endurance trained: -4.44 (-
8.44, -0.43) Heterogeneity: Tau² = 15.10; Chi² = 16.76, df = 4 (P = 0.002); I² = 76% Test for 




2.4.8. Maximal Oxygen Consumption (VO2max) 
A meta-analysis was conducted for VO2max for studies that made direct 
comparisons with master endurance athletes (Figure 7); this allowed for the greatest 
number of within-study comparisons to be incorporated into the statistical analysis. 
VO2max was measured in 43 studies (Aagaard et al., 2007a, Anselme et al., 1994, Arbab-
Zadeh et al., 2004, Ari et al., 2004, Bhella et al., 2014, Bjork et al., 2012, Buford et al., 
2010, Buyukyazi, 2004, Carrick-Ranson et al., 2014, DubÉ et al., 2016, Franzoni et al., 
2005, Galetta et al., 2005, Galetta et al., 2006, Hawkins et al., 2001, Hayes et al., 2015, 
Katzel et al., 1998, Katzel et al., 2001, Mackey et al., 2014, Marcell et al., 2003, Marcell 
et al., 2014, Matelot et al., 2016, Mikkelsen et al., 2013, Molmen et al., 2012, Mortensen 
et al., 2012, Mucci et al., 1999, Nyberg et al., 2012, Ojanen et al., 2007, Pollock et al., 
2015, Prasad et al., 2007, Prefaut et al., 1994, Proctor and Joyner, 1997, Rivier et al., 
1994, Sanada et al., 2009, Schmidt et al., 2015, Shibata and Levine, 2012, Sundstrup et al., 
2010, Suominen and Rahkila, 1991, Tarpenning et al., 2004, Thomas et al., 2013, Trappe 
et al., 2013, Witkowski et al., 2010, Yataco et al., 1997) using treadmill or cycle/rowing 
ergometer protocols. All studies reported the data relative to bodyweight (ml.kg-1.min-1). 
Forty-nine study groups included master endurance athletes (42.0 ± 6.6 ml.kg-1.min-1, 
n=889), 3 study groups included master power athletes (26.5 ± 2.3 ml.kg-1.min-1, n=37), 
32 study groups included older controls (27.1 ± 4.3 ml.kg-1.min-1, n=602), 13 study groups 
included young endurance trained individuals (60.0 ± 5.4 ml.kg-1.min-1, n=143) and 16 
study groups included young controls (43.1 ± 6.8 ml.kg-1.min-1, n=221). VO2max was 
higher in master endurance athletes than older controls (P<0.0001) and master power 
athletes (P=0.0005). VO2max was higher in endurance trained young than all other groups 




strength/power athletes (P<0.01). No significant differences were observed between young 
controls and master endurance athletes or between older controls and master 
strength/power athletes.  Young strength/power trained individuals were not included in 
the meta-analyses as no eligible studies made direct within-study comparisons with the 
other included groups. 
2.4.9. Strength 
Maximal voluntary contraction (MVC) was measured in 16 studies (Aagaard et al., 
2007a, Couppe et al., 2014, Korhonen et al., 2006, Korhonen et al., 2012, Marcell et al., 
2014, Mikkelsen et al., 2013, Mosole et al., 2014, Pollock et al., 2015, Power et al., 2012, 
Power et al., 2010, Sanada et al., 2009, Sipila and Suominen, 1991, Stenroth et al., 2016, 
Sundstrup et al., 2010, Suominen and Rahkila, 1991, Tarpenning et al., 2004, Zampieri et 
al., 2015); 9 studies with 22 study groups were included in a meta-analysis. A meta-
analysis was conducted for studies that made direct comparisons with master endurance 
athletes (Figure 8); to allow for the greatest number of within-study comparisons to be 
incorporated into the statistical analysis. Due to the diversity of measurement 
scales/methods of assessment (i.e. knee extension, plantar flexion, elbow flexion and 
handgrip dynamometry) data are presented as SMD ± 95% CI in Figure 8. MVC was 
significantly greater in master strength/power athletes (0.60 (0.28, 0.93)) and young 
healthy controls (0.71 (0.06, 1.36)) than master endurance athletes P<0.01 and P<0.05, 
respectively. No significant differences were observed in MVC between master endurance 
athletes when compared with older controls and young endurance trained individuals. 
Young strength/power trained individuals were not included in the meta-analyses as no 






Figure 7. Forest plot of the results from a random-effects meta-analyses shown and mean 
difference with 95% CI on VO2max (ml.kg-1.min-1) in old control, master power athletes, 
endurance trained young and young control. The vertical dotted line represents the VO2max for 
the master endurance athletes. For each study the square represents the mean difference with 
the horizontal line indicating the upper and lower limits of the 95% CI. The size of the square 
indicates the relative weighted contribution of each study to the meta-analyses. The diamond in 
each section indicates the pooled mean difference for each respective group. Master endurance 
athletes vs. old control: -15.41 (-17.39, -13.43) Heterogeneity: Tau² = 28.97; Chi² = 439.62, df 
= 31 (P < 0.00001); I² = 93% Test for overall effect: Z = 15.27 (P < 0.00001). Master 
endurance athletes vs. master power athletes: -7.77 (-12.03, -3.50) Heterogeneity: Tau² = 9.37; 
Chi² = 6.54, df = 2 (P = 0.04); I² = 69% Test for overall effect: Z = 3.57 (P = 0.0004). Master 
endurance athletes vs. young control: 0.55 (-4.88, 5.98) Heterogeneity: Tau² = 116.92; Chi² = 
547.90, df = 15 (P < 0.00001); I² = 97% Test for overall effect: Z = 0.20 (P = 0.84). Master 
endurance athletes vs. young endurance trained: 16.79 (13.50, 20.09) Heterogeneity: Tau² = 
31.81; Chi² = 128.46, df = 12 (P < 0.00001); I² = 91% Test for overall effect: Z = 9.99 (P < 





Figure 8. Forest plot of the strength results from random-effects meta-analyses shown presented 
as standardised mean difference with 95% CI in master power athletes, old control, endurance 
trained young and young control. The vertical dotted line represents the master endurance 
athletes. For each study the square represents the standardised mean difference with the 
horizontal line indicating the upper and lower limits of the 95% CI. The size of the circle 
indicates the relative weighted contribution of each study to the meta-analyses. The diamond in 
each section indicates the pooled mean difference for each respective group Master endurance 
athletes vs. master power athletes: 0.60 [0.28, 0.93] Heterogeneity: Tau² = 0.00; Chi² = 3.68, df 
= 4 (P = 0.45); I² = 0% Test for overall effect: Z = 3.63 (P = 0.0003). Master endurance athletes 
vs. old control: -0.25 [-0.77, 0.27] Heterogeneity: Tau² = 0.48; Chi² = 36.17, df = 8 (P < 
0.0001); I² = 78% Test for overall effect: Z = 0.93 (P = 0.35). Master endurance athletes vs. 
young control: 0.71 [0.06, 1.36] Heterogeneity: Tau² = 0.47; Chi² = 18.91, df = 5 (P = 0.002); I² 
= 74% Test for overall effect: Z = 2.13 (P = 0.03). Master endurance athletes vs. young 
endurance trained: 0.75 [-0.34, 1.85] Heterogeneity: Tau² = 0.78; Chi² = 12.12, df = 2 (P = 




2.4.10. Muscle Architecture 
Three studies reported muscle architecture outcomes (Korhonen et al., 2006, 
Ojanen et al., 2007, Sipila and Suominen, 1991); included in those studies were 
measurements of muscle thickness (3 studies) and fascicle length (1 study). Of the studies 
that measured muscle thickness, one study (Korhonen et al., 2006) used the midpoint of 
the vastus lateralis in young controls 18-33 y (2.61 ± 0.08 cm, n=16) and master sprinters 
of 60-69 (2.1 ± 0.09 cm, n=21) and 70-84 y (1.96 ± 0.08 cm, n=20). Another study 
(Ojanen et al., 2007) summed muscle thickness measurements of the vastus lateralis and 
vastus intermedius in master throwers of 65 (3.9 ± 0.7 cm, n=12) and 70 (3.7 ± 0.7 cm, 
n=9) years compared with older controls, 60 (3.8 ± 0.4 cm, n=10) and 75 (3.1 ± 0.2 cm, 
n=5), with no differences between the groups. The final study (Sipila and Suominen, 
1991)  measured muscle thickness of the rectus femoris, finding no difference between 
master strength/power athletes (2.73 ±0.37 cm, n=7), master endurance athletes (2.77 ± 
0.39 cm, n=14) and older controls (2.8 ± 0.56 cm, n=11). One study (Korhonen et al., 
2006) included measurements of vastus lateralis fascicle length which identified no 
significant differences between the groups of 18-33 year olds (7.91 ± 0.49 cm, n=16), 60-
69 (7.99 ± 0.27 cm, n=21) and 70-84 (7.38 ± 0.27 cm, n=20) year old sprint athletes.  
 
2.4.11. Muscle Cross-Sectional Area 
Four studies (Couppe et al., 2014, Mikkelsen et al., 2013, Rantalainen et al., 2014, 
Sipila and Suominen, 1991)  reported muscle CSA; two of which used MRI at the mid-
thigh level, another used mid-thigh CSA with B-mode ultrasonography and another study 
used p-QCT to measure mid-tibia muscle CSA. Mid-thigh muscle CSA was reported in 




with older individuals and also greater in trained individuals compared with untrained 
controls; young endurance trained (7859 ± 636 mm2, n=10), young controls (6792 ± 696 
mm2, n=12), master endurance trained (6481 ±775 mm2, n=15) and older controls (5504 ± 
727 mm2, n=12) (Couppe et al., 2014, Mikkelsen et al., 2013). Muscle CSA measured 
using ultrasonography in another study did not identify any differences between master 
power athletes (5250 ± 1080 mm2, n=7), master endurance athletes (5270 ± 880 mm2, 
n=14) or older controls (4840 ±1110 mm2, n=11) (Sipila and Suominen, 1991).  CSA of 
the mid-tibia region indicated that exercising individuals have a larger muscle CSA than 
non-exercising individuals and young individuals have a larger mid-tibia muscle CSA than 
older controls with no age-group interaction observed (Rantalainen et al., 2014); young 
power athletes (7140 ± 820 mm2, n=26), young control (7040 ± 1310 mm2, n=41), master 
power athletes (6270 ± 910 mm2, n=35), older controls (5890 ± 890 mm2, n=24).  
 
2.4.12. Muscle Fibre Area 
In total 9 studies (Aagaard et al., 2007a, Cristea et al., 2008, Korhonen et al., 2006, 
Larsson et al., 1997, Mackey et al., 2014, Mosole et al., 2014, Sundstrup et al., 2010, 
Tarpenning et al., 2004, Zampieri et al., 2015) measured muscle fibre morphology 
(type/distribution), including measures of type I, type II, type IIa, type IIx, type IIax and 
denervated fibres; using a variety of analytical techniques. 
  Type 1 fibre area was reported in 5 groups of master endurance athletes (5367 ± 
588 µm2, n=74), 4 groups of master power athletes (4750 ± 1273 µm2, n=34), 3 groups of 
older controls (5488 ± 459 µm2, n=28), 2 groups of young controls (4282 ± 26 µm2, n=28) 




Type 2 fibre area was reported in 3 groups of master endurance athletes (4478 ± 
347 µm2, n=55), 1 group of older controls (4149 ± 903 µm2, n=12) 1 group of young 
controls (4783 ± 872 µm2, n=12) and 1 group of young endurance trained (5498 ± 1559 
µm2, n=10).  
Type 2a fibre area was reported in 2 groups of master endurance athletes (5043 ± 
41 µm2, n=19), 4 groups of master strength/power athletes (4755 ± 1404 µm2, n=34), 2 
groups of older controls (5411 ± 484 µm2, n=16) and 1 young control group (4700 ± 560 
µm2, n=16).  
Type 2x fibre area was reported in 2 groups of master endurance athletes (3955 ± 
88 µm2, n=19), 4 groups of master strength/power athletes (4019 ± 990 µm2, n=34), 2 
groups of older controls (3794 ± 0 µm2, n=16) and 1 young control group (3200 ± 2720 
µm2, n=16).  
Type 2ax fibre area was reported in 1 young control group (3700 ± 760 µm2, n=16) 
and 3 groups of master strength/power athletes (4120 ± 495 µm2, n=27). 
 
2.4.13. Muscle Fibre Distribution 
Type 1 fibre distribution was reported in 7 groups of master endurance athletes 
(60.8 ± 10.7 %, n=96), 5 groups of master strength/power athletes (48.0 ± 8.0 %, n=59), 6 
groups of older controls (49.8 ± 4.2 %, n=45), 4 young control groups (43.5 ± 4.5 %, 




Type 2 fibre distribution was reported in 5 groups of master endurance athletes 
(38.4 ± 11.3 %, n=77), 3 groups of older controls (50.3 ± 4.0 %, n=27), 2 young control 
groups (53.5 ± 5.0 %, n=17) and 2 young endurance trained groups (48.6 ± 13.5 %, n=15).  
Type 2a fibre distribution was reported in 2 groups of master endurance athletes 
(32.6 ± 10.7 %, n=19), 5 groups of master strength/power athletes (31.8 ± 3.8 %, n=59), 2 
groups of older controls (23.5 ± 0 %, n=16) and 1 young control group (35 ± 12 %, n=16).  
Type 2x fibre distribution was reported in 3 groups of master endurance athletes 
(10.3 ± 2.7 %, n=21), 5 groups of master strength/power athletes trained individuals (10.7 
± 4.1 %, n=59) 3 groups of older controls (22.2 ± 13.1 %, n=18) and 2 young control 
groups (7.5 ± 6.4 %, n=20). 
Type 2ax fibre distribution was reported in 2 groups of master endurance athletes 
(6.3 ± 8.1 %, n=9), 4 groups of master strength/power athletes (11.6 ± 2.6 %, n=52), 2 
groups of older controls (5.9 ± 5.8 %, n=8), 2 young control groups (12.0 ± 00 %, n=20) 
and 1 groups of young endurance trained individuals (0.5 ± 0.6 %, n=5). 
The percentage of denervated fibres, defined as fibre size smaller than 30µm, was 
reported in 2 groups of master endurance athletes (1.9 ± 0.1 %, n=22), 2 groups of older 
controls (5.3 ± 1.8 %, n=15) 1 young control group (0.3 ± 0.0 %, n=5) nand1 young 





To our knowledge, this is the first systematic review and meta-analyses to focus on 
the effect of long-term exercise (i.e., endurance or strength/power) on physical function, 
muscular strength, muscle mass and morphology, to understand whether chronic exercise 
training preserves these parameters compared with age-matched untrained individuals, as 
well as younger trained and untrained individuals. There has been considerable debate 
about the relative contribution of primary and secondary ageing to the deterioration in 
performance and skeletal muscle parameters and whether or not this deterioration is 
inevitable in ageing. Our principal findings demonstrate that master endurance athletes are 
able to completely prevent the decline in VO2max found in age-matched untrained 
individuals; to values similar to those observed in young untrained individuals. In 
addition, we demonstrate that master strength/power athletes possess greater strength 
compared with age-matched master endurance athletes and untrained individuals; 
comparable with young untrained individuals. Further, all master athletes maintained a 
similar body fat percentage to untrained young controls, whereas untrained older 
individuals had a higher body fat percentage than endurance trained young. In the absence 
of structured exercise training, many older individuals displaying impairments in exercise 
performance and functional capacity (Tanaka and Seals, 2008), increased fat and reduced 
lean mass (Evans and Campbell, 1993) and changes to muscle fibre morphology (i.e. fibre 
atrophy and shifts in fibre sub-type) (Zampieri et al., 2015). Nevertheless, our findings, as 
well as those of others, demonstrate that older individuals maintain the capacity to adapt to 
exercise stimuli (Malbut et al., 2002, Newton et al., 2002). The results from this review 
highlight that regardless of the exercise modality (i.e., endurance or strength/power), 




function and body composition. The maintenance/continuation of structured exercise 
training into older age may therefore be seen as the cornerstone to optimal ageing and 
extension of the health-span in our ageing population.   
 
2.5.1 VO2max  
The reduction in function of multiple bodily systems observed with ageing leads to 
a decline of VO2max at a rate of equivalent to ~10-12% per decade (or ~1% per annum)  
(Rogers et al., 1990). Cardiorespiratory fitness is independently associated with all-cause 
mortality regardless of age, smoking status, body composition, and other risk factors (Lee 
et al., 2011, Lee et al., 2010) and thus a high VO2max may be protective against premature 
mortality. Meta-analysis comparisons revealed a 57% (15.4 ml·kg-1·min-1) greater VO2max 
in master endurance athletes compared with age-matched untrained individuals. 
Furthermore, master endurance athletes exhibited a greater VO2max (7.8 ml·kg-1·min-1) 
than master strength/power athletes. Collectively, these findings highlight that age-related 
declines in VO2max can be prevented by chronic exercise in an exercise mode-specific 
manner. 
The reduction in VO2max reported in master athletes appear to begin at the same age 
and decline at a similar (Faulkner et al., 2008, Wilson and Tanaka, 2000), if not greater 
((Tanaka et al., 1997, Fitzgerald et al., 1997, Eskurza et al., 2002)), rate compared with 
age-matched untrained individuals; providing evidence that despite continuous endurance 
exercise training there is an unavoidable decline of aerobic capacity. It is proposed that as 
age progresses, master athletes undergo a greater alteration to their activity status (e.g. 
training intensity and volume) (Eskurza et al., 2002, Fitzgerald et al., 1997), which may 




et al., 1997). However, the studies included in the current review highlighted no 
observable difference in training frequency (Aagaard et al., 2007a, Bhella et al., 2014, 
Buyukyazi, 2004, Carrick-Ranson et al., 2014, Couppe et al., 2014, DubÉ et al., 2016, 
Franzoni et al., 2005, Galetta et al., 2005, Galetta et al., 2006, Korhonen et al., 2006, 
Korhonen et al., 2012, Larsson et al., 1997, Marcell et al., 2003, Marcell et al., 2014, 
Molmen et al., 2012, Ojanen et al., 2007, Power et al., 2010, Sallinen et al., 2008, Sanada 
et al., 2009, Sipila and Suominen, 1991, Sundstrup et al., 2010, Witkowski et al., 2010, 
Yataco et al., 1997, Zampieri et al., 2015), distance (Arbab-Zadeh et al., 2004, Couppe et 
al., 2014, Hawkins et al., 2001, Mackey et al., 2014, Marcell et al., 2003, Marcell et al., 
2014, Mikkelsen et al., 2013, Power et al., 2010, Shibata and Levine, 2012, Stenroth et al., 
2016, Suominen and Rahkila, 1991, Tarpenning et al., 2004, Thomas et al., 2013, 
Witkowski et al., 2010) and session duration (Ari et al., 2004, Bjork et al., 2012, Buford et 
al., 2010, Buyukyazi, 2004, Carrick-Ranson et al., 2014, Couppe et al., 2014, Korhonen et 
al., 2006, Korhonen et al., 2012, Matelot et al., 2016, Mortensen et al., 2012, Mosole et al., 
2014, Mucci et al., 1999, Nyberg et al., 2012, Proctor and Joyner, 1997, Rantalainen et al., 
2014, Rivier et al., 1994, Sanada et al., 2009, Schmidt et al., 2015, Stenroth et al., 2016, 
Suominen and Rahkila, 1991, Trappe et al., 2013, Zampieri et al., 2015) between younger 
and older endurance athletes; although alterations to training intensity cannot be excluded 
as none were reported. VO2max values included in this meta-analysis were ~32% lower in 
master endurance athletes (42 ± 6.6 ml·kg-1·min-1) than young endurance trained 
individuals (62.0 ± 5.4 ml·kg-1·min-1), which is supported by recent research 
demonstrating an inescapable reduction in VO2max in master endurance athletes, despite 
continuous levels of endurance exercise training (Everman et al., 2018). It is beyond the 




studies were incorporated. Regardless of the rate at which VO2max declines with age, the 
maintenance of endurance-type exercise and thus cardiorespiratory fitness are paramount 
to offset age-associated health decrements. The greater VO2peak in these highly trained 
master athletes may therefore allow larger reductions to occur before reduced physical 
capacity and functional independence is compromised, compared with age-matched 
untrained individuals.  
Although not established in the current review, it is generally acknowledged that 
reduced physical activity is a key contributor towards the development of disease, 
disability and physical dysfunction (Booth et al., 2012). Continuation of exercise training 
may protect against the deterioration of health status and age-associated co-morbidities, by 
commencing the decline in bodily function from an elevated VO2peak the ageing process 
reflects inherent ageing uncompromised by inactivity (Harridge and Lazarus, 2017). From 
a mechanistic perspective, the parameters that determine VO2max (cardiac output and 
arterio-venous difference) are known to decrease with advancing age; inclusive of master 
athletes (Tanaka and Seals, 2008). The relative contribution of each parameter is unclear, 
though the reduction of VO2max observed in master endurance athletes may be due to 
maintenance of stroke volume and O2 extraction, as they do not appear to decrease by the 
same magnitude as heart rate with age (Pollock et al., 1987). Consistent with this, maximal 
heart rate has been shown to decrease at approximately 0.7 beat.min-1.year-1, and this is 
similar regardless of sex or physical activity status (Rodeheffer et al., 1984). In addition, 
peripheral factors influencing the arterio-venous difference proposed to contribute to the 
differences in VO2max between older, young, trained and control groups, include the 
amount of fat-free and fat mass (Tanaka and Seals, 2008), which have been shown to 




2009). However, the results from the present review demonstrated no discernible 
differences between groups in the amount of fat-free mass for master endurance athletes, 
age-matched untrained individuals, young untrained individuals and young endurance 
trained individuals. Wroblewski and colleagues (2011) demonstrated that chronic 
endurance exercise is able to preserve thigh muscle CSA in master athletes (Wroblewski 
et al., 2011). From our data, it is perhaps surprising that the older untrained individuals did 
not display a marked reduction in fat-free mass with advancing age. However, it has 
previously been shown that VO2max remains lower in older trained individuals compared 
with young trained individuals, despite corrections for muscle mass (Proctor and Joyner, 
1997). Therefore, it is more likely that reductions in capillary density, mitochondrial 
function and enzyme activity (Coggan et al., 1990) are responsible for the lower VO2max 
values observed in master endurance athlete and older controls.  
 
2.5.2. Strength 
Muscle strength and power are ~40 and ~80 % lower in older vs. younger 
individuals (Thom et al., 2007). At the top level of competition, this is reflected by 
decreases in sprint times, jumping and throwing distances (Gava et al., 2015). In terms of 
the general population, the functional significance of this decline impacts individuals’ 
ability to maintain ADL such as stair climbing, rising from a chair or opening a jar (Hairi 
et al., 2010). Moreover, low levels of muscular strength are strongly associated with an 
elevated risk of functional impairment (Cruz-Jentoft et al., 2010) and all-cause mortality 
(Ruiz et al., 2008, Ortega et al., 2012). The current meta-analyses (Figure 8) revealed that 
chronic endurance exercise does not prevent age-related declines in muscular strength. 




with young untrained individuals, again suggesting that preservation of physical function 
into older age is specific to the mode of exercise performed.  
It should be noted that assessment of strength within the studies included in the 
meta-analyses was achieved through a variety of methods; knee extension MVC, unilateral 
(Zampieri et al., 2015, Sundstrup et al., 2010, Sipila and Suominen, 1991, Mosole et al., 
2014, Pollock et al., 2015, Mikkelsen et al., 2013, Marcell et al., 2014, Korhonen et al., 
2012, Couppe et al., 2014, Aagaard et al., 2007a) and bilateral (Korhonen et al., 2006), 
plantar flexion MVC (Stenroth et al., 2016), dorsiflexion MVC (Power et al., 2010), elbow 
flexion MVC (Power et al., 2012) and handgrip strength (Suominen and Rahkila, 1991, 
Sanada et al., 2009)). In addition, the present review lacked a young strength/power 
trained group for comparison, as no studies incorporating this population met the inclusion 
criteria for the review. Therefore, we cannot draw firm conclusions on whether master 
strength/power athletes were able to maintain strength similar to that of young 
strength/power trained athletes. However, it is generally accepted that, similar to VO2max, 
there is an inevitable decline in muscle strength/power with ageing (Goodpaster et al., 
2006, Rittweger et al., 2009), evidenced longitudinally in the performance decrements of 
master power vs. young power trained athletes (Gava et al., 2015).  This suggests that the 
relative rate of decline in muscle strength is similar between trained individuals and age-
matched controls. However, the higher absolute levels of strength provide strength-trained 
individuals with a much greater strength reserve, thus delaying the onset of impaired 





2.5.4. Muscle Mass and Morphology 
One mechanism responsible for age-related strength loss is the decline in muscle 
mass (sarcopenia) (Narici and Maffulli, 2010). In young healthy individuals, muscle mass 
is generally maintained until the 5th decade of life, after which loss of mass progresses at a 
rate of ~0.5-1% per year (Mitchell et al., 2012b); and is exacerbated by protracted disuse 
events (Alkner and Tesch, 2004). Thus, by the age of 80 years an individual may have lost 
~30-40% of peak muscle mass (Janssen et al., 2000). Due to the central role of skeletal 
muscle in physical function, basal metabolism and nutrient deposition, muscle loss can 
have significant health implications. The results from the current review suggest no age or 
training-related differences in muscle mass between groups (master endurance, older 
untrained, young untrained and young endurance trained individuals). This may be due to 
a paucity of studies that incorporated muscle mass assessment, or that most of the included 
studies used techniques (BIA, DXA, hydrostatic weighing) with lower precision and 
sensitivity in cross-sectional comparisons (MacDonald et al., 2011). The absence of any 
difference in muscle mass between groups is perhaps surprising given that the older 
individuals included in the current review were over 60 years and, therefore, beyond the 
age-range where sarcopenia or pre-sarcopenia (loss of muscle mass prior to any functional 
decline (Pereira et al., 2015)) may begin to manifest. The lack of consistency between 
studies highlights that further investigation into age and training-related differences in 
muscle mass is warranted.  
It has been shown muscle mass/volume is associated with muscular strength in 
young and older men and women (Young et al., 1984, Strasser et al., 2013), however there 
is a clear dissociation in the rate at which each declines, with strength loss progressing at a 




Concomitant with the changes in muscle mass, alterations to the neuromuscular 
system may also influence muscle force generating capacity, including reductions in the 
number of motor units, increased size and stimulation thresholds of existing motor units as 
a result of cyclical denervation and re-innervation, and increased instability of 
transmission at the neuromuscular junction (Piasecki et al., 2016c, Piasecki et al., 2016b). 
Two studies (Mosole et al., 2014, Zampieri et al., 2015) identified the presence of greater 
numbers of denervated fibres in the muscles of the older controls, when compared with 
young and older untrained individuals. This lends credence to the notion that chronic 
exercise training, both endurance and resistance, is able to preserve the neural component 
of muscular contraction. There is evidence to suggest that the muscle quality (i.e., the 
force per unit of muscle) is more important than muscle mass per se and more closely 
associated with mortality (Newman et al., 2006). Muscle quality diminishes with age due 
to changes in architecture (Strasser et al., 2013), fibre type morphology (Lexell, 1995) fat 
and non-contractile tissue infiltration (Kent-Braun et al., 2000), satellite cells and 
myonuclei (Kadi et al., 2004). Although it was not possible to draw firm conclusions on 
the impact of chronic exercise training on muscle mass and quality, it is clear that chronic 
strength/power exercise can prevent age-associated strength decrements. 
Ageing is accompanied by a reduction in the total number of muscle fibres, but 
more critically the cross-sectional area and proportion of Type II fibres (Lexell, 1995). 
However, due to the paucity of studies reporting muscle cross sectional area (Couppe et 
al., 2014, Mikkelsen et al., 2013, Rantalainen et al., 2014, Sipila and Suominen, 1991), 
muscle architecture (Korhonen et al., 2006, Ojanen et al., 2007, Sipila and Suominen, 
1991) and fibre morphology (Aagaard et al., 2007a, Cristea et al., 2008, Korhonen et al., 




2010, Tarpenning et al., 2004, Zampieri et al., 2015), it is challenging to elucidate their 
relative contribution to the observed loss or preservation of muscle mass and strength 
between master athletes and age-matched untrained individuals. Nevertheless, previous 
studies have highlighted an association between muscle architecture and performance 
(Kumagai et al., 2000), and that muscle architecture may differ across sporting disciplines 
(Abe et al., 2000). Upon further investigation, differences in muscle CSA, thickness and 
morphology may be an artefact of differing analytical methods (i.e. MRI, CT, ultrasound) 
at divergent anatomical sites (i.e. thigh vs. mid-tibia). Though not statistically analysed in 
the current review, individual studies have shown that master strength/power athletes 
maintain greater fibre cross-sectional area compared with untrained older individuals 
(Aagaard et al., 2007a, Korhonen et al., 2006). In addition to fibre atrophy, ageing 
increases the intramuscular infiltration of fat and connective tissue (Taaffe et al., 2009), 
impairing contractile properties (Lexell, 1995). Studies have revealed conflicting findings 
with respect to muscle fibre distribution between young and older endurance trained 
individuals (Mackey et al., 2014, Mosole et al., 2014, Sundstrup et al., 2010, Zampieri et 
al., 2015), which are likely underpinned by differences in the specific mode of exercise 
training and analytical methods used (Summary data for studies that measured these 
outcomes demonstrate large heterogeneity; presented in Table 3).  
 
2.5.5. Body Fat Mass 
Age-related alterations in body composition, specifically the increase in adiposity, 
likely contributes to impairments in muscle strength and physical function, increases 
dependence on support services and the likelihood of institutionalised care (Guralnik et al., 




current meta-analyses (Figure 6) illustrated that master endurance athletes had a 
significantly lower body fat percentage compared with age-matched controls. Body fat 
percentage was similar between master endurance, master strength/power and untrained 
young individuals, whereas young endurance trained individuals had a significantly lower 
body fat percentage than master endurance trained individuals. These data indicate that 
chronic exercise, endurance or strength/power oriented, can attenuate the increase in body 
fat with ageing. It has been shown that higher levels of physical activity are preventative 
for body fat mass gain (Ekelund et al., 2011). Further, the reduction in physical activity 
that occurs during ageing (from retirement, family commitments, and a lack of other 
preoccupations) is a critical driver of increasing body fat mass (Booth et al., 2012). 
Unfortunately, few studies included in this review provided data for absolute values of fat 
and fat-free mass, making it difficult to draw conclusions about effect that chronic 
exercise training has on these parameters. Interestingly, it has previously been shown that 
obese individuals possess higher levels of fat-free mass compared with healthy older 
individuals (Murton et al., 2015), suggesting a minor protective role of obesity against 
sarcopenia.  Nevertheless, we posit that muscle quality, and not quantity per se, plays a 
more important role in the maintenance of whole-body metabolic health (Smeuninx et al., 
2017).  
 
2.6 Conclusions and Practical applications  
The aim of this systematic review and meta-analyses was to determine whether, 
and to what extent, chronic exercise preserves some of the functional and biological 




age-associated decrements in physical function in an exercise-mode specific manner and 
also protects against unfavourable changes in body composition.  
Current physical activity guidelines for older adults suggest 150 minutes per week 
of moderate-to-vigorous physical activity per week, unless chronic conditions prevent 
them doing so (American College of Sports, 2009). Guidelines also recommend that older 
adults incorporate some form resistive based exercise at least twice a week. However, the 
prevalence of functional impairment and reduced independence in older age suggests 
many older individuals are not meeting these criteria. The master athlete cohorts included 
in this review provide evidence that canonical age-related impairments in physical 
function, cardiorespiratory fitness, muscular strength and body composition can be 
delayed through chronic training, in an exercise mode-specific manner. The continuation 
of endurance type exercise to maintain high levels of cardiorespiratory fitness and 
strength/power training to preserve muscular strength offers a viable strategy to extend the 
health-span of older individuals, compressing the area under the morbidity curve and 
allowing maintenance of functional independence and good quality of life. It is apparent 
that few high quality studies have been conducted in unique master athlete cohorts, and 
that further research studies encompassing a comprehensive selection of sophisticated 
measurement tools need to be conducted in order to fully characterise specific benefits of 
strength/power training and endurance training. Finally, the inclusion of only 268 females 
in this review reflects a preponderance of males included in the study of master athletes. 
This disparity warrants further investigation, as it has been documented that men and 
women may undergo somewhat divergent deterioration in skeletal muscle mass and 
strength with advancing age, perhaps due to reductions in sex-specific hormones (Smith et 




specific exercise training interventions, or manipulation of certain training variables, may 
















Table 1 Included studies and associated measures. DXA, Dual energy x-ray absorptiometry; H + E, Hematoxylin and eosin; MVC, maximal 























Table 2. Anthropometric characteristics and training background of study groups (mean ± SD) included in this review, (e.g. n, age, height, weight, 





Table 3. Body composition, muscle mass and morphology (mean ± SD) not included in a meta-analysis (e.g. fat-free mass, fat-mass, relative fat-mass 
(additional data ineligible to be included in meta-analysis), muscle thickness, fascicle length, muscle CSA, fibre area, fibre distribution). First 






3. Physiological Function and 
Skeletal Muscle Morphology in 
Chronically Trained Master 
Endurance Athletes Compared with 








Background: To better understand the role of inherent ageing and biological factors in the 
progression of age-related muscle deterioration, and the potency of exercise training for 
enhancing physiological function and health, we conducted a comprehensive phenotypic 
comparison of chronically exercise trained older individuals (Master Athletes; MA) 
against untrained young and older individuals. 
Methods: In a cross-sectional design 15 young controls (YC) (20±2.7 y, 78.9±13.3 kg), 12 
untrained older controls (OC) (69.8±4.1 y, 77.5±14.2 kg) and 14 endurance trained MA 
(67.1±4.1 y, 68.7±6.5 kg) underwent assessments of body composition, maximal aerobic 
fitness, leg strength, muscle architecture and fibre-type morphology. 
Results: Skeletal muscle index was lower and body fat greater in OC vs. MA (P=0.001 
and P<0.002, respectively). VO2max was similar between MA and YC, but lower in OC 
(P<0.001). Maximal isometric leg strength was greater in YC than OC and MA (P<0.001 
and P=0.006, respectively). Type I fibre area was greater for MA compared with OC 
(P=0.028), whilst Type II fibre area was greater for YC compared with OC (P=0.008).  
Type II fibre myonuclear domain size was greater in YC than OC and MA (P=0.005 and 
P=0.016, respectively), whereas satellite cell content was similar between groups. MA had 
greater Type I and Type II fibre capillarisation compared with OC and YC.   
Conclusions: Body composition, physiological function and muscle fibre morphology 
generally deteriorated in OC compared with YC, whereas MA were generally 
indistinguishable from YC. Thus, chronic exercise training enhances skeletal muscle 




The shift towards an ageing population presents a significant and overwhelming 
global demand on healthcare resources. The major trepidation is not that individuals are 
living longer (i.e. lifespan), but that they endure a larger portion of their later years with 
multiple age-associated co-morbidities (i.e. healthspan) (Harper, 2014). Thus, strategies to 
close the gap between health- and life-span are of paramount importance.  
Age-related reductions of skeletal muscle mass, strength and function (termed 
‘sarcopenia’) and cardiorespiratory fitness may prematurely force individuals into a state 
of physical dependence and are independent predictors of all-cause mortality (Blair et al., 
1996, Kelley and Kelley, 2017, Newman et al., 2006). Skeletal muscle mass is 
indispensable for locomotion, basal metabolism, energy storage and nutrient deposition 
(Frontera and Ochala, 2015). By the 8th decade of life skeletal muscle mass has is reduced 
by ~18% in men and 27% in women (Janssen et al., 2000) and is accompanied by a loss of 
muscle strength that is ~3-5 times greater (Goodpaster et al., 2006). Sarcopenia is 
characterised by reductions in muscle fibre cross-sectional area (CSA) (Nilwik et al., 
2013), satellite cell content (Nederveen et al., 2016), motor unit remodelling (Piasecki et 
al., 2018), infiltrations of fat and connective tissue (Smeuninx et al., 2017), alterations to 
the microcirculation (Barnouin et al., 2017, Pollock et al., 2018, Nederveen et al., 2016) 
and reduced oxidative capacity (Wilson and Tanaka, 2000). The extent to which this 
physiological deterioration is due to inherent biological processes (primary ageing), free 
from artefacts of secondary ageing that exacerbate the decline (i.e., physical inactivity), is 
unclear.  
From an evolutionary biological perspective, the default state of human well-being 
is a lifestyle incorporating physical activity/exercise (Booth and Lees, 2006). Therefore, 
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the study of individuals who have chronically undertaken structured exercise training and 
continue to compete, into their later years, referred to as Master Athletes (MA), provides a 
model to investigate the impact of inherent ageing on physiological function, without 
confounding aspects of biological ageing. In a recent meta-analysis, we reported that 
endurance-based MA displayed a 55% greater aerobic capacity compared with age-
matched untrained individuals, whereas resistance trained MA demonstrated greater 
strength than age-matched untrained individuals (McKendry et al., 2018). Furthermore, 
others have shown that although a decline in physiological function remains apparent in 
MA, high physical activity may ultimately improve the healthspan by shifting the ‘set 
point’ of age-related physiological deterioration upwards and to the right (Harridge and 
Lazarus, 2017, Pollock et al., 2015, Pollock et al., 2018). Nevertheless, firm conclusions 
on the influence of ageing and chronic exercise on physiological deterioration cannot be 
drawn, as very few studies have included sufficient parameters to comprehensively 
characterise skeletal muscle morphology at macro- and microscopic level in MA (Mackey 
et al., 2014, Zampieri et al., 2015, Piasecki et al., 2016a). Studies that have characterised 
MA report conflicting findings, with some demonstrating superior leg strength and muscle 
fibre diameter in senior sportsmen compared with untrained older individuals  (Zampieri 
et al., 2015), and others showing similar muscle size, strength and fibre CSA between MA 
and untrained older individuals (Mackey et al., 2014, Piasecki et al., 2016a). These 
discrepant findings may relate to different analytical methods, the specific muscle studied 
or the population selected for comparison against MA.  
Therefore, to better understand the role of inherent ageing processes in 
physiological function, and the extent to which chronic exercise training might improve 
the healthspan, the aim of the current study was to compare physical function, 
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cardiorespiratory fitness, body composition, muscle strength, architecture and fibre-type 
morphology in MA, with healthy untrained younger and age-matched older individuals. 
We hypothesised that untrained older individuals would exhibit an impairment in all of the 
above parameters compared with younger individuals, which would be partially or, in 





Fifteen young (YC) and 12 older untrained controls (OC) were recruited alongside 
14 Master endurance athletes (MA) through local advertisements, the British Masters 
Athletics Federation and the League of Veteran Racing Cyclists. Young (18-35 years) and 
older untrained controls (60-80 years) were deemed eligible for study participation only if 
they maintained habitual activity and had not previously participated in any form of 
structured exercise training outside of recreational activities. Master athletes (60-80 years) 
were included only if they had maintained continuous endurance training at least twice per 
week for ≥20 years preceding the study. Participant anthropometric and training 
characteristics are detailed in Table 1. All participants were informed of the purpose and 
methodology of the study, were deemed healthy by completion of a general health 
questionnaire assessment, and provided their written informed consent. Ethical approval 
was obtained through the West Midlands - Solihull Research Ethics Committee 
(16/WM/0167). The study conformed to the standards set by the Declaration of Helsinki 
(7th version).  
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3.3.2. Study design 
In a parallel study design, three divergent groups YC, OC and MA were recruited 
to investigate the effect that continuous endurance exercise exerts on indices of muscle 
mass, function and morphology. Following initial study screening and consenting, 
participants reported to the School of Sport, Exercise and Rehabilitation Sciences 
(SportExR) laboratory on two separate occasions with each visit separated by ~7 days. For 
each visit participants reported to SportExR in an overnight fasted-state, having refrained 
from strenuous physical activity and alcohol for at least 48 h previously, and from caffeine 
consumption on the day of the trial. During the initial visit, participants underwent 
assessments of body composition, aerobic capacity, maximal limb strength and a battery 
of functional tests. Approximately 1 week later, participants underwent ultrasound 
scanning, a single venous blood sample and a single muscle biopsy.  
 
3.3.2.1. Visit 1 
Body mass, height and composition: Body mass was determined by weighing each 
participant in loose clothing, without shoes, to the nearest 0.1kg using a digital balance 
scale (Esca 813, Hamburg, Germany). Height measurements were made to the nearest 
0.1cm using a stadiometer (Seca 217, Hamburg, Germany). Participants underwent a dual-
energy x-ray absorptiometry (DXA) scan (Discovery DXA Systems, Hologic Inc., 
Bedford, MA) to determine whole-body and regional fat- and fat-free mass.  
 
Blood pressure: Blood pressure was measured using a standard fully automatic blood 
pressure monitor (OMRON M2, OMRON Healthcare UK Ltd., UK). Participants were 
asked to remove any clothing that obstructed the blood pressure cuff. Participants were 
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seated with their legs uncrossed and back supported, encouraged to relax and refrain from 
talking during the assessment. This test was repeated 3 times and the highest reading 
taken.  
 
Aerobic capacity: Participants underwent the Ekblom-Bak test (Bjorkman et al., 2016); a 
submaximal cycle ergometry test for the estimation of V̇O2max. Briefly, the test is based on 
the change in heart rate between a standardised low workload and a higher workload 
predetermined by sex and current habitual activity. Participants were instructed to 
maintain a constant cadence of 60 rpm throughout the test. First, the participant cycled for 
4 min, while investigators ensured constant cadence and resistance. Heart rate was 
recorded every 15 s and averaged during the final minute of the low workload. The 
Electrocardiogram (ECG) was monitored over 5 min prior-to and continuously throughout 
exercise by a cardiologist. The resistance was then increased to the predetermined level for 
the next 4 min, whilst cadence and resistance remained constant. During the second 
minute at the higher workload, individuals communicated their rate perceived exertion 
(RPE) using a standard scale (Borg, 1982). If RPE was <10 the resistance was increased 
by 1kp and the second workload timings started again. If RPE was 10-11, the workload 
was increased by 0.5kp and the second workload timings started again. If RPE was 12-16 
participants were instructed to maintain this workload. If RPE >17 the exercise bout was 
stopped. Heart rate was recorded every 15 s and averaged during the final minute of the 
higher workload. V̇O2max was calculated using the following equation (Bjorkman et al., 
2016):  
!̇#$%&' = 4.98196 − 2.88618 1
∆34
∆5#6 + 0.65015(;<=) − 0.01712(@A<) 
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Where ΔHR is the difference in the average heart rate between the two workloads, ΔPO is 
a constant reflecting the difference in power output between the two workloads, where sex 
is 0=woman and 1=man, and age is participants age in years as an integer.  
 
Handgrip strength: Individuals stood, feet side-by-side, with their arms adducted, wrists 
neutrally rotated and the dynamometer (Jamar Hydraulic, Patterson Medical, UK) 
positioned comfortably in the participant’s self-reported dominant hand. Participants were 
instructed to squeeze the handle as hard as possible and three attempts were recorded, with 
the highest value included in future analysis.  
 
Short physical performance battery (SPPB): This battery of tests assesses three areas 
critical to successful and independent function with advancing age; balance, gait speed and 
low limb power (Guralnik et al., 1994). The tests were always performed in the same 
order. First, the balance test was comprised of three separate, increasingly difficult stances 
(side-by-side, semi-tandem, full tandem), which participants were required to hold for 10 
sec. Second, the gait speed test in which participants were instructed to walk a short, 3-
metre-long course ‘at your usual speed as if walking to the shops’. Finally, a repeated 
chair stand test, in which participants were instructed to rise from a chair, arms folded, 
five times as quickly as possible. The result from each of the three tests were scored out of 
4 marks (maximum total of 12), against predetermined criteria to provide an overall score 
of physical function.  
 
Limb strength: Maximal knee extension and elbow flexion isometric strength were 
measured using a KinCom Dynamometer (KinCom 125AP, KinCom, USA) on the self-
 101 
reported dominant limb. Participants were seated, with the tested limb, chest and hips 
stabilised and with the knee and elbow angle positioned at 70 degrees of flexion, 
respectively. Participants were allowed 3 practices of increasing exertion to familiarise 
themselves with the isometric contraction. After this, participants performed 3 maximal 
voluntary contractions, the greatest of which was included in subsequent analysis.  
 
Dietary analysis: Between visits 1 and 2, participants were provided with a 4-day weighed 
food diary designed to capture habitual food intake on 2 consecutive weekdays and 2 
weekend days. Participants were instructed not to change their usual diet and to be as 
accurate as possible when describing the food (cooking method, brand, amount etc.). 
Dietary intake was analysed using MyFitnessPal software (MyFitnessPal Inc.).  
 
Physical Activity: Between visits 1 and 2 (~7 days), participants were provided with a 
wrist-worn accelerometer (GENEActiv, ActivInsights Ltd., UK) designed to capture 
habitual activity in free-living conditions over 5 consecutive days (including both weekend 
days). Accelerometers were initialized to sample data at a 10 Hz. Data were converted into 
60 second epochs and analysed using the GENEActiv software (version 2.2, 
ActivInsights). Activities were split into 4 categories based on metabolic equivalent 
(MET) values; i) sedentary activity (<1.5 METs) ii) light activity (1.5 – 3.99 METs) iii) 





3.3.2.2. Visit 2  
Muscle architecture: B-mode ultrasonography with a linear array probe was used for all 
measurements of muscle architecture. Participants lay fully relaxed in a supine position 
with a small towel rolled and placed under the knee for anterior measurements. For 
posterior measurements, participants were in a fully relaxed prone position with feet 
overhanging the end of the bed. Biceps Brachii architecture was measured with the 
participants seated on the edge of the bed with the arm freely hanging. The muscles 
measured included; Vastus Lateralis, Vastus Intermedius, Rectus Femoris, Biceps Brachii, 
Gastrocnemius Medialis, and Tibialis Anterior. Measurements of muscle thickness (MT), 
pennation angle (θ), fascicle length (Lf) were made in triplicate.  MT was considered to be 
the distance between deep and superficial aponeuroses. θ was calculated as the angle 
between the muscle fascicle and the deep aponeurosis. Fascicle length was measured as 
the length of the fascicular path between the 2 aponeuroses. A mark was drawn on each 
pre-determined anatomical site to ensure constant probe positioning. Specifically, the 
measurement sites were set at 60% of the upper arm length distal to the acromion process 
for Biceps Brachii, 50% of the muscle length for upper thigh muscles, and 30% of the leg 
length distal to the popliteal crease for lower leg muscles (Kawakami et al., 2006). The 
ultrasonography probe was covered with water-soluble transmission gel, to provide 
acoustic contact without compressing the dermal surface, and an image was taken when a 
number of fascicles could clearly be identified. The orientation of the probe varied slightly 
between participants due to the individual characteristics.  
 
Blood sample: A single blood sample was obtained via venepuncture from an antecubital 
forearm vein. Blood was collected in separate ethylenediaminetetraacetic acid (EDTA) 
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and serum-separating polymer gel containing BD vacutainers (BD, Oxford, UK). Blood 
samples were centrifuged at 3000g for 10 min at 4°C, and serum and plasma aliquots were 
frozen at −80°C for later analysis. 
 
Muscle Biopsy: A muscle biopsy sample was obtained from the quadriceps vastus 
lateralis under local anaesthesia (1% lidocaine) using the Bergström needle technique 
(Bergstrom, 1975). Muscle biopsy tissue was quickly rinsed in ice-cold saline and blotted 
to remove any visible fat and connective tissue before being frozen in liquid nitrogen or 
placed in a pipette tip with optimum cutting temperature compound (Tissue-Tek® 
(O.C.T.) Compound, Sakura® Finetek) and frozen in liquid nitrogen-cooled isopentane 




Blood: Plasma glucose was analysed using a commercially available blood glucose 
analyser (HemoCue® Hb 201+ System, HemoCue AB, Sweden). Serum insulin 
(Coefficient of variation (CV) = 2.65 ± 1.46%) and C-reactive protein (CRP) (CV = 4.68 ± 
1.10%) were analysed using commercially available enzyme-linked immunosorbent assay 
(ELISA) kits (IBL International GmbH, Hamburg, Germany) following the manufacturer 
instructions. Postabsorptive insulin sensitivity was also estimated using the homeostasis 




i) Muscle Fibre Type and Cross-sectional area:  This analysis was carried out on a subset 
of participants (YC; n=13: MA; n=14: OC; n=11). Serial 10µm sections of skeletal muscle 
biopsies were cut in the cryostat at -20°C. Briefly, slides were washed in triton x100 (0.02 
%) to permeabilise the fibres. Slides were blocked for 90 mins in 5 % normal goat serum 
(Invitrogen, UK) and then incubated overnight in the primary antibody cocktail; myosin 
heavy chain (MHC) I, BAF8 (Developmental Studies Hybridoma Bank (DSHB, USA) 
1:25; MHC II, SC-71 (DSHB, USA) 1:20; Laminin (ab11575) 1:500 (Abcam, Cambridge, 
UK) in phosphate buffered saline (PBS).  Slides were washed in 3 x 5 min in PBST and 
incubated in the secondary antibody cocktail; MHC I, Alexa Fluor 546 IgG2b 1:100 
(Thermo Fisher Scientific, Paisley, UK); MHC II, Alexa fluor 488 IgG1 1:100 (Thermo 
Fisher Scientific, Paisley, UK); Laminin, Alexa Fluor 488 IgG 1:100 (Thermo Fisher 
Scientific, Paisley, UK). Slides were then washed and mounted with coverslips in prolong 
gold anti-fade mountant (Thermo Fisher Scientific, Paisley, UK). Prepared slides were 
observed under a Nikon E600 microscope using a 20 × 0.75 numerical aperture objective. 
Images per area were captured under two colour filters achieved by a SPOT RT KE colour 
three-shot CCD camera (Diagnostic Instruments Inc., MI, USA), illuminated by a 170 W 
Xenon light source. Texas red (540–580 nm) excitation filter was used to capture MHC I 
images and FITC (465– 495 nm) excitation filter was used to capture MHC II and 
Laminin. Microscope slides were prepared such that each slide contained two serial 
sections from one individual from each of the included groups. Images were captured, and 
measured, such that ~ 600-1000 muscle fibres were included for analysis from each group. 
All viable muscle fibres in any particular image, excluding those displaying freeze fracture 
artefact and any longitudinal fibres (assessed as those with a circularity of <0.6), were 
included for analysis and were analysed using Image J Fiji (Schindelin et al., 2012). 
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ii) Myonuclear domain: This analysis was carried out on a subset of participants (YC; 
n=10: MA; n=12: OC; n=11). Briefly, tissue sections were fixed in 4% paraformaldehyde 
(PFA) for 10 min, washed 3 x 5 min in PBST, blocked for 60 min at RT (in PBS 
containing 2% bovine serum albumin, 5% FBS, 0.2% Triton x-100, 0.1% NaAzide, and 
2% goat serum). Sections were incubated in primary antibody cocktail; MHC I (DSHB, 
A4.951 slow isoform; neat) and MHC II (Abcam, Cambridge, MA, USA ab91506, 
1:1000) at RT overnight as previously described. Slides were washed in 3 x 5 min in 
PBST and incubated in the secondary antibody as previously described. Nuclei were 
labelled with DAPI (49,6-diamidino-2-phenylindole) (1:20000, Sigma-Aldrich, Oakville, 
ON, Canada), prior to cover slipping with DAKO fluorescent mounting media 
(Burlington, ON, Can). Slides were visualised with the Nikon Eclipse Ti Microscope 
(Nikon Instruments, Inc., Melville, NY, USA), equipped with a high-resolution 
Photometrics CoolSNAP HQ2 fluorescent camera (Nikon Instruments). Images were 
captured and analysed using the Nikon NIS Elements AR 3.2 software (Nikon 
Instruments). All images were obtained on the x20 objective. 
 
iii) Myofibre satellite cell analysis: This analysis was carried out on a subset of 
participants (YC; n=10: MA; n=11: OC; n=10). Muscle sections were cut at 5µm in the 
cryostat at 20°C. Muscle sections were fixed for 10 min in PFA followed by 3 x 5 min 
wash in PBS. Sections were covered for 90 mins in blocking solution (2% bovina serum 
albumin, 5% foetal bovine serum, 0.2% Triton X-100, 0.1% NaAzide, and 5% goat 
serum), then incubated overnight in primary antibodies specific for Pax7 (neat Pax7) 
(DSHB, USA) at 4°C overnight. Sections were incubated in appropriate secondary 
antibodies and re-fixed and re-blocked prior to incubation in primary antibodies specific 
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for laminin (ab11575; 1:500) (Abcam, Cambridge, UK) and MHC I, (BAF8) (DSHB, 
USA). slides were washed treated with appropriate secondary antibodies. Nuclei were 
labelled with DAPI (49,6-diamidino-2-phenylindole) (1:20000, Sigma-Aldrich, Oakville, 
ON, Canada), prior to cover slipping with DAKO fluorescent mounting media 
(Burlington, ON, Can). Slides were viewed and images captured as described in the 
myonuclear domain section. 
 
iv) Myofibre capillary analysis: This analysis was carried out on a subset of participants 
(YC; n=10: MA; n=12: OC; n=11). Muscle sections were fixed and blocked as previously 
described. Muscle sections were incubated in the primary antibody CD31 (Abcam 
ab28364, 1:30) at 4°C overnight. Following washes, sections were then incubated in the 
appropriate secondary antibodies. Sections were then again re-blocked in 10% GS in PBS 
and incubated sequentially in the third primary antibodies, a primary antibody cocktail 
consisting of MHC I, MHC II and laminin. Sections were then incubated in secondary 
antibody cocktail, nuclei were labelled with DAPI (49,6-diamidino-2-phenylindole) 
(1:20000, Sigma-Aldrich, Oakville, ON, Canada) and imaged as described above.  
 
Calculations and Measurements: Myonuclear domain was determined as the fibre area 
(µm2) per nucleus and the number of nuclei per muscle fibre cross section.  Quantification 
of (i) capillary contacts (CC, the number of capillaries around a fibre), (ii) the capillary-to-
fibre ratio on an individual fibre basis (C/Fi), (iii) the number of fibres sharing each 
capillary (i.e., the sharing factor), and (iv) the capillary-to-fibre perimeter exchange index 




Statistical Analysis: Data were expressed as mean ± standard deviation (SD). Normality 
of data was assessed using the Shapiro-Wilk test. Between group differences were 
identified via one-way ANOVA analysis (with group as the between-subject factor). 
Muscle morphological data were analysed via mixed-design ANOVA (with group as the 
between subject factor and fibre type as the within subject factors). Bonferroni correction 
was applied for multiple comparisons. Bonferroni correction was applied to correct for 
multiple comparisons. Significance level was set at P < 0.05. All calculations were 





Participant Characteristics: Participant anthropometric and training characteristics are 
detailed in Table 1. YC were taller than MA (P=0.031). MA had lower whole-body fat 
mass (P=0.011), a lower body fat percentage (P=0.002) and a greater skeletal muscle 
index (P=0.001) than OC. YC had significantly greater appendicular lean mass than OC 
(P=0.03). YC and MA had significantly lower fasting glucose concentrations than OC 
(P=0.005 and P=0.009, respectively). MA had significantly lower serum insulin (P=0.048 
and P=0.041) and HOMA-IR (P=0.03 and P=0.003) than YC and OC, respectively. There 










Age (years) 20.0 ± 2.7**## 67.1 ± 6.4 69.8 ± 4.1 
Height (m) 1.80 ± 0.04* 1.70 ± 0.06 1.80 ± 0.07 
Body mass (kg) 78.9 ± 13.3 68.7 ± 6.6 77.5 ± 14.2 
BMI (kg×m-2) 24.6 ± 3.6 23.0 ± 2.0 24.5 ± 3.8 
Whole-body FFM (kg) 56.9 ± 6.6 52.2 ± 3.5 52.9 ± 7.8 
Whole-body FM (kg) 17.6 ± 7.4 13.3 ± 3.9# 20.9 ± 7.1 
Body fat (%) 22.0 ± 5.5 19.2 ± 4.1## 26.8 ± 5.4 
Skeletal Muscle Index (%) 74.0 ± 5.2 77.0 ± 4.0## 69.8 ± 5.1 
ALM/Height2 (kg.m-2) 8.18 ± 0.79# 7.71 ± 0.54 7.39 ± 0.95 
Systolic Blood Pressure (mmHg) 126 ± 9 125 ± 7 137 ± 18 
Diastolic Blood Pressure (mmHg) 64 ± 8 76 ± 7 83 ± 11 
Fasting Plasma Glucose  (mmol·L-1)   5.33 ± 0.39## 5.35 ± 0.63## 5.96 ± 0.35 
Fasting Serum Insulin (µIU/mL) 10.95 ± 3.24* 7.21 ± 3.10 11.42 ± 4.38* 
HOMA-IR  2.59 ± 0.75** 1.65 ± 0.61 3.05 ± 1.16** 
CRP (mg·L-1) 1.71 ± 1.89 0.77 ± 0.43 1.10 ± 0.53 
Training Experience (years) - 36.5 ± 8.1 - 
Training Frequency (sessions·week-1) - 4.5 ± 1.4 - 
Training Duration (hrs·week-1) - 7.6 ± 4.7 - 
Training Distance (km·week-1) - 210±112 / 50±15 - 
 
Table 4. Participant anthropometric and training characteristics Data presented as mean ± SD. 
FFM; fat-free mass, FM; fat mass, ALM; appendicular lean mass. Training Distance separated 
into cyclists (left) and runners (right). * Indicates significantly different from MA, P<0.05. ** 
Indicates significantly different from MA, P<0.01. # Significantly different from OC, P<0.05. ## 






Physical Function: Physical function characteristics are detailed in table 2. There were no 
significant differences between groups for any of the SPPB component nor total scores or 
handgrip strength. YC produced significantly greater knee extension MVC than MA and 
OC (P=0.006 and P<0.001, respectively) and significantly greater elbow flexion than MA 













SPPB Standing Balance (s) 10.0 ± 0 10.0 ± 0 10.0 ± 0 
SPPB Semi-Tandem (s) 10.0 ± 0 10.0 ± 0 10.0 ± 0 
SPPB Full Tandem (s) 10.0 ± 0 9.7 ± 1.0 9.7 ± 1.1 
SPPB 3m Walk (s) 2.37 ± 0.34 2.43 ± 0.28 2.45 ± 0.44 
SPPB 5x Sit-to-stand (s) 7.27 ± 1.34 7.97 ± 1.88 7.88 ± 2.03 
Handgrip Strength (kg) 50.9 ± 7.6 47.0 ± 5.9 46.3 ± 8.4 
Knee Extension MVC (N)  638.3 ± 82.4**## 520.4 ± 105.3 471.4 ± 117.9 
Elbow Flexion MVC (N) 292.9 ± 48.6** 223.0 ± 42.8 256.8 ± 49.2 
V̇O2max (ml·kg-1·min-1) 53.2 ± 7.3## 49.3 ± 3.6## 36.7 ± 6.5 
 
Table 5. Physical function and strength Data presented as mean ± SD. * Indicates 
significantly different from MA, P<0.05. ** Indicates significantly different from MA, 
P<0.01. # Indicates significantly different from OC, P<0.05. ## Indicates significantly 
different from OC, P<0.01. SPPB, short physical performance battery. MVC, maximal 
voluntary contraction. Nm, Newton metres.  
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Muscle architecture: Muscle architecture results are detailed in Table 3. YC had 
significantly greater MT than OC for Vastus lateralis (P<0.001), Vastus intermedius 
(P=0.002), Rectus femoris (P<0.001) and greater MT than MA for Rectus femoris 
(P<0.001). YC had significantly greater θ than OC for Vastus lateralis (P=0.007), Vastus 
intermedius (P=0.014), Rectus femoris (P=0.002) and significantly greater θ than MA for 
Rectus femoris (P=0.04). MA had significantly greater Lf than OC for Gastrocnemius 
medialis (P=0.032) and YC had significantly greater Lf than OC (P=0.024) and MA 
(P=0.041) for Gastrocnemius lateralis.  
 
Habitual Dietary Intake and Physical Activity: Dietary intake results are detailed in Table 
4 (upper). YC total energy (P=0.014), fat (P=0.019), protein (P<0.001), relative fat 
(P=0.044) and relative protein intake (P=0.005) were greater than OC. Whereas, MA total 
energy (P=0.003), carbohydrate (P=0.014), relative carbohydrate (P=0.008), relative fat 
(P<0.007) and relative protein intake (P=0.029) were greater than OC. No differences in 
dietary intake were observed between YC and MA. Habitual activity can be found in 
Table 4 (lower). MA carried out significantly more absolute and relative vigorous activity 
than both YC (P<0.001) and OC (P<0.001). There were no other differences identified 

















Vastus Lateralis Thickness (mm) 25.7 ± 3.6## 21.7 ± 5.5 18.2 ± 4.5 
Pennation Angle (°) 17.9 ± 3.8## 14.5 ± 4.5 12.4 ± 4.7 
Fascicle Length 
(mm) 
84.4 ± 14.3 85.5 ± 17.7 73.4 ± 17.9 
Vastus 
Intermedius 
Thickness (mm) 18.6 ± 3.5## 16.6 ± 2.7 14.0 ± 3.4 
Pennation Angle (°) 14.9 ± 4.4## 13.1 ± 2.0 11.0 ± 2.5 
Fascicle Length 
(mm) 
74.8 ± 20.7 73.9 ± 12.4 71.4 ± 22.1 
Rectus Femoris Thickness (mm) 26.3 ± 3.5**## 19.7 ± 3.0 17.6 ± 5.0 
Pennation Angle (°) 15.6 ± 3.1*## 12.9 ± 2.7 11.6 ± 2.4 
Fascicle Length 
(mm) 
95.5 ± 14.0 88.2 ± 13.4 83.5 ± 12.1 
Tibialis Anterior Thickness (mm) 30.2 ± 3.5 28.8 ± 3.7 30.9 ± 3.1 
Pennation Angle (°) 13.6 ± 1.6 15.8 ± 3.2 15.1 ± 2.6 
Fascicle Length 
(mm) 
79.3 ± 14.7 69.4 ± 13.6 74.8 ± 14.1 
Gastrocnemius 
Medialis 
Thickness (mm) 17.5 ± 4.1 16.3 ± 3.1 15.0 ± 4.0 
Pennation Angle (°) 25.5 ± 4.5 23.5 ± 5.2 24.4 ± 6.3 
Fascicle Length 
(mm) 
42.8 ± 8.8 44.7 ± 8.9# 35.4 ± 8.0 
Gastrocnemius 
Lateralis 
Thickness (mm) 15.5 ± 2.9 13.5 ± 3.7 13.6 ± 4.5 
Pennation Angle (°) 14.7 ± 4.3 16.9 ± 5.4 18.1 ± 4.2 
Fascicle Length 
(mm) 
61.3 ± 14.6*## 49.1 ± 11.7 47.2 ± 10.1 
Bicep Brachii Thickness (mm) 34.7 ± 5.4 31.3 ± 4.0 33.4 ± 4.5 
 
Table 6. Muscle Architecture characteristics. Data presented as mean ± SD. * Indicates 
significantly different from MA, P<0.05. ** Indicates significantly different from MA, 
P<0.01. # Indicates significantly different from OC, P<0.05. ## Indicates significantly 










Total Energy (kcal·day-1)  2700 ± 546# 2820 ± 437## 2113 ± 568 
Total Carbohydrate (g·day-1) 303 ± 85 317 ± 51# 230 ± 84 
Total Fat (g·day-1) 97 ± 17# 93 ± 19 73 ± 28 
Total Protein (g·day-1) 122 ± 27## 100 ± 22 83 ± 20 
Relative Carbohydrate (g·kg-1·day-1) 4.0 ± 1.6 4.6 ± 0.7## 3.0 ± 1.2 
Relative Fat (g.kg-1·day-1) 1.3 ± 0.3# 1.4 ± 0.3## 0.9 ± 0.4 
Relative Protein (g·kg-1·day-1) 1.6 ± 0.4## 1.5 ± 0.4# 1.1 ± 0.3 
Sedentary Activity (mins·day-1)  551 ± 134 585 ± 60 586 ± 129 
Light Activity (mins·day-1) 64 ± 25 90 ± 35 85 ± 22 
Moderate Activity (mins·day-1) 148 ± 76 148 ± 44 164 ± 70 
Vigorous Activity (mins·day-1) 13 ± 14** 49 ± 29 4 ± 6** 
Sedentary Activity (%·day-1)  77.5 ±27.1 67.2 ± 6.7 81.2 ±45.3 
Light Activity (%·day-1) 8.4 ± 3.1 10.1 ± 3.6 10.2 ± 2.6 
Moderate Activity (%·day-1) 22.2 ±19.4 16.9 ± 4.2 20.3 ± 8.4 
Vigorous Activity (%·day-1) 1.7 ±1.5** 5.6 ± 3.2 1.1 ± 2.6** 
 
Table 7. Habitual dietary intake (upper) and physical activity (lower) Data presented as 
mean ± SD. * Indicates significantly different from MA, P<0.05. ** Indicates significantly 
different from MA, P<0.01. # Indicates significantly different from OC, P<0.05. ## 









Muscle fibre properties: Muscle fibre data are detailed in Figure 9 A-E. MA displayed 
larger Type I fibre CSA than OC (P=0.031), whereas YC had significantly larger Type II 
fibre CSA than OC (P=0.008). MA (57 ± 15 %) had a significantly greater proportion of 
Type I muscle fibres compared with YC (35 ± 10 %, P<0.001) and OC (41 ±10 %, 
P=0.008). MA (43 ± 15 %) had a significantly lower proportion of Type II fibres 
compared with YC (65 ± 10 %, P<0.001) and OC (58 ± 10%, P=0.012).  
 
Myonuclear domain: Muscle fibre data are detailed in Figure 10 A-E. No significant 
differences were observed between any of the groups for Type I fibre myonuclear domain. 
YC had significantly greater Type II fibre specific myonuclear domain than MA 
(P=0.018) and OC (P=0.006). No significant differences were observed between the 
groups for nuclei per Type II fibre. MA had significantly more nuclei per Type I myofibre 
than OC (P=0.021). 
 
Capillarisation and satellite cells: Capillarisation and SC data are detailed in Figure 11 A-
G and 12 A-C, respectively. MA had significantly more capillary contacts (CC) per Type I 
myofibre compared with YC and OC (P=0.002 and P<0.001, respectively). MA had more 
CC per Type II fibre compared with OC (P=0.006). Type I capillary-to-fibre ratio (C/Fi) 
was greater in MA compared with YC and OC (P=0.001 and P<0.001, respectively). MA 
had a greater Type II C/Fi ratio than OC (P=0.004). Capillary fibre perimeter exchange 
(CFPE) index was greater in MA compared with YC and OC in both Type I (P=0.002 and 
P<0.003, respectively) and Type II fibres (P=0.002 and P<0.003, respectively). No 















Type I 1034 ± 166 930 ± 145 933 ± 126 
Type II 1276 ± 230*## 1001 ± 209 953 ± 215 
Nuclei / Fibre 
Type I 4.19 ± 1.11 4.63 ± 0.57# 3.72 ± 0.48 
Type II 3.71 ± 0.83 3.90 ± 0.35 3.49 ± 0.41 
Capillary Contacts  
Type I 4.64 ± 0.72 6.21 ± 1.29††## 4.52 ± 0.73 
Type II 4.82 ± 0.94 5.50 ± 1.08## 4.19 ± 0.71 
Capillary to Fibre 
Ratio  
Type I 1.75 ± 0.32 
2.52 ± 0.62†† 
## 
1.71 ± 0.33 
Type II 1.81 ± 0.41 2.20 ± 0.50## 1.59 ± 0.32 
Capillary to Fibre 
Perimeter Exchange  
Type I 6.94 ± 0.71 
9.23 ± 1.96†† 
## 
7.06 ± 1.13 
Type II 6.43 ± 0.99 8.48 ± 1.58††## 6.53 ± 1.11 
Satellite Cells / 
Fibre 
Type I 0.071 ± 0.029 0.095 ± 0.059 0.056 ± 0.022 
Type II 0.077 ± 0.031 0.057 ± 0.051 0.045 ± 0.032 
     
 
Table 8. Muscle morphological features. Data presented as mean ± SD. * Indicates 
significantly different from MA, P<0.05. ** Indicates significantly different from MA, 
P<0.01. # Indicates significantly different from OC, P<0.05. ## Indicates significantly 
different from OC, P<0.01. † Indicates significantly different from YC, P<0.05. †† Indicates 






Figure 9. Cross-sectional area (CSA) of Type I (A) and Type II muscle fibres (B) and 
relative abundance of Type I (C) and Type II muscle fibres (D) in young untrained 
individuals (YC), old endurance trained Master Athletes (MA) old untrained individuals 
(OC). Representative immunohistochemical image of muscle fibre CSA from a biopsy 
sample in YC (left), MA (centre) and OC (right) with Type I fibre MHC in red, Type II 
fibre MHC in green and laminin stained cell membrane in green (E). Significance was set 
at P < 0.05. # indicates significantly different from OC (P < 0.05), † indicates 
significantly different from YC (P < 0.05) and * indicates significantly different from MA 
(P < 0.05). Values are presented as the median (central horizontal line), 25th and 75th 






Figure 10. Myonuclear domain in Type I (A) and Type II muscle fibres (B) and number of 
nuclei per Type I (C) and Type II muscle fibre (D) in young untrained individuals (YC), 
old endurance trained Master Athletes (MA) old untrained individuals (OC). 
Representative immunohistochemical image of fibre-type myonuclei from a biopsy sample 
in YC (left), MA (centre) and OC (right) with DAPI stained nuclei in blue, Type I fibre 
MHC in green and laminin stained cell membrane in green (E). Significance was set at P 
< 0.05. # indicates significantly different from OC (# P < 0.05 and ## P < 0.01), * 
indicates significantly different from MA (P < 0.05). Values are presented as the median 
(central horizontal line), 25th and 75th percentiles (box), minimum and maximum values 




Figure 11. Capillary contacts per fibre (CC), capillary to fibre ratio (Cfi) and capillary to fibre 
perimeter exchange index in Type I fibres (A, C and E, respectively) and Type II fibres (B, D and 
F, respectively), in young untrained individuals (YC), old endurance trained Master Athletes 
(MA) old untrained individuals (OC). Representative immunohistochemical image of fibre-type 
capillarisation from a biopsy sample in YC (top), MA (middle) and OC (bottom) with CD31 
stained capillaries in purple (denoted by white arrows), Type I fibre MHC stained in green and 
laminin stained cell membrane in green (G). Significance was set at P < 0.05. ## indicates 
significantly different from OC (P < 0.01), †† indicates significantly different from MA (P < 
0.01). Values are presented as the median (central horizontal line), 25th and 75th percentiles 
(box), minimum and maximum values (vertical lines) and mean (cross). 
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Figure 12. Satellite cell (SC) number per Type I (A) and Type II muscle fibre (B), in young 
untrained individuals (YC), old endurance trained Master Athletes (MA) old untrained 
individuals (OC). in young untrained individuals (YC), old endurance trained Master Athletes 
(MA) old untrained individuals (OC). Representative immunohistohemical image of fibre-type 
SC from a biopsy sample in YC (left), MA (centre) and OC (right) with DAPI stained nuclei in 
blue, Type I fibre MHC stained in green, laminin stained cell membrane in green and Pax7 
stained SC in red (C). Circles represent SC (Pax7) overlaid with nuclei (DAPI). White circles 
represent SC associated with a Type I fibre (MHCI positive), yellow circles represent SC 
associated with a Type II fibre (MHCI negative). Significance was set at P < 0.05. Values are 
presented as the median (central horizontal line), 25th and 75th percentiles (box), minimum and 
maximum values (vertical lines) and mean (cross). 
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3.5. DISCUSSION 
Ageing has a deleterious effect on physiological function, muscle mass, and 
strength (sarcopenia) and muscle oxidative capacity that may be exacerbated by low 
physical activity. As such, individuals who have chronically undertaken structured 
exercise training, or Master Athletes (MA), provide an opportunity to study mechanisms 
of inherent physiological ageing dissociated from inactivity (Lazarus and Harridge, 2017). 
Previously, we have highlighted the dearth of studies providing a comprehensive 
characterisation of the MA phenotype (McKendry et al., 2018). Herein, we address this 
issue by firstly demonstrating that endurance-trained MA display superior body 
composition (lower body fat and higher skeletal muscle mass index) and aerobic fitness 
compared with untrained age-matched older individuals (OC), to a level comparable with 
untrained healthy young individuals (YC). Secondly, our novel morphological insights 
demonstrate that MA displayed larger Type I muscle fibre area than OC and no evidence 
of an age-related reduction in Type II fibre area compared with YC. Furthermore, MA 
displayed greater capillarisation of Type I and II fibres compared with OC and YC. Type 
II fibre myonuclear domain size was greater in YC compared with OC and MA, whereas 
SC content was similar between groups. Taken together, these data suggest that chronic 
exercise training promotes superior physiological conditioning, which may have 
implications for healthspan extension.  
Sarcopenia is often accompanied, and in some cases masked, by increased 
adiposity (Baumgartner, 2000) and ectopic and visceral fat deposition (Goodpaster et al., 
2000a, Smeuninx et al., 2017). Reduced muscle mass and increased body fat are 
independently and concomitantly associated with increased risk of metabolic disease (Lu 
et al., 2013), frailty (Buch et al., 2016), and mortality (Atkins et al., 2014). It is well 
established that exercise training leads to improvements in body composition. Thus, the 
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absence of sufficient physical activity in the face of surplus energy intake in older age, 
increases the likelihood of unfavourable changes in body composition (i.e., reduced 
muscle mass and increased body fat). Furthermore, periods of inactivity and disuse impair 
the normal muscle anabolic response to protein nutrition and accelerate the progression of 
sarcopenia (Breen et al., 2013). Our data demonstrate that MA had a greater skeletal 
muscle index and lower body fat than OC. This more favourable lean-to-fat mass ratio in 
MA vs. OC, in combination with high habitual activity, offers a likely explanation for the 
lower whole-body insulin resistance. Thus, it is clear that the continuation of structured 
endurance exercise training promotes a favourable body composition and likely confers 
significant physiological benefits. 
Age-related loss of skeletal muscle mass and strength involves alterations in 
architectural properties and fibre-type morphology. With ageing, muscle fibre fascicle 
length and pennation angle decrease, indicating a loss of sarcomeres (in series and 
parallel) that would impair muscle force generating capacity (Narici et al., 2003). Our 
findings demonstrate that muscle fibre fascicle length and pennation angle properties were 
generally lower in OC and MA, compared with YC, with no clear differences between 
MA and OC. Similarly, previous studies have reported equivalent vastus lateralis fascicle 
length between young and old sprint athletes (Korhonen et al., 2006). However, fibre 
pennation angle and fascicle length of the vastus intermedius and gastrocnemius medialis, 
respectively, were greater in YC compared with OC only, with no difference between OC 
and MA. These data indicate that the alterations to muscle architectural properties with 
advancing age are not preserved with chronic endurance exercise training. The observed 
architectural modifications in MA and OC may be necessary to arrest the decline in force 
production with age-related muscle loss. In comparison with endurance exercise, 
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contractile loading in the form of resistance training may be required to generate sufficient 
mechanical tension to enhance muscle architectural properties in older individuals (Reeves 
et al., 2004a). 
 Reductions in muscle fibre number and area, specifically of Type II fibres, is a 
characteristic of sarcopenia (Nilwik et al., 2013). In older individuals, resistance training 
increases Type II fibre area (Kosek et al., 2006), whereas endurance exercise training 
primarily augments Type I fibre area (Harber et al., 2012). Skeletal muscle morphology 
data in MA are scarce, and available studies have yielded conflicting findings (Zampieri et 
al., 2015, Mackey et al., 2014, McKendry et al., 2018), making it difficult to fully 
elucidate the mechanisms through which chronic exercise enhances physiological function 
and healthspan. In line with previous findings (Aagaard et al., 2007b, Zampieri et al., 
2015, Mosole et al., 2014), we demonstrate that endurance trained MA have larger Type I 
fibres than OC, and a greater proportion of Type I fibres compared with YC and OC. 
Compared with OC, the superior Type I fibre properties of MA suggests that their greater 
maximal aerobic capacity may be partly underpinned by a greater muscle oxidative 
potential, although we acknowledge the contribution of cardiorespiratory factors in 
VO2max. Although there was no significant difference in Type II fibre area between MA 
and YC, neither was there any significant difference in MA vs. OC. However, it is worth 
noting that OC were very healthy, based on strict exclusion criteria, which may explain 
why we were unable to detect a difference in Type II fibre area compared with MA. 
Regardless, we are unable to conclude that chronic endurance exercise preserves Type II 
fibre area and due to technical limitations, we were only able to analyse two fibre types. 
Given evidence that ageing leads to a reduction in Type IIA fibres, an increased proportion 
of fibres co-expressing different MHC isoforms, and that physical activity can offset these 
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alterations (StJeanPelletier et al., 2017), future investigations should seek to 
determine more specific and hybrid fibre-types. Nevertheless, the current data suggest that 
chronic endurance exercise elicits a mode-specific remodelling of muscle fibres, such that 
fibre area is greater (Type I) or indistinguishable (Type II) from YC. 
Skeletal muscle SC, as the main source of new myonuclei, play an important 
regulatory role in the repair and regeneration of skeletal muscle (Snijders et al., 2015). 
Given that age-related Type II fibre atrophy is accompanied by a reduction in Type II SC, 
and that SC content is a strong predictor of muscle fibre size in older individuals (Verdijk 
et al., 2007, Verdijk et al., 2010), reductions in SC may impair the capacity for muscle 
maintenance in old age. As such, we were surprised to find no age-related difference in 
fibre-specific SC content between YC and OC. That we observed no influence of chronic 
endurance exercise on SC is consistent with evidence that the SC pool remains constant in 
response to endurance-based training programmes in humans (Joanisse et al., 2015). The 
absence of any difference in fibre-specific SC between groups, could be due to a large 
within-group variability in the sub-set of samples available for analysis. In addition to SC 
content, others have shown that SC activity, which is critical for muscle repair and 
regeneration with exercise-induced damage, is delayed in older individuals (Snijders et al., 
2014) and increases in response to endurance training programmes (Joanisse et al., 2015). 
Measurement of SC activation was beyond the scope of the current study, but could be 
maintained in MA and warrants further investigation. The area of the cell governed by 
each myonucleus (myonuclear domain) was greater in Type II fibres of YC compared with 
OC and MA, whereas Type I fibre myonuclear domain size was similar between groups. 
Taken together, these data indicate that larger Type I fibre area in MA vs. OC, occurs 
independently of alterations in SC content or myonuclear domain, which appear relatively 
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constant with ageing and chronic endurance training. Furthermore, the lower Type II fibre 
area in OC vs. YC was mirrored by a diminution of the myonuclear domain and we 
speculate preceded any change in SC content. Finally, diminution of the Type II fibre 
myonuclear domain in MA compared with YC, preceded any detectable reduction in Type 
II fibre area.    
Impairments in muscle perfusion and the delivery of oxygen and nutrients to 
skeletal muscle from nearby capillaries, may impair muscle oxidative capacity and 
contribute to the development of age-related muscle anabolic resistance and sarcopenia. 
Indeed, capillary density is reduced in older age, particularly in Type II fibres (Proctor et 
al., 1995), thereby impairing muscle fibre perfusion. In older muscle, the capillary-to-fibre 
ratio and the capillary-to-fibre perimeter exchange index is reduced, and the distance 
between satellite cells and the nearest capillary is greater in Type II fibres compared with 
younger individuals (Nederveen et al., 2016). This may have consequences for the 
responsiveness of SC to facilitate skeletal muscle repair and remodelling processes in 
response to contraction-induced muscle damage. In contrast to the findings of Nederveen 
et al. (2016), we did not observe any age-related reduction of indices of capillarisation, 
which may be reflective of the greater aerobic capacity of our cohort (~10.0 mL·kg-1·min-
1), and our relatively small sample size. Nevertheless, it is clear from our results that 
chronic endurance exercise training leads to greater Type I and II fibre capillarisation in 
MA compared with OC and, in some cases, YC. These findings are consistent with 
previous evidence that the continuation of endurance training into older age maintains 
skeletal muscle capillarisation (Coggan et al., 1990, Proctor et al., 1995), regardless of 
training mode and intensity (Gries et al., 2018). However, recent evidence from a cross-
sectional analysis of highly trained cyclists suggests that chronic endurance training does 
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not prevent a degree of decline in capillary density (Pollock et al., 2018). Nevertheless, the 
greater muscle fibre capillarisation observed in our cohort of endurance-trained MA may 
explain their larger Type I fibre area and ‘youthful’ aerobic fitness, alongside any notable 
age-related decline in Type II fibre area (Snijders et al., 2017).  
Whilst our findings demonstrate superior aerobic capacity, body composition and 
muscle morphology in MA compared with OC, in many cases MA were indistinguishable 
from OC. This suggests that chronic endurance exercise is not completely protective 
against the age-related decline in a number of parameters. In addition, the cross-sectional 
nature of this study, and absence of a young endurance trained cohort precludes us from 
determining how chronic exercise influences the trajectory of physiological decline. 
Nonetheless, evidence suggests that MA still experience physiological and functional 
deterioration compared with their untrained age-matched counterparts (Pollock et al., 
2015, Pearson et al., 2002). Therefore, according to the theory of Lazarus and Harridge 
(Lazarus and Harridge, 2017), chronic exercise shifts the ‘set-point’ from which the 
deterioration of physiological health, function or muscle morphology begins, but does not 
necessarily slow the rate of age-related deconditioning. Nonetheless, chronic exercise 
training appears to ostensibly compress the time spent with disease and disability closer to 
the natural end of life. Given the suggestion that the rate of physiological deterioration 
may be greater beyond the age of 75 years in MA compared with their untrained older 
counterparts (Lazarus and Harridge, 2017), it would be prudent to examine whether the 
differences in physiological function and morphology reported here are still apparent 
beyond 80 years of age. In our recent meta-analysis, we identified that chronic exercise 
training protects against the age-related loss of physiological function and adverse shifts in 
body composition in a mode-specific manner (McKendry et al., 2018). Consistent with 
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this, our findings show that chronic exercise training did not promote superior strength in 
MA compared with OC, and that YC were stronger than both OC and MA. Given the 
unquestionable potency of strength training for maintenance of muscle mass, strength and 
function in older age, investigations of physiological function and muscle morphology in 
strength trained MA will improve our understanding of the chronic health benefits of 
different exercise modes. Finally, given suggestions that the rate of physiological decline 
and impairments in muscle protein turnover may differ between older men and women 
(Kim et al., 2018), there is a need for further exploration of potential sex-specific 
differences in physiological function and muscle morphology of MA.  
In conclusion, our findings demonstrate that chronically endurance trained MA 
display superior aerobic fitness, body composition, and indices of muscle fibre 
morphology compared with age-matched untrained older individuals, and display a 
phenotype that, in some respects, more closely resembles that of a healthy young untrained 
individual. These novel insights shed light on the extent to which chronic endurance 
training promotes physiological health and function in older age. Irrespective of whether 
chronic endurance exercise offsets the trajectory of sarcopenia or simply shifts the set-
point from which muscle deterioration begins, the continuation of chronic exercise 
training appears to ‘buy back’ years of physiological function and health. Although the 
endurance trained older individuals in this study were competitive Master Athletes, this 
high-level of training may not be necessary to reap significant physiological function and 
health benefits. Instead, the incorporation of regular structured exercise training, that 
elicits sufficient intensity of effort,  offers a viable strategy to arrest age-related 






4. Integrated Muscle Protein 
Synthesis Rates Are Comparable 
Between Endurance-Trained 






Background: An impaired muscle anabolic response to exercise and protein nutrition is 
thought to underpin age-related muscle loss. This muscle ‘anabolic resistance’ of old age 
may be exacerbated by aspects of biological ageing that may not be present in chronically 
trained older individuals, or master athletes (MA). The aim of this study was to compare 
basal and exercise-induced rates of integrated muscle protein synthesis (iMPS) and 
intracellular anabolic signaling in MA with healthy age-matched untrained individuals 
(OC).  
Methods: In a parallel study design, iMPS rates were determined over a 48 h basal period 
and over 48 h following a bout of resistance exercise in 8 OC (73.5 ± 3.3 y) and 7 MA 
(68.9 ± 5.7 y). Serial skeletal muscle biopsies and daily saliva samples were obtained to 
determine iMPS rates using deuterated water (D2O). In addition, intramuscular anabolic 
signalling was determined at 1 h post-exercise. Physical activity was monitored 
throughout and dietary intake was controlled during the iMPS measurement period.   
Results: Anthropometric characteristics, habitual daily activity and dietary intake were 
similar between groups (P>0.05). There was no difference in basal rates of iMPS between 
OC (1.47 ± 0.06%·day-1) and MA (1.46 ± 0.08%·day-1). Resistance exercise significantly 
increased iMPS in both OC (1.61 ± 0.08%·day-1, P<0.01) and MA (1.61 + 0.08%·day-1, 
P<0.01), with no difference between groups (P>0.05). AktThr308 phosphorylation was 
significantly increased at 1h post-exercise in OC (P<0.05), but not MA (P>0.05). No other 
differences in intramuscular anabolic signalling were apparent between groups (P>0.05) .  
Conclusions: Overall these data suggest that basal and exercise-induced iMPS are 
indistinguishable between MA and OC. Importantly, the OC retain a capacity for exercise-




The rapidly expanding ageing population presents a substantial concern amongst 
healthcare professionals and researchers alike. By the year 2050, ~23 million people will 
be aged 60 years or older, accounting for >30% of the UK population (Office for National 
Statistics: https://www.ons.gov.uk). The overwhelming challenge is that the time spent in 
good health in older age (i.e. health-span) is not expanding at the same rate as average life 
expectancy (Seals et al., 2016). Thus, it is critical that effective strategies to minimise the 
gap between life- and health-span are identified.  Skeletal muscle is vital for the 
maintenance of physical function, nutrient deposition and basal metabolism (Frontera and 
Ochala, 2015). Ageing leads to a progressive loss of skeletal muscle mass, which 
progresses at a rate of 0.5-1% per annum from the 5th decade, alongside 3-5-fold greater 
reductions in strength (Janssen et al., 2000, Delmonico et al., 2009). Accordingly, 
sarcopenia may drive the development, and progression, of many adverse health events 
(Biolo et al., 2014, Narici and Maffulli, 2010) and force a dependence on external 
healthcare services (Sonn, 1996, Pinedo-Villanueva et al., 2019).  
 Sarcopenia (age related loss of muscle mass and function) (Rosenberg, 1989) 
progression is thought to be underpinned by inherent ageing factors (i.e. hormonal 
changes) and aggravated by environmental and lifestyle factors (i.e. poor nutrition, obesity 
and reduced activity) (Narici and Maffulli, 2010, Smeuninx et al., 2017), that blunt the 
muscle protein synthesis (MPS) response to normally robust anabolic stimuli, such as 
amino acids (Breen and Phillips, 2011, Shad et al., 2016). This age-related muscle 
‘anabolic resistance’ may be underpinned by impairments in ribosomal biogenesis and/or 
translational efficiency in the mechanistic target of rapamycin complex 1 (mTORC1) 
signaling pathway (Guillet et al., 2004, Brook et al., 2016, Kumar et al., 2009). Although 
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exercise is effective at enhancing muscle anabolic sensitivity (Timmerman et al., 2012, 
Yang et al., 2012) and augmenting muscle mass and strength in older individuals 
(Fiatarone et al., 1990, Frontera et al., 1988), adaptive remodelling responses are 
attenuated compared with younger individuals (Greig et al., 2011, Brook et al., 2016). 
However, chronic structured exercise training is known to alter muscle protein turnover 
rates in young and older individuals (Wilkinson et al., 2008b, Short et al., 2004b, 
Yarasheski et al., 1999). Therefore, commencing exercise training in early adulthood, and 
continuing this practice through middle-to-older age, may prevent the decline in muscle 
protein synthesis and onset of muscle anabolic resistance typically seen with advancing 
age.  
 Highly-active older individuals that have maintained structured exercise training 
habits (Master Athletes; MA) display superior indices of physiological function (VO2max 
and strength), muscle morphology and more favourable body composition than their 
untrained age-matched counterparts (McKendry et al., 2018), which could be explained by 
differences in MPS. The only study to date to investigate MPS in MA, reported that 
highly-trained master triathletes (>50 y) displayed a lower MPS rate 72 h following a bout 
of downhill running compared with younger triathletes (Doering et al., 2016). However, 
basal MPS was not measured, which prevents firm conclusions regarding the net MPS 
response to the exercise stimulus. Furthermore, comparison of MA with an untrained older 
cohort (>60 y) is required to understand whether chronic endurance exercise modulates 
MPS. A recent study has demonstrated that physiological function (i.e., VO2max, strength) 
and indices of muscle morphology appear to deteriorate at a similar relative (if not 
absolute) rate in highly-trained MA and untrained older individuals (Pollock et al., 2015, 
Pollock et al., 2018, Pearson et al., 2002). However, the impact of chronic exercise 
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training on in vivo metabolic and molecular regulation of skeletal muscle mass in older 
age, is less clear.  
Therefore, the primary aim of this study was to compare 48 h basal and exercise 
contraction-induced integrated MPS (iMPS) rates between MA and age-matched untrained 
individuals. The secondary aim was to establish the acute intramuscular signalling 
response to an acute bout of exercise contraction. We hypothesised that basal iMPS rates 
would be similar between groups, but that contraction-induced iMPS rates and 
intramuscular signalling responses would be greater in MA versus age-matched untrained 
individuals, indicative of a greater (or maintained) capacity for muscle remodelling in 
lifelong exercisers.  
 
4.3 METHODS  
4.3.1. Participants 
Eight untrained older individual controls (OC) and 7 master endurance athletes 
(MA) were recruited through local advertisement at athletics and cycling clubs, the British 
Masters Athletics Federation and the League of Veteran Racing Cyclists. Older control 
participants (60-80 years) were deemed eligible for the study only if they had maintained 
habitual activity levels and had not previously participated in any form of structured 
exercise training outside of recreational activities. Master athletes (60-80 years) were 
included only if they self-reported maintaining continuous endurance training at least 
twice per week for ≥20 years preceding the study. Participant anthropometric and training 
characteristics are detailed in  
Table 9. All participants were informed of the purpose and methodology of the 
study, were deemed healthy by completion of a general health questionnaire assessment, 
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and provided their written informed consent. Ethical approval was obtained through the 
East Midlands – Derby Research Ethics Committee (18/EM/0004). The study conformed 
to the standards set by the Declaration of Helsinki (7th version). 
 
4.3.2. Study design 
In a parallel study design, OC and MA were recruited to investigate the effects of 
chronic endurance training on the regulation of muscle mass in an older population 
(detailed in the study schematic, Figure 13). Following initial study screening and 
consenting, participants reported to the School of Sport, Exercise and Rehabilitation 
Sciences (SportExR) laboratory on four separate occasions. For each visit, participants 
reported to SportExR in an overnight fasted-state and were asked to refrain from caffeine 
consumption on the day of the trial. Further, participants were asked to refrain from 
strenuous physical activity and alcohol for the duration of study involvement.  
 
Visit 1: During the initial visit, participants underwent physical anthropometry and body 
composition measurements, and provided a single saliva sample which was collected daily 
throughout study involvement. After a baseline assessment of blood pressure and body 
composition, participants undertook bilateral 1 repetition maximum (1RM) strength 
testing and familiarisation with the exercise protocol. Following this, participants were 
given a bolus of deuterated water (D2O) and daily top-ups for the measurement of muscle 
protein synthetic rates. Participants were supplied with a pedometer to monitor their 
habitual daily activity.  
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Visit 2: Seventy-two hours following visit 1, participants provided a single saliva sample 
and a muscle biopsy was collected. Participants were provided with a weight maintenance 
food parcel, matched for total calories and macronutrient content for the subsequent 4 days 
to standardise dietary conditions and reduce the influence of dietary variances between 
individuals.  
 
Visit 3: Forty-eight hours following visit 2, participants provide a single saliva sample and 
a muscle biopsy was collected to determine basal iMPS. Following this, participants 
completed an intense bout of leg resistance exercise, which involved performing 6 sets of 
10 repetitions of leg extension exercise at 75% of their predetermined 1RM. Each set was 
separated by 2 mins of passive rest. Participants then rested for 1 hour before another 
muscle biopsy was collected to examine the acute intramuscular signalling response to the 
resistance exercise bout.  
 
Visit 4: Forty-eight hours following visit 3, participants reported to SportExR to provide a 
final saliva and muscle biopsy sample to determine exercise-induced iMPS, after which 
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Figure 13. Schematic overview of the experimental design. LBM; lean body mass. 
 134 
4.3.3. Experimental Procedures 
Body mass, height and composition: Body mass was determined by weighing each 
participant in loose clothing, without shoes, to the nearest 0.1 kg using a digital balance 
scale (Seca 813, Hamburg, Germany). Height measurements were made to the nearest 0.1 
cm using a stadiometer (Seca 217, Hamburg, Germany). Participants underwent 
bioelectrical impedance analysis in order to determine fat and fat-free mass (Bodystat 
QuadScan 4000, Bodystat Ltd, Isle of Man, British Isles). Individuals were instructed to 
lie in a supine position for  ~10 mins to allow for any fluid shifts and electrodes were 
attached to the right-side hand and foot.  
 
Blood Pressure: Blood pressure was measured using a standard fully automatic blood 
pressure monitor (OMRON M2, OMRON Healthcare UK Ltd., UK). Participants were 
asked to remove any clothing that obstructed the blood pressure cuff. Participants were 
seated with their legs uncrossed and back supported, encouraged to relax and refrain from 
talking during the assessment. This test was repeated 3 times and the highest reading 
taken. 
 
Leg extension 1RM and exercise familiarisation: Individuals undertook 1RM bilateral 
knee-extension strength testing (Elite Series – Leg Extension / Curl, Fitness Warehouse 
Ltd, Preston, Lancashire, UK). Participants were instructed on proper lifting technique and 
carried out a warm up set of 10 repetitions at ~ 40% 1RM. Following which, the weight 
was increased and the repetitions reduced utilising a standardised 1RM testing protocol 
adapted from Mayhew et al. (1992) (Mayhew et al., 1992) until the participants could no 
longer lift the desired load, with correct form, for 1 repetition. Individuals provided 
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feedback on the difficulty of each set using an adapted Borg Scale (CRT-10) (Day et al., 
2004, Buckley and Borg, 2011) . Participants rested for 2 mins between each set, and 3 
min rest was provided between 1RM attempts. The inclusion of a resistance exercise 
stimulus in this study provided a novel stimulus for both OC and MA cohorts; as it has 
been demonstrated that chronic exercise training in young elicits a more refined, fraction 
specific skeletal muscle remodelling response (Tang et al., 2008, Wilkinson et al., 2008a).   
 
Physical activity and dietary control: Participants were provided with a standard, wrist-
worn, pedometer (ID115HR LETSCOM, Hong Kong) to record the average total daily 
step count over the duration of the study. Participants were asked to refrain from strenuous 
exercise for the duration of study involvement. Participants were also provided with a 
standardised, weigh-maintenance diet (~50% carbohydrate, ~30% fat and ~15% protein) 
to consume during involvement in the study. Energy requirements were calculated using 
the Harris-Benedict equation (Harris and Benedict, 1919). Participants could choose from 
a selection of pre-packaged food options, which consisted of 3 main meals (breakfast 
lunch and dinner), between-meal snacks and beverages. Food was provided between visit 
2 and visit 4, over the course of iMPS measurement. Participants also consumed a 
beverage containing 20g of whey isolate protein (MyProtein, Northwich, UK), following 
the second biopsy on visit 3 (i.e. 1 h post-exercise) to augment exercise-induced MPS 
similarly in MA and OC in the initial several hours of recovery (Yang et al., 2012).   
 
D2O Protocol: Stable isotopically labelled D2O was provided to participants throughout 
study involvement. To rapidly increase the body water enrichment of deuterium (2H) to 
~0.2%, participants consumed a bolus dose of D2O on day 1 (0.8 x 3 x lean body mass 
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(LBM)). To maintain the ~0.2% enrichment of body water throughout study involvement, 
participants consumed a daily top dose of D2O (0.3 x LBM). Total body water enrichment 
was used as a surrogate for deuterated-alanine labelling as previously described 
(Wilkinson et al., 2014). All doses were consumed in the morning, immediately following 
saliva sample provision. Saliva samples were collected in the morning, immediately on 
waking. Participants chewed a cotton swab for ~2 mins or until completely saturated. 
Samples were stored in the fridge and brought in during their next lab visit. Saliva was 
pressed out of the swab using a 5 mL syringe into two separate glass vials, sealed and 
stored at -20°C until later analysis.  
 
Muscle Biopsy: Muscle biopsy samples were obtained from the quadriceps vastus 
lateralis under local anaesthesia (1% lidocaine) using the Bergström needle technique 
(Bergstrom, 1975). Muscle biopsy tissue was quickly rinsed in ice-cold saline and blotted 
to remove any visible fat and connective tissue before being frozen in liquid nitrogen. 
 
4.3.4. Data analyses 
Muscle protein synthesis: Muscle samples (~30-35mg) were homogenised in ice cold 
homogenisation buffer. Samples were centrifuged to separate the sarcoplasmic and 
myofibrillar fractions. The myofibrillar fraction was purified and hydrolysed to the 
constituent amino acids. The free amino acids were further purified on cation-exchange 
columns, dried and reconstituted in 0.1m HCl before analysis by gas chromatography 
combustion isotope ratio mass spectrometry (Metabolic Solutions, Nashua, NH). Muscle 
preparations were analysed for deuterated-alanine (2H-alanine) with a Thermo Finnigan 
Delta V isotope ratio mass spectrometry coupled to a Thermo Trace GC Ultra with a gas 
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chromatography combustion interface III and Conflow IV. The N-acetyl n-propyl ester of 
alanine was analysed using a splitless injection and a Zebron ZB-5 column of 30 m × 0.25 
mm × 0.50 μm film thickness (Phenomenex, Torrance, CA). The gas chromatography 
oven was programmed with an initial column temperature of 80°C with a 2-minute hold, 
followed by a ramp of 30°C min−1 to 330°C. Eluents were directed into the pyrolysis 
reactor, heated at 1450 °C, and converted to hydrogen gas (Metabolic Solutions, Nashua, 
NH); as described previously (Bell et al., 2015). Saliva samples were analysed for 2H 
enrichment by cavity ring-down spectroscopy (L2130-i, Picarro Inc., California, USA). 
The water phase of the saliva was injected six times, and the average of the last three 
measurements was used for data analysis. The 2H isotopic enrichments for muscle and 
saliva initially expressed as δ2H‰ were converted to atom percent excess using standard 
equations as previously described (Wilkinson et al., 2014).  
 
Intramuscular signalling: Western blot analyses were performed on the sarcoplasmic 
fraction obtained during myofibrillar isolation (previously described (Smeuninx et al., 
2018)). Sarcoplasmic protein content was determined by a DC protein assay before 
western blot aliquots of 2 µg protein per 1 µL were prepared in 4X Laemmli sample buffer 
and sucrose lysis buffer and subsequently boiled for 5 min. Equal amounts of protein (30 
µg) were loaded onto 8-12.5% gels and separated by SDS-PAGE for ~1 h. Following 
electrophoresis, proteins were transferred onto a biotrace nitrocellulose membrane (Pall 
Laboratory, Portsmouth, UK.) for 1 h at 100 V. Membranes were subsequently blocked in 
5% skimmed milk for 1 h and washed 3 times for 5 mins in TBST before overnight 
incubation at 4 ˚C in following primary antibodies (1:1000): phospho-70 kDa S6 protein 
kinase (p70S6K1) Thr389 (#9205), total p70S6K1(#9202), phospho-eukaryotic initiation 
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factor 4E binding protein (4E-BP1) Thr37/46 (#9459), total 4E-BP1 (#9452), phospho-
eukaryotic elongation factor 2 (eEF2) Thr56 (#2331), total eEF2 (#2332), phospho-protein 
kinase B (Akt) Ser473 (#3787), total Akt (#9272), phospho-AMP activated protein kinase 
a (AMPK⍺) Thr172 (#2535), total AMPK⍺ (#5831), phospho-p44/42 MAPK (Erk 1/2) 
Thr202/Tyr204 (#4370), total p44/42 MAPK (#4695), phospho-S6 Ser240/244 (#5364), 
total S6 (#2217), phospho-tuberous sclerosis 2 (TSC2) Thr1462 (#3611), total TSC2 
(#4308) (Cell Signalling Technology, UK.). Membranes were washed 3 times for 5 min in 
TBST and incubated for 1 h in their respective secondary antibody (Anti-Rabbit IgG, 
HRP-linked Antibody (#7074)) (1:10000) and washed again 3 times for 5 min in TBST. 
Protein quantification was achieved by incubating the membranes for 5 min in Immobilon 
Western chemiluminescent HRP substrate (Merck Millipore, Watford, UK.) before being 
imaged using a G:BOX Chemi XT4 imager using GeneSys capture software (Syngene, 
Cambridge, UK.). Bands were quantified using Image Studio Lite (Li-Cor, Lincoln, 
Nebraska, U.S.).  
 
Calculations: The fractional synthetic rate (FSR) of myofibrillar protein was calculated 
using the standard precursor-product method as described previously (Chinkes et al., 
1993). In brief: 
!"#	(%	'()*+) = 	 .(/0123 − /012+)/56	7	8
9 7	3.7	7	100 
 
Where EAlaX is the protein-bound enrichment (in atom percent excess) from muscle 
biopsies at time X. EBW is the mean 2H enrichment (in atom percent excess) in total body 
water between the time points. t is the tracer incorporation time in days. Multiplication by 
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3.7 adjusts for the average number of 2H atoms that can become incorporated into alanine, 
and multiplication by 100 converts the values to percentages. 
 
Statistics: Baseline characteristics were compared using an independent samples t-test. 
Normality of data was assessed using the Shapiro-Wilk test. Muscle protein synthesis and 
intramuscular signalling were compared using a mixed-design ANOVA, one between-
group factor (group) and one within group factor (time). Significance was set at P<0.05. 
Data are presented as means ± standard deviation unless otherwise indicated. All analyses 
were performed using SPSS version 25 for Windows (SPSS, Inc., Chicago, Illinois). 
 
4.4 RESULTS 
Participant characteristics: Participant anthropometric and training characteristics are 
detailed in Table 9. No significant differences were apparent in any of the baseline 
characteristics between the groups, excluding exercise training background.  
 
Exercise and habitual daily activity: No significant difference was apparent between OC 
(92 ± 18 kg) and MA (100 ± 7 kg) in bilateral knee extension 1RM strength and total 
exercise volume completed (i.e., sets x repetition x load) was not difference between OC 
(3861 ± 581 kg) and MA (4277 ± 373 kg). The rating of perceived exertion (RPE) was not 
difference between OC (8 ± 2) and MA (8 ± 2). Average daily step count over the course 
of the study was not significantly different between OC (8386 ± 1708 steps·day-1) and MA 
(7746 ± 1831 steps·day-1).  
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 OC (N=8) 
MA 
(N=7) 
Age (years) 73.5 ± 3.3 68.9 ± 5.7 
Height (m) 1.73 ± 0.06 1.76 ± 0.08 
Body mass (kg) 73.8 ± 8.5 70.0 ± 4.5 
BMI (kg×m-2) 24.8 ± 3.3 22.0 ± 1.6 
Whole-body FFM (kg) 52.9 ± 3.6 52.0 ± 3.8 
Whole-body FM (kg) 20.9 ± 6.9 16.0 ± 1.5 
Body fat (%) 27.8 ± 6.7 23.6 ± 1.9 
Skeletal Muscle Index (%) 72.2 ± 6.7 76.4 ± 1.9 
Systolic Blood Pressure (mmHg) 134 ± 10 130 ± 8 
Diastolic Blood Pressure (mmHg) 78 ± 9 81 ± 3 
Training Experience (years) - 47.7 ± 14.8 
Training Frequency (sessions.week-1) - 4.3 ± 1.6 
Training Duration (hrs.week-1) - 8.4 ± 6.6 
Training Distance (km.week-1) - 180 ± 29 / 55 ±15 
 
Table 9. Participant anthropometric characteristics and training background. Data 
presented as mean ± SD. FFM; fat-free mass, FM; fat mass. * Indicates significantly 










Body water 2H enrichment: Body water 2H enrichment is shown in Figure 14. Body water 
2H enrichment significantly increased in both groups (P<0.001) and steady-state was 
maintained throughout, with no significant difference between groups at any time point.  
 
 
Figure 14. Body water 2H enrichment (Atom Percent Excess; APE) in older untrained 
controls (OC, grey circles) and Master Athletes (MA, white circles). Values are presented 
































Myofibrillar protein synthesis: iMPS is shown in Figure 15. Rates of day-to-day iMPS 
were not different between OC (1.47 ± 0.064 %·day-1) and MA (1.45 ± 0.078 %·day-1). 
iMPS increased significantly in response to resistance exercise in both OC (1.60 ± 0.083 
%·day-1, P=0.032) and MA (1.61 ± 0.078 %·day-1, P=0.034), with no significant 
difference between groups.  
 
 
Figure 15. 48 h Integrated myofibrillar Protein Synthesis rates in the basal state and 
following a bout of resistance exercise in older untrained controls (OC, grey bars) and 
Master Athletes (MA, white bars). ** indicates significantly different from basal values (P 
< 0.01). Values are presented as the median (central horizontal line), 25th and 75th 
percentiles (box), minimum and maximum values (vertical lines) and mean (cross). 
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Intramuscular anabolic signalling: Intramuscular anabolic signalling is shown in Figure 
16. Phosphorylation of AktThr308 increased significantly from basal in OC only at 1 h post-
exercise (P=0.032) and phosphorylation of AktThr308 was significantly greater in OC 
compared with MA at 1 h post-exercise (P<0.05). Phosphorylation of p70S6KThr241 tended 
to increase from basal in OC at 1 h post-exercise (P=0.064) with a trend for a greater 
phosphorylation in OC compared with MA at 1 h post-exercise (P=0.079). 
Phosphorylation of RPS6Ser240/244 increased significantly from basal in OC (P=0.033) and 




Figure 16. Intramuscular anabolic signalling at rest and 1 h post resistance exercise in older untrained controls (OC, black bars) and 
Master Athletes (MA, white bars). Significance was set at P < 0.05. * indicates significantly different from basal (P < 0.05). # indicates 




A loss of skeletal muscle mass is a commonly observed consequence of ageing 
(sarcopenia). Anabolic resistance is often proposed as a key mechanism contributing to the 
development, and progression, of sarcopenia (Burd et al., 2013). Anabolic resistance is 
apparent with inherent ageing but thought to be exacerbated by aspects of environmental 
and lifestyle factors (i.e., inactivity, obesity (Smeuninx et al., 2017)). Individuals that have 
regularly undertaken structured exercise training (Master Athletes; MA) display superior 
levels of physiological function and muscle morphology compared with age-matched non-
athletes (OC), and provide an opportunity to unpick the contribution of inherent and 
biological ageing in sarcopenia (Lazarus and Harridge, 2007). However, there are a dearth 
of in vivo mechanistic studies of muscle metabolic regulation in MA (McKendry et al., 
2018). Here, we provide the first comparison of day-to-day iMPS rates between MA and 
OC under basal and exercise-induced conditions, while under strict control and monitoring 
of diet and activity. Our findings demonstrate no discernible difference in basal or 
exercise-induced iMPS rates between MA and OC. Furthermore, we highlight minor 
differences in the intramuscular anabolic signalling response to exercise between MA and 
OC (i.e., mTORC1 pathway). Taken together, these data suggest that despite divergent 
lifelong exercise habits, MA and OC display a similar capacity to upregulate anabolic 
signalling and iMPS in response to resistance exercise.  
Understanding the underlying causes of sarcopenia and the development of 
therapeutic strategies to combat this disease are of paramount importance. Generally, 
physical activity declines with advancing age (Jefferis et al., 2014) and reductions in 
activity status (i.e., step-reduction or immobilisation) results in the development of muscle 
anabolic resistance and considerable muscle atrophy in young (Glover et al., 2008, Tanner 
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et al., 2015) and old (Breen et al., 2013, Drummond et al., 2012). Although exercise is a 
potent stimulus for increasing acute intramuscular anabolic signalling and MPS, this 
response has been found to be delayed or absent in older compared with younger 
individuals (Drummond et al., 2008, Kumar et al., 2009), alongside a blunted adaptive 
response to exercise training interventions (Greig et al., 2011, Brook et al., 2016). 
Importantly, our MA cohort reported consistent training habits for an average of ~50 
years, and displayed superior physiological function, body composition and muscle fibre 
morphology compared with OC (see chapter 3) (Zampieri et al., 2015, McKendry et al., 
2018). Given evidence that chronic exercise training alters basal and exercise-induced 
MPS responses (Wilkinson et al., 2008b, Short et al., 2004a), it is intuitive to expect that 
MA may demonstrate divergence in their capacity for skeletal muscle remodelling 
compared with OC. Surprisingly, and contrary to our initial hypothesis, basal and 
exercise-induced rates of iMPS were indistinguishable between MA and OC. Thus, the 
superior physiological function and muscle morphological properties reported in MA do 
not appear to be reflected by alterations to either basal or exercise-stimulated MPS rates. 
The current study extends earlier work demonstrating that middle-aged master 
triathletes aged ~53 years have a significantly lower iMPS response to a downhill running 
stimulus compared with young triathletes aged ~27 years (Doering et al., 2016). The 
absence of a basal iMPS measurement and untrained age-matched cohort in the study of 
Doering and colleagues (Doering et al., 2016), precluded the authors from identifying 
whether advancing age and training/activity status influences the iMPS response to 
exercise. The incorporation of a basal measurement of iMPS in the present study 
demonstrates that chronic exercise does not alter the muscle anabolic responsiveness to 
exercise contraction in older age. Previously, no differences in basal iMPS have been 
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reported when comparing young and old individuals (Brook et al., 2016). In the present 
study, OC and MA displayed similar basal rates of iMPS, which are consistent with values 
reported elsewhere in older individuals (i.e., ~1.40 - 1.50%·day-1) (McGlory et al., 2018). 
Thus, differences in physiological function and muscle morphology between MA and 
untrained older individuals (McKendry et al., 2018), appear not to be driven by differences 
in basal iMPS. It is well established that resistance exercise-induced contraction is a potent 
stimulus for MPS in young and old (Moore et al., 2009b, Yang et al., 2012) and that 
chronic exercise training can alter muscle protein turnover rates in young and older 
individuals (Wilkinson et al., 2008b, Short et al., 2004b, Yarasheski et al., 1999). Given 
the plausibility of a diminished exercise-induced iMPS with advancing age in OC (Brook 
et al., 2016), we expected that the iMPS response to exercise-contraction would be greater 
in MA vs. OC. However, our data demonstrate that OC display a similar capacity to 
increase iMPS rates in response to exercise contraction as MA (~10% increase over 48 h 
post-exercise). Despite a similar exercise-induced iMPS response between MA and OC, a 
likely explanation for the disparity in physiological function and muscle morphology 
between MA and OC, may be explained by repeated stimulation of iMPS and muscle 
protein accretion/maintenance over ~50 y of consistent training habits in MA. Finally, 
assuming similar basal iMPS rates between the present study and Doering et al. (Doering 
et al., 2016), the collective evidence suggests that the iMPS response to exercise is 
reduced with advancing age, irrespective of training status.  
To gain further insight into the mechanistic regulation of iMPS, and to identify 
whether detectable differences in MA and OC were apparent, the phosphorylation status 
of a number of intramuscular signalling intermediates were measured at 1 h post-exercise 
contraction. We observed only subtle differences between the groups, in that Akt 
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phosphorylation increased by ~60% at 1 h post-exercise in OC, but not MA. Additionally, 
the phosphorylation of rpS6 increased two-fold in OC and MA, with no differences 
between groups. Unexpectedly, we did not observe a significant increase in the 
phosphorylation of p70S6K or 4E-BP1 in MA, and only a tendency for an increase in 
p70S6K phosphorylation in OC (P=0.06). It may be that the phosphorylation of signalling 
events that regulate MPS is delayed with ageing, regardless of training status, and that a 
response occurred >1 h post-exercise (Smeuninx et al., 2018, Farnfield et al., 2012, 
Drummond et al., 2008). Conversely, the small numbers (i.e., n=8 vs. n=7) recruited for 
this investigation may preclude the identification of within- and between-group 
differences due to the large inter-individual variability in the phosphorylation of anabolic 
signalling proteins. Furthermore, given that protein/amino acid feeding is required to 
maximize intramuscular anabolic signalling events and MPS, fasted-state post-exercise 
biopsy sampling in our study may have only captured a dampened signalling response. 
Therefore, the inclusion of additional post-exercise biopsy collection points, including the 
presence of protein/amino acids, may be required to provide a greater temporal resolution 
of the post-exercise anabolic signalling regulation in MA and OC. Regardless, the acute 
intramuscular phosphorylation events following exercise contraction are complex, and a 
discordance between anabolic signalling responses, MPS and muscle mass gain over time 
have been reported (Mitchell et al., 2014). As such, it is doubtful that transient 
phosphorylation of a single protein could explain a large degree of variation in skeletal 
muscle remodelling. The marginally greater degree of Akt and p70S6K phosphorylation 
evident in OC, could indicate that OC require a greater stimulation of the mTORC1 
pathway intermediates in order to achieve a comparable iMPS response to MA; though 
this speculation requires further confirmation. Taken together, acute basal and exercise 
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contraction-induced anabolic signalling phosphorylation generally were indistinguishable 
between MA and OC, mirroring the equivalent iMPS rates between groups.  
Age-related muscle anabolic resistance is most readily detectable in conditions of 
insufficient exercise volume and/or low doses of protein nutrition (Shad et al., 2016), thus 
mimicking typical habits of older individuals. Previous studies utilising acute intravenous 
infusions of stable isotope tracers have demonstrated age-related muscle anabolic 
resistance in response to exercise (Kumar et al., 2009) and feeding (Breen et al., 2013, 
Smeuninx et al., 2017). The incorporation of an orally ingested D2O isotope tracer in the 
present study, enabled us to assess iMPS in free-living conditions over 48 h, unconstrained 
by a strictly controlled laboratory environment. Recent work has demonstrated that iMPS 
rates measured using D2O closely predict muscle mass gain over time in younger 
individuals (Damas et al., 2016). As such, our findings provide insight into skeletal muscle 
remodelling that may be more reflective of changes in muscle mass over a prolonged 
period than previous acute studies. Specifically, the capacity for exercise-induced muscle 
remodelling appears to be similar between MA and OC. Nevertheless, a number of 
important considerations need to be addressed in future studies. Muscle protein breakdown 
plays an important role in skeletal muscle remodelling (Tipton et al., 2018), and it cannot 
be discounted that disparities exist in the rates of proteolysis between OC and MA. In 
addition, this study did not include a young group for comparison which prevents the 
identification of age-related impairments in iMPS and anabolic signalling. Finally, a RE 
stimulus was incorporated in this study as it presented a novel exercise challenge for both 
MA and OC, although it should be considered that differences in skeletal muscle 
remodelling may become apparent in these two cohorts when investigating fraction-
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specific iMPS (i.e., chronic endurance training may preferentially modify mitochondrial 
protein synthesis rates) (Wilkinson et al., 2008b).  
In conclusion, we have demonstrated for the first time, equivalent rates of basal 
and exercise contraction-induced iMPS in OC and MA, which coincided with a similar 
acute post-RE signalling responses between groups. Irrespective of the superior physical 
capabilities commonly observed in MA, OC still retain the capacity to increase iMPS in 
response to exercise. Furthermore, as MA regularly undertake exercise training, the 
repeated stimulation of adaptive remodelling responses may explain their superior 
physiological function and muscle morphology compared with OC. As a result, emphasis 
should be placed on encouraging individuals to undertake structured exercise training 
early in adulthood to shift the set-point from which age-related physiological deterioration 
begins. Importantly, this should be reflected in revised exercise guidelines, for older 








5. General Discussion   
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The rapidly expanding ageing population warrants investigation into strategies to 
enhance age-related musculoskeletal health with a view to reducing associated healthcare 
costs. Muscle mass and function progressively deteriorate from middle-to-older age 
(termed ‘sarcopenia’). Preservation of skeletal muscle mass and function are critical for 
those looking to progress into their later years, unburdened by disease and illness. 
Protracted periods of disuse (i.e., reductions in physical activity and immobilisation) and 
the presence of obesity, prominent characteristics in the ageing population, exacerbate the 
rate at which skeletal muscle is lost. The continuation of structured exercise training with 
ageing may offer a viable strategy for those looking to postpone the decrease in muscle 
mass and physiological function, and extend their healthspan. Master athletes (MA) are a 
unique older population that have continued to undertake structured exercise training from 
younger through to older age. The study of MA provides an opportunity to distinguish the 
relative contribution of inherent ageing and secondary lifestyle factors (i.e., inactivity, 
obesity) to the reductions in muscle mass and function, and establish the extent and 
mechanisms through which lifelong physical activity can promote healthy musculoskeletal 
ageing and improve quality of life. Despite the obvious significance of studying MA, 
research in this cohort is scarce.  
Therefore, the purpose of this thesis was threefold:  
i) To summarize the current knowledge-base on whether MA preserve indices of physical 
function and skeletal muscle properties by conducting a thorough, systematic, synthesis 
and evaluation of the current literature.  
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ii) To build upon current research by conducting a high-quality cross-sectional study, 
utilising sophisticated measurement techniques to comprehensively characterise 
physiological function, muscle mass and morphology in chronically trained MA.  
iii) To investigate the metabolic regulation of skeletal muscle mass in chronically trained 
MA, and determine whether MA demonstrate superior skeletal muscle remodelling during 
basal conditions and following an exercise stimulus, and to characterise the intramuscular 
mechanisms coordinating this response.  
This chapter provides a brief summary of the key findings from the studies 
reported in Chapters 2-4 of this thesis. First, based on Chapter 2, this section discusses the 
findings of the systematic review carried out, highlighting what has been overlooked in the 
research and provides recommendations for the directions of future research in MA. 
Second, this chapter discusses how the characterisation study carried out in Chapter 3 
addresses some of the shortcomings of previous research and speculates how chronic 
exercise training of divergent modalities in a variety of populations may have altered the 
present findings. Third, Chapter 4 discusses how ageing and chronic exercise training 
impact skeletal muscle mass regulation. Finally, this chapter summarises the collective 
findings of this thesis, identifies the implications of chronic structured exercise training 
and makes recommendations for future research directions. 
 
5.1. Muscle Morphology and Performance in Master Athletes 
The systematic review carried out in Chapter 2 is the first qualitative and 
quantitative synthesis of research carried out in a MA population (McKendry et al., 2018). 
Importantly, this study included MA above 60 years, as typically untrained older 
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individuals at this life stage would have undergone some degree of muscle deterioration in 
skeletal muscle function, mass and morphology as a result of the canonical ageing process. 
The work reported in this thesis has clearly demonstrated that some, but not all, age-
related decrements may be delayed with chronic structured exercise training. Specifically, 
this work has shown that body composition (i.e. ratio of lean to fat mass) and indices of 
skeletal muscle function are superior in MA compared with OC in an exercise mode-
specific manner. Specifically, individuals that have carried out chronic endurance training 
display a higher VO2max and those that have undertaken chronic strength training display 
greater muscular strength (McKendry et al., 2018). Poor aerobic capacity and muscular 
strength coupled with a sub-optimal body composition (i.e., low muscle mass and 
increased body fat) drastically increases the risk for the development of disease and 
disability (Ruiz et al., 2008, Lee et al., 2010, Ortega et al., 2012). Thus, older individuals 
should be encouraged to undertake structured exercise training of different modalities. In 
fact, the development of muscular strength, aerobic capacity and a healthy body 
composition through structured exercise training should be a primary focus for individuals 
from a young age or early adulthood. The continuation of endurance and strength training 
throughout the lifespan offers a viable strategy to maintain or enhance aerobic capacity 
and muscular strength. The physiological benefits of lifelong exercise training would 
therefore shift the set-point from which a loss of physiological function occurs, reducing 
the risk, and delaying the onset, of disability, disease and reliance on healthcare services. 
Consequently, functional independence would be maintained, the health-span extended 
and the over-all quality of life improved in chronically trained older individuals.  
In Chapter 2, this work highlighted a dearth of studies utilising sophisticated 
measurement techniques to characterise skeletal muscle mass and morphological 
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characteristics in MA. Accordingly, there was no clear consensus as to whether or not 
chronic exercise training, regardless of modality, can protect against the canonical age-
related alterations to physiological function, strength, muscle mass, architectural 
properties and muscle fibre morphology. Furthermore, the present work identified data for 
only 268 women, whereas data for 2181 men were included. Seemingly, men and women 
undergo distinct age-related physiological deterioration; perhaps driven by sex-specific 
hormonal alterations (Hansen and Kjaer, 2014, Kim et al., 2016b). Taken together, this 
work has identified a paucity of modality-specific, mechanistic research of men and 
women MA. In order to address this, future studies should adopt a more mechanistic 
approach, utilising appropriate measurement tools, to identify the impact of chronic 
exercise training on physical function, skeletal muscle mass and morphological properties.  
 
5.2. Superior Physiological Function and Skeletal Muscle Morphology in Chronically 
Trained Master Endurance Athletes Compared with Untrained Older Individuals 
Chapter 3 set out to address some of the shortcomings of MA-related research 
identified in the preceding chapter. The aim of this study was to compare physical 
function, cardiorespiratory fitness, body composition, muscle strength, architecture and 
fibre-type properties in MA, with healthy untrained younger and age-matched older 
individuals. As a result, the present work has shown that endurance trained MA display a 
superior body composition (i.e., lower body fat and higher skeletal muscle index) and 
aerobic fitness compared with OC, and similar to that of YC. At the architectural level, 
fibre pennation angle and fascicle length in MA and OC are generally lower than YC, with 
some exceptions (i.e. fibre pennation angle and fascicle length of the vastus intermedius 
and gastrocnemius medialis were greater in YC compared with OC, but not MA). 
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Furthermore, at the morphological level MA displayed larger Type I muscle fibre area 
than OC and no evidence of an age-related reduction in Type II fibre area compared with 
YC. Thus, in many cases, MA provide evidence that chronic structured endurance training 
can delay the age-related deterioration in physical function and skeletal muscle properties. 
However, in some cases (i.e., capillarisation) MA were superior to both OC and YC, 
highlighting the potency of endurance training in promoting favourable morphological 
alterations that likely support the superior levels of function and morphology in this 
cohort. In conclusion, the present work demonstrated that irrespective of whether 
structured exercise training alters the trajectory at which age-related deterioration occurs, 
and upward rightward shift of physiological function and its supporting mechanisms may 
be critical in extending the health-span in older individuals who undertake chronic 
exercise training.  
Divergent exercise modes underpin the development of distinct phenotypes and 
functional benefits. The MA cohort included in this study had strictly undertaken chronic 
endurance exercise for a period of ~40 years, consecutively. Initially, this study attempted 
to recruit a fourth group of strength/power trained MA, however we were unable to recruit 
sufficient numbers of Master Power Athletes (MPA) to provide meaningful comparison. 
Nevertheless, it is well established that resistance exercise enhances muscular strength, 
muscle mass and Type II fibre CSA (Kosek et al., 2006), along with alterations to skeletal 
muscle architecture (Suetta et al., 2008, Reeves et al., 2004b). Thus, it could be expected 
that the results observed in endurance trained MA (i.e., greater VO2max) would be mirrored 
in MPA (i.e., greater strength, muscle mass and type II fibre area than OC). Furthermore, 
the absence of young strength and endurance trained men and women, prevents firm 
conclusions on whether or not skeletal muscle parameters do decline in MA, and whether 
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or not sex influences this decline. The decline of men and women’s world-records in 
almost every sporting discipline, leads one to assume that young well-trained individuals, 
regardless of sex or exercise training modality, would display superior physiological 
function and skeletal muscle morphology when compared with MA and MPA. However, it 
is still evident that deterioration in physiological function and skeletal muscle parameters 
still occurs in MA despite continuous exercise training (Pollock et al., 2015, Pearson et al., 
2002). Nevertheless, structured exercise training throughout life offers an excellent 
strategy to shift the set point of deterioration upwards and to the right, to support optimal 
ageing.  
 This work drew attention to the scarcity of fibre-type specific satellite cell data in 
MA research. A reduction in satellite cell content of older muscle, specifically in Type II 
fibres (Snijders et al., 2009), has been demonstrated. In Chapter 3, this work has shown no 
difference in satellite cell content between MA, OC and YC between Type I or Type II 
muscle fibres or between groups. This discrepancy could be explained by the high 
physical function and aerobic capacity displayed in our cohort of OC. It should be 
considered that satellite cell content, under basal-rested conditions, may not be indicative 
of skeletal muscle repair capacity. Nevertheless, twelve weeks of heavy resistance 
exercise results in an increase in satellite cell content (Mackey et al., 2007), and aerobic 
exercise has been shown to increase satellite cell content, specifically in Type I muscle 
fibres (Fry et al., 2014). Considering these findings, our observations appear perplexing. 
The inclusion of an exercise stimulus and additional muscle biopsy samples would provide 
a more comprehensive insight into whether chronic exercise training is preventative of 
age-related decline in skeletal muscle repair mechanisms. However, the purpose of this 
study was a cross-sectional characterisation of muscle function, mass and morphological 
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characteristics and future studies should endeavour to delineate the potential differences in 
satellite cell responsiveness in these cohorts. Nevertheless, an acute exercise stimulus has 
been demonstrated to activate satellite cells in young men, and this response is reportedly 
delayed with ageing (Snijders et al., 2014) perhaps indicating older individuals require 
more extensive recovery periods to successfully adapt to the imposed exercise stimulus. 
Based on the only study to investigate the effect of chronic endurance exercise training on 
the satellite cell proliferative response (Murach et al., 2016), the present work led the 
authors to speculate that structured exercise training, over many years, may refine the 
adaptive response of satellite cells in skeletal muscle repair, without necessarily 
modulating the number of satellite cells per fibre.  
The delivery of oxygen and nutrients to skeletal muscle is dependent on the 
adequate perfusion, underpinned by nearby capillaries.  In Chapter 3, this work 
demonstrated that MA have a superior number of capillary contacts, capillary-to-fibre 
ratio and capillary-to-fibre perimeter exchange index than OC, in Type I and Type II 
muscle fibres. Moreover, MA demonstrate superior capillarisation of Type I and greater 
capillary-to-fibre perimeter exchange index in Type II fibres when compared with YC. 
Collectively, these data clearly demonstrate that chronic structured endurance training, 
over many years, is a potent stimulus to increase skeletal muscle blood supply. 
Interestingly, the absence of an age-related reduction in capillarisation in our hands, is 
likely reflective of the relatively high degree of physical function of the OC cohort in this 
study, when compared with previous studies (i.e., a VO2max of 36.7 ml·kg-1·min-1 in 
untrained individuals of ~70 years) (Nederveen et al., 2016). The enhanced capillary 
network surrounding skeletal muscle in MA may play an important role in the delivery of 
nutrients and the activation of satellite cells to support skeletal muscle hypertrophy in 
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response to exercise (or offset sarcopenia) (Snijders et al., 2017). Thus, the investigation 
of whether MA, with a superior capillary network, are able to activate satellite cells to a 
greater extent and support enhanced muscular hypertrophy with exercise training merits 
further investigation.  
Finally, the inclusion of MA aged ~70 years is particularly interesting, as at this 
life-stage, untrained individuals would typically have undergone a notable degree of age-
related deterioration in physiological function. However, the MA cohort in this study have 
maintained extraordinary physiological function, similar to the YC. Whereas, the 
physiological function has drastically decline in the OC. It is often observed that 
decrements in physiological function are hastened beyond the age of 80 years, evidenced 
by the severe deterioration of world record performances previously identified (Lazarus 
and Harridge, 2017). Therefore, the study of MA beyond this age may provide important 
insights into the physiological and muscle-specific benefits of continued structured 
exercise training, or perhaps MA deteriorate more rapidly beyond this point and close the 
gap between untrained counterparts. However, it should be noted that with the age of MA 
competition beginning at ~35 years, it is likely that very few MA exist above this 
threshold and recruitment of these individuals for invasive research studies would be 
difficult to overcome.  
In summary, Chapter 3 provides a deeper, mechanistic insight into the role that chronic 
endurance training has in offsetting the deterioration of function, body composition and a 
number of skeletal muscle morphological features. As hypothesised, it appears chronic 
structured exercise training is beneficial on a number of levels, however the lack of a 
resistance trained MA cohort and young trained groups (both men and women) precludes 
a number of important insights. Nevertheless, the continuation of exercise training 
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throughout the ageing process, is undoubtedly important in the maintenance of physical 
independence, health-span extension and enhancement in quality of life. 
 
5.3. Integrated Muscle Protein Synthesis Rates Are Comparable Between 
Endurance-Trained Master Athletes and Untrained Older Individuals 
MA have maintained structured exercise training throughout adulthood, and as a 
result demonstrate a superior phenotype (i.e., skeletal muscle function and morphology) 
compared with age-matched untrained individuals (see previous chapter). However, the 
dearth of studies focussed on skeletal muscle remodelling in this highly active population 
needed to be addressed. Therefore, the aim of Chapter 4 was to investigate how skeletal 
muscle is regulated in MA compared with untrained age-matched individuals, both during 
basal rested conditions and following an acute bout of resistance exercise; to understand 
whether any such differences could provide further mechanistic explanation for the 
superior physiological function and muscle morphology reported in Chapter 3.  
In Chapter 4, this work has shown that MA and OC display equivalent rates of 
integrated MPS (iMPS) during basal conditions, and following a resistance exercise 
stimulus. Previous studies have demonstrated that basal rates of MPS do not differ 
between old and young individuals (Volpi et al., 2001). Furthermore, ten weeks of 
endurance training did not alter basal MPS rates in young individuals (Wilkinson et al., 
2008b). As a result, it was anticipated that basal rates of iMPS would be similar between 
MA and OC. The study carried out in Chapter 4 confirmed our hypothesis, as it was 
demonstrated that iMPS rates were similar between groups; indicating that the superior 
phenotype commonly observed in MA is not reflective of alterations to basal iMPS. The 
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potency of resistance exercise in stimulating MPS and the superior skeletal muscle 
properties of MA observed in Chapter 3 led us to propose that MA would demonstrate a 
superior skeletal muscle remodelling response to exercise. However, interestingly, both 
MA and OC increased iMPS to a similar extent over the 48 hours of recovery following a 
resistance exercise stimulus. This suggests that the superior phenotype reported in MA, in 
Chapter 3, cannot be explained by alterations to exercise-induced skeletal muscle 
remodelling. Exercise training has been shown to refine the MPs response to an exercise 
bout both in magnitude and duration (i.e., the MPS response increases to a greater extent 
but the duration is shorter) (Tang et al., 2008). This would suggest that chronic training, 
over many years, would further refine exercise-induced remodelling and subsequently 
enhance the capacity to rapidly repair skeletal muscle in response to exercise-induced 
mechanical loading, through the addition of myofilaments to the contractile machinery 
(Damas et al., 2016). However, the shorter duration of the MPS response previously 
reported with acute tracer approaches would be captured over a 48-hour iMPS; the 
inclusion of D2O as the isotopic tracer in this study allowed assessment of iMPS, over a 
prolonged period, which may be more reflective of MPS and subsequent muscle mass gain 
over time. Regardless of whether MA and OC have similar basal and exercise-induced 
rates of iMPS, it could be speculated that OC do not stimulate this muscle adaptive 
process (iMPS) to the same extent, or with the same frequency, as MA, and consistently 
remain within basal levels of iMPS. Combined with equivalent with satellite cell content 
in MA and OC observed in chapter 3, this provides further evidence that the skeletal 
muscle remodelling capacity in response to resistance exercise does not differ between 
groups, but the fact MA repeatedly initiate this adaptive process underpins the superior 
phenotype reported in Chapter 3. However, it remains unknown whether the muscle 
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adaptive response differs between OC and MA in response to an endurance exercise 
stimulus.   
Exercise training is known to alter the synthesis of specific muscle sub-fractions 
(i.e., myofibrillar vs. mitochondrial protein synthesis) (Wilkinson et al., 2008b). The focus 
of this thesis was to investigate the impact of a resistance exercise stimulus on the 
remodelling of the contractile component of skeletal muscle (i.e., myofibrillar protein). 
The recruitment of endurance trained MA and the utilisation of a resistance exercise 
stimulus, provided a novel exercise stimulus for both cohorts and made it possible to 
examine how chronic exercise training, in general, impacts skeletal muscle remodelling. 
The findings reported by Wilkinson et al. (2008) demonstrate that with a comparably short 
training period, fraction-specific MPS is altered. Specifically, endurance training enhanced 
exercise-induced mitochondrial protein synthesis, whereas resistance training modified the 
myofibrillar fraction. The MA included in this study have been training for a period of ~50 
years, and it was speculated that the continuation of exercise training for such an extended 
period could potentially drive further refinement in skeletal muscle remodelling that 
would, one assumes, plateau at an earlier point in adulthood (i.e. endurance exercise-
induced stimulation of mitochondrial MPS and modulation of this process with continued 
training, must, intuitively, level-off after several years of training). Therefore, it would 
have been of interest for us to investigate the mitochondrial protein synthetic response to 
endurance training between MA and OC, to determine whether MA displayed a superior 
capacity for fraction-specific remodelling of mitochondrial proteins compared with OC, 
which may have been the case (both the magnitude and time-course of the response).  
The blunting of exercise-induced MPS in older compared with younger individuals 
is frequently reported (Kumar et al., 2009, Brook et al., 2016). Protracted periods of 
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inactivity, common with advancing age, contributes to the development of age-related 
muscle anabolic resistance and sarcopenia (Breen et al., 2013). Upon further inspection, 
the first validation study utilising D2O to assess MPS utilised a unilateral study design 
(i.e., exercise vs. non-exercise leg) over 8 days and demonstrated that iMPS rates were 
~1.4-1.5 %·day-1 in a non-exercised control leg, and ~2 %·day-1 in an exercise leg 
(Wilkinson et al., 2014). Despite, the D2O dosing strategy being different to our approach 
in Chapter 4, the rates of iMPS reported in the young cohort from this study are ~0.4 
%·day-1 greater than reported in the present work, and by others (McGlory et al., 2018), in 
older individuals. The absence of a young cohort in the current study prevents the 
identification of muscle anabolic resistance to resistance exercise per se. Therefore, it is 
imperative that future studies address this shortcoming to confirm that, regardless of 
training status, inherent ageing leads to a reduction in exercise-induced MPS.  
The inability to upregulate key intramuscular anabolic signalling markers is often 
proposed to as a mechanistic explanation for the observation of muscle anabolic resistance 
in response to resistance exercise. Previously, deficits in anabolic signalling have been 
shown in acute MPS investigations (Kumar et al., 2009). Here, this work has shown subtle 
differences between MA and OC, however the acute intramuscular phosphorylation events 
following exercise are convoluted, and a discordance exists between anabolic signalling 
responses, MPS and skeletal muscle remodelling over time.  In order to provide better 
insight into acute phosphorylation events following exercise, a unilateral exercise model 
should be employed to identify difference in the fed and exercise-plus-fed state, over the 
initial several hours of recovery following exercise cessation.  
In summary, Chapter 4 addressed a number of shortcomings of the previous investigation 
(Doering et al., 2016) and generated novel data that provides important new mechanistic 
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insight into the impact of chronic exercise training on skeletal muscle remodelling in MA. 
This work demonstrated that MA and OC display similar rates of iMPS during basal and 
exercise-induced conditions and this coincide with intramuscular anabolic signalling. 
However, the absence of a YC group and fraction specific MPS precluded a number of 
important insights. Contrary to our hypothesis, this work has shown OC retain the capacity 
to upregulate skeletal muscle remodelling, similar to MA. 
5.4. Future Research 
Despite the detailed whole-body functional to deeper mechanistic investigation of MA in 
the current thesis, further examination of this unique cohort is critical to delineate the 
relative contribution of ageing and inactivity to age-related deterioration. Future studies 
should endeavour to investigate the extent to which MA deteriorate when compared with a 
young trained cohort. Furthermore, considerable effort should be made to incorporate a 
comprehensive analysis of individuals that have undertaken both endurance and resistance 
training throughout the lifespan; incorporating women and the ‘oldest’ old. Finally, insight 
into skeletal muscle remodelling requires the inclusion of young trained and untrained 
individuals, and insight into fraction specific MPS.  
5.5. Conclusions 
In conclusion, this thesis has provided a comprehensive summary of the current status of 
the literature on MA and offered a comprehensive insight into how structured exercise 
training throughout early adulthood into older age promotes the superior phenotype 
observed in MA. In addition, this work was the first to have shed light on the skeletal 
muscle remodelling events that regulate muscle mass in MA during basal and exercise-
induced conditions. Finally, this work has shown that, irrespective of training status, older 
 
 165 






5.6. REFERENCE LIST 
 
2015. The 2015 Ageing Report: Economic and budgetary projections for the 28 EU 
Member States (2013-2060). In: COMMISSION, E. (ed.) Economic and Financial 
Affairs. 
AAGAARD, P., MAGNUSSON, P. S., LARSSON, B., KJAER, M. & KRUSTRUP, P. 
2007a. Mechanical muscle function, morphology, and fiber type in lifelong trained 
elderly. Medicine and Science in Sports and Exercise, 39, 1989-1996. 
AAGAARD, P., MAGNUSSON, P. S., LARSSON, B., KJAER, M. & KRUSTRUP, P. 
2007b. Mechanical muscle function, morphology, and fiber type in lifelong trained 
elderly. Med Sci Sports Exerc, 39, 1989-96. 
ABE, T., DEHOYOS, D. V., POLLOCK, M. L. & GARZARELLA, L. 2000. Time course 
for strength and muscle thickness changes following upper and lower body 
resistance training in men and women. Eur J Appl Physiol, 81, 174-80. 
ALKNER, B. A. & TESCH, P. A. 2004. Knee extensor and plantar flexor muscle size and 
function following 90 days of bed rest with or without resistance exercise. Eur J 
Appl Physiol, 93, 294-305. 
AMERICAN COLLEGE OF SPORTS, M. 2009. American College of Sports Medicine 
position stand. Progression models in resistance training for healthy adults. 
Medicine and science in sports and exercise, 41, 687-708. 
ANDERSEN, P. & HENRIKSSON, J. 1977. Capillary supply of the quadriceps femoris 
muscle of man: adaptive response to exercise. The Journal of physiology, 270, 
677-690. 
ANKER, S. D., MORLEY, J. E. & VON HAEHLING, S. 2016. Welcome to the ICD-10 
code for sarcopenia. Journal of cachexia, sarcopenia and muscle, 7, 512-514. 
ANSELME, F., CAILLAUD, C., COURET, I., ROSSI, M. & PREFAUT, C. 1994. 
Histamine and exercise-induced hypoxemia in highly trained athletes. Journal of 
Applied Physiology, 76, 127-32. 
ARBAB-ZADEH, A., DIJK, E., PRASAD, A., FU, Q., TORRES, P., ZHANG, R., 
THOMAS, J. D., PALMER, D. & LEVINE, B. D. 2004. Effect of aging and 
physical activity on left ventricular compliance. Circulation, 110, 1799-805. 
 
 167 
ARETA, J. L., BURKE, L. M., ROSS, M. L., CAMERA, D. M., WEST, D. W., BROAD, 
E. M., JEACOCKE, N. A., MOORE, D. R., STELLINGWERFF, T. & PHILLIPS, 
S. M. 2013. Timing and distribution of protein ingestion during prolonged 
recovery from resistance exercise alters myofibrillar protein synthesis. The Journal 
of physiology, 591, 2319-2331. 
ARI, Z., KUTLU, N., UYANIK, B. S., TANELI, F., BUYUKYAZI, G. & TAVLI, T. 
2004. Serum testosterone, growth hormone, and insulin-like growth factor-1 levels, 
mental reaction time, and maximal aerobic exercise in sedentary and long-term 
physically trained elderly males. International Journal of Neuroscience, 114, 623-
637. 
ASTRAND, I., ASTRAND, P. O., HALLBACK, I. & KILBOM, A. 1973. Reduction in 
maximal oxygen uptake with age. J Appl Physiol, 35, 649-54. 
ATKINS, J. L., WHINCUP, P. H., MORRIS, R. W., LENNON, L. T., PAPACOSTA, O. 
& WANNAMETHEE, S. G. 2014. Sarcopenic obesity and risk of cardiovascular 
disease and mortality: a population-based cohort study of older men. Journal of the 
American Geriatrics Society, 62, 253-260. 
BAAR, K. & ESSER, K. 1999. Phosphorylation of p70S6k correlates with increased 
skeletal muscle mass following resistance exercise. American Journal of 
Physiology-Cell Physiology, 276, C120-C127. 
BAKER, A. B. & TANG, Y. Q. 2010. Aging performance for masters records in athletics, 
swimming, rowing, cycling, triathlon, and weightlifting. Exp Aging Res, 36, 453-
77. 
BAKER, A. B., TANG, Y. Q. & TURNER, M. J. 2003. Percentage decline in masters 
superathlete track and field performance with aging. Exp Aging Res, 29, 47-65. 
BALLOR, D. L. & KEESEY, R. E. 1991. A meta-analysis of the factors affecting 
exercise-induced changes in body mass, fat mass and fat-free mass in males and 
females. Int J Obes, 15, 717-26. 
BARNOUIN, Y., MCPHEE, J. S., BUTLER-BROWNE, G., BOSUTTI, A., DE VITO, 
G., JONES, D. A., NARICI, M., BEHIN, A., HOGREL, J. Y. & DEGENS, H. 
2017. Coupling between skeletal muscle fiber size and capillarization is 




BAUMGARTNER, R. N. 2000. Body composition in healthy aging. Annals of the New 
York Academy of Sciences, 904, 437-448. 
BEAUDART, C., REGINSTER, J.-Y., SLOMIAN, J., BUCKINX, F., DARDENNE, N., 
QUABRON, A., SLANGEN, C., GILLAIN, S., PETERMANS, J. & BRUYERE, 
O. 2015. Estimation of sarcopenia prevalence using various assessment tools. 
Experimental gerontology, 61, 31-37. 
BELL, K. E., SEGUIN, C., PARISE, G., BAKER, S. K. & PHILLIPS, S. M. 2015. Day-
to-Day Changes in Muscle Protein Synthesis in Recovery From Resistance, 
Aerobic, and High-Intensity Interval Exercise in Older Men. J Gerontol A Biol Sci 
Med Sci, 70, 1024-9. 
BERGSTROM, J. 1975. Percutaneous needle biopsy of skeletal muscle in physiological 
and clinical research. Scand J Clin Lab Invest, 35, 609-16. 
BETIK, A. C. & HEPPLE, R. T. 2008. Determinants of VO2 max decline with aging: an 
integrated perspective. Appl Physiol Nutr Metab, 33, 130-40. 
BHASIN, S., STORER, T. W., BERMAN, N., CALLEGARI, C., CLEVENGER, B., 
PHILLIPS, J., BUNNELL, T. J., TRICKER, R., SHIRAZI, A. & CASABURI, R. 
1996. The effects of supraphysiologic doses of testosterone on muscle size and 
strength in normal men. New England Journal of Medicine, 335, 1-7. 
BHELLA, P. S., HASTINGS, J. L., FUJIMOTO, N., SHIBATA, S., CARRICK-
RANSON, G., PALMER, M. D., BOYD, K. N., ADAMS-HUET, B. & LEVINE, 
B. D. 2014. Impact of lifelong exercise "dose" on left ventricular compliance and 
distensibility. Journal of the American College of Cardiology, 64, 1257-66. 
BIOLO, G., CEDERHOLM, T. & MUSCARITOLI, M. 2014. Muscle contractile and 
metabolic dysfunction is a common feature of sarcopenia of aging and chronic 
diseases: From sarcopenic obesity to cachexia. Clinical Nutrition, 33, 737-748. 
BIOLO, G., MAGGI, S. P., WILLIAMS, B. D., TIPTON, K. D. & WOLFE, R. R. 1995. 
Increased rates of muscle protein turnover and amino acid transport after resistance 
exercise in humans. Am J Physiol, 268, E514-20. 
BJORK, L., JENKINS, N. T., WITKOWSKI, S. & HAGBERG, J. M. 2012. Nitro-
Oxidative Stress Biomarkers in Active and Inactive Men. International Journal of 
Sports Medicine, 33, 279-284. 
 
 169 
BJORKMAN, F., EKBLOM-BAK, E., EKBLOM, O. & EKBLOM, B. 2016. Validity of 
the revised Ekblom Bak cycle ergometer test in adults. Eur J Appl Physiol, 116, 
1627-38. 
BLAIR, S. N. 2009. Physical inactivity: the biggest public health problem of the 21st 
century. Br J Sports Med, 43, 1-2. 
BLAIR, S. N., KAMPERT, J. B., KOHL, H. W., 3RD, BARLOW, C. E., MACERA, C. 
A., PAFFENBARGER, R. S., JR. & GIBBONS, L. W. 1996. Influences of 
cardiorespiratory fitness and other precursors on cardiovascular disease and all-
cause mortality in men and women. JAMA, 276, 205-10. 
BLAIR, S. N., KOHL, H. W., PAFFENBARGER, R. S., CLARK, D. G., COOPER, K. H. 
& GIBBONS, L. W. 1989. Physical-Fitness and All-Cause Mortality - a 
Prospective-Study of Healthy-Men and Women. Jama-Journal of the American 
Medical Association, 262, 2395-2401. 
BOIRIE, Y., GACHON, P. & BEAUFRERE, B. 1997. Splanchnic and whole-body 
leucine kinetics in young and elderly men. American Journal of Clinical Nutrition, 
65, 489-495. 
BOOTH, F. W. & LEES, S. J. 2006. Physically active subjects should be the control 
group. Medicine and Science in Sports and Exercise, 38, 405-406. 
BOOTH, F. W., ROBERTS, C. K. & LAYE, M. J. 2012. Lack of Exercise Is a Major 
Cause of Chronic Diseases. Comprehensive Physiology, 2, 1143-1211. 
BORG, G. A. 1982. Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 
14, 377-81. 
BREEN, L. & PHILLIPS, S. M. 2011. Skeletal muscle protein metabolism in the elderly: 
Interventions to counteract the 'anabolic resistance' of ageing. Nutrition and 
Metabolism, 8. 
BREEN, L., STOKES, K. A., CHURCHWARD-VENNE, T. A., MOORE, D. R., 
BAKER, S. K., SMITH, K., ATHERTON, P. J. & PHILLIPS, S. M. 2013. Two 
weeks of reduced activity decreases leg lean mass and induces "anabolic 
resistance" of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol 
Metab, 98, 2604-12. 
BROOK, M. S., WILKINSON, D. J., ATHERTON, P. J. & SMITH, K. 2017. Recent 
developments in deuterium oxide tracer approaches to measure rates of substrate 
 
 170 
turnover: implications for protein, lipid, and nucleic acid research. Curr Opin Clin 
Nutr Metab Care, 20, 375-381. 
BROOK, M. S., WILKINSON, D. J., MITCHELL, W. K., LUND, J. N., PHILLIPS, B. 
E., SZEWCZYK, N. J., GREENHAFF, P. L., SMITH, K. & ATHERTON, P. J. 
2016. Synchronous deficits in cumulative muscle protein synthesis and ribosomal 
biogenesis underlie age-related anabolic resistance to exercise in humans. Journal 
of Physiology-London, 594, 7399-7417. 
BROOK, M. S., WILKINSON, D. J., MITCHELL, W. K., LUND, J. N., SZEWCZYK, N. 
J., GREENHAFF, P. L., SMITH, K. & ATHERTON, P. J. 2015. Skeletal muscle 
hypertrophy adaptations predominate in the early stages of resistance exercise 
training, matching deuterium oxide-derived measures of muscle protein synthesis 
and mechanistic target of rapamycin complex 1 signaling. The FASEB Journal, 29, 
4485-4496. 
BUCH, A., CARMELI, E., BOKER, L. K., MARCUS, Y., SHEFER, G., KIS, O., 
BERNER, Y. & STERN, N. 2016. Muscle function and fat content in relation to 
sarcopenia, obesity and frailty of old age—an overview. Experimental 
gerontology, 76, 25-32. 
BUCKLEY, J. P. & BORG, G. A. 2011. Borg’s scales in strength training; from theory to 
practice in young and older adults. Applied physiology, nutrition, and metabolism, 
36, 682-692. 
BUFORD, T. W., COOKE, M. B., MANINI, T. M., LEEUWENBURGH, C. & 
WILLOUGHBY, D. S. 2010. Effects of Age and Sedentary Lifestyle on Skeletal 
Muscle NF-kappa B Signaling in Men. Journals of Gerontology Series a-
Biological Sciences and Medical Sciences, 65, 532-537. 
BURD, N. A., GORISSEN, S. H. & VAN LOON, L. J. 2013. Anabolic resistance of 
muscle protein synthesis with aging. Exerc Sport Sci Rev, 41, 169-73. 
BURD, N. A., HOLWERDA, A. M., SELBY, K. C., WEST, D. W., STAPLES, A. W., 
CAIN, N. E., CASHABACK, J. G., POTVIN, J. R., BAKER, S. K. & PHILLIPS, 
S. M. 2010a. Resistance exercise volume affects myofibrillar protein synthesis and 




BURD, N. A., WEST, D. W., STAPLES, A. W., ATHERTON, P. J., BAKER, J. M., 
MOORE, D. R., HOLWERDA, A. M., PARISE, G., RENNIE, M. J., BAKER, S. 
K. & PHILLIPS, S. M. 2010b. Low-load high volume resistance exercise 
stimulates muscle protein synthesis more than high-load low volume resistance 
exercise in young men. PLoS One, 5, e12033. 
BUSKIRK, E. R. & HODGSON, J. L. 1987. Age and aerobic power: the rate of change in 
men and women. Fed Proc, 46, 1824-9. 
BUYUKYAZI, G. 2004. Differences in the cellular and humoral immune system between 
sedentary and endurance-trained elderly males. / Appareil immunitaire cellulaire et 
humoral: comparaison entre sujets ages sedentaires et endurants. Science & Sports, 
19, 130-135. 
CAMPBELL, M. J., MCCOMAS, A. J. & PETITO, F. 1973. Physiological changes in 
ageing muscles. J Neurol Neurosurg Psychiatry, 36, 174-82. 
CAO, L. & MORLEY, J. E. 2016. Sarcopenia is recognized as an independent condition 
by an international classification of disease, tenth revision, clinical modification 
(ICD-10-CM) code. Journal of the American Medical Directors Association, 17, 
675-677. 
CARRARO, F., HARTL, W. H., STUART, C. A., LAYMAN, D. K., JAHOOR, F. & 
WOLFE, R. R. 1990. Whole-Body and Plasma-Protein Synthesis in Exercise and 
Recovery in Human-Subjects. American Journal of Physiology, 258, E821-E831. 
CARRICK-RANSON, G., HASTINGS, J. L., BHELLA, P. S., FUJIMOTO, N., 
SHIBATA, S., PALMER, M. D., BOYD, K., LIVINGSTON, S., DIJK, E. & 
LEVINE, B. D. 2014. The effect of lifelong exercise dose on cardiovascular 
function during exercise. Journal of Applied Physiology, 116, 736-745. 
CHEEK, D. B. 1985. The control of cell mass and replication. The DNA unit--a personal 
20-year study. Early Hum Dev, 12, 211-39. 
CHINKES, D. L., ROSENBLATT, J. & WOLFE, R. R. 1993. Assessment of the 
mathematical issues involved in measuring the fractional synthesis rate of protein 
using the flooding dose technique. Clinical science, 84, 177-183. 
CHURCHWARD-VENNE, T. A., BREEN, L., DI DONATO, D. M., HECTOR, A. J., 
MITCHELL, C. J., MOORE, D. R., STELLINGWERFF, T., BREUILLE, D., 
OFFORD, E. A., BAKER, S. K. & PHILLIPS, S. M. 2014. Leucine 
 
 172 
supplementation of a low-protein mixed macronutrient beverage enhances 
myofibrillar protein synthesis in young men: a double-blind, randomized trial. Am 
J Clin Nutr, 99, 276-86. 
CLARK, B. C. & MANINI, T. M. 2010. Functional consequences of sarcopenia and 
dynapenia in the elderly. Current Opinion in Clinical Nutrition and Metabolic 
Care, 13, 271-276. 
COGGAN, A. R., SPINA, R. J., KING, D. S., ROGERS, M. A., BROWN, M., NEMETH, 
P. M. & HOLLOSZY, J. O. 1992. Skeletal muscle adaptations to endurance 
training in 60-to 70-yr-old men and women. Journal of applied physiology, 72, 
1780-1786. 
COGGAN, A. R., SPINA, R. J., ROGERS, M. A., KING, D. S., BROWN, M., NEMETH, 
P. M. & HOLLOSZY, J. O. 1990. Histochemical and enzymatic characteristics of 
skeletal muscle in master athletes. Journal of Applied Physiology, 68, 1896-1901. 
COUPPE, C., SVENSSON, R. B., GROSSET, J. F., KOVANEN, V., NIELSEN, R. H., 
OLSEN, M. R., LARSEN, J. O., PRAET, S. F., SKOVGAARD, D., HANSEN, 
M., AAGAARD, P., KJAER, M. & MAGNUSSON, S. P. 2014. Life-long 
endurance running is associated with reduced glycation and mechanical stress in 
connective tissue. Age, 36, 9665. 
CRISTEA, A., KORHONEN, M. T., HÄKKINEN, K., MERO, A., ALÉN, M., SIPILÄ, 
S., VIITASALO, J. T., KOLJONEN, M. J., SUOMINEN, H. & LARSSON, L. 
2008. Effects of combined strength and sprint training on regulation of muscle 
contraction at the whole-muscle and single-fibre levels in elite master sprinters. 
Acta Physiologica, 193, 275-289. 
CRUZ-JENTOFT, A. J., BAEYENS, J. P., BAUER, J. M., BOIRIE, Y., CEDERHOLM, 
T., LANDI, F., MARTIN, F. C., MICHEL, J. P., ROLLAND, Y., SCHNEIDER, 
S. M., TOPINKOVA, E., VANDEWOUDE, M., ZAMBONI, M. & EUROPEAN 
WORKING GROUP ON SARCOPENIA IN OLDER, P. 2010. Sarcopenia: 
European consensus on definition and diagnosis: Report of the European Working 
Group on Sarcopenia in Older People. Age Ageing, 39, 412-23. 
CRUZ-JENTOFT, A. J., BAHAT, G., BAUER, J., BOIRIE, Y., BRUYÈRE, O., 
CEDERHOLM, T., COOPER, C., LANDI, F., ROLLAND, Y. & SAYER, A. A. 
 
 173 
2018. Sarcopenia: revised European consensus on definition and diagnosis. Age 
and ageing. 
CUTHBERTSON, D., SMITH, K., BABRAJ, J., LEESE, G., WADDELL, T., 
ATHERTON, P., WACKERHAGE, H., TAYLOR, P. M. & RENNIE, M. J. 2004. 
Anabolic signaling deficits underlie amino acid resistance of wasting, aging 
muscle. Faseb Journal, 18, 422-+. 
DAMAS, F., LIBARDI, C. A. & UGRINOWITSCH, C. 2018. The development of 
skeletal muscle hypertrophy through resistance training: the role of muscle damage 
and muscle protein synthesis. European journal of applied physiology, 118, 485-
500. 
DAMAS, F., PHILLIPS, S. M., LIBARDI, C. A., VECHIN, F. C., LIXANDRAO, M. E., 
JANNIG, P. R., COSTA, L. A. R., BACURAU, A. V., SNIJDERS, T., PARISE, 
G., TRICOLI, V., ROSCHEL, H. & UGRINOWITSCH, C. 2016. Resistance 
training-induced changes in integrated myofibrillar protein synthesis are related to 
hypertrophy only after attenuation of muscle damage. Journal of Physiology-
London, 594, 5209-5222. 
DASKALOPOULOU, C., STUBBS, B., KRALJ, C., KOUKOUNARI, A., PRINCE, M. 
& PRINA, A. M. 2017. Physical activity and healthy ageing: A systematic review 
and meta-analysis of longitudinal cohort studies. Ageing Res Rev, 38, 6-17. 
DAY, M. L., MCGUIGAN, M. R., BRICE, G. & FOSTER, C. 2004. Monitoring exercise 
intensity during resistance training using the session RPE scale. The Journal of 
Strength & Conditioning Research, 18, 353-358. 
DEGENS, H. 2007. Age-related skeletal muscle dysfunction: causes and mechanisms. J 
Musculoskelet Neuronal Interact, 7, 246-52. 
DELMONICO, M. J., HARRIS, T. B., VISSER, M., PARK, S. W., CONROY, M. B., 
VELASQUEZ-MIEYER, P., BOUDREAU, R., MANINI, T. M., NEVITT, M., 
NEWMAN, A. B., GOODPASTER, B. H., HEALTH, A. & BODY 2009. 
Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J 
Clin Nutr, 90, 1579-85. 
DICKINSON, J. M., DRUMMOND, M. J., COBEN, J. R., VOLPI, E. & RASMUSSEN, 
B. B. 2013. Aging differentially affects human skeletal muscle amino acid 
 
 174 
transporter expression when essential amino acids are ingested after exercise. 
Clinical Nutrition, 32, 273-280. 
DIRKS, M. L., WALL, B. T., VAN DE VALK, B., HOLLOWAY, T. M., HOLLOWAY, 
G. P., CHABOWSKI, A., GOOSSENS, G. H. & VAN LOON, L. J. 2016. One 
Week of Bed Rest Leads to Substantial Muscle Atrophy and Induces Whole-Body 
Insulin Resistance in the Absence of Skeletal Muscle Lipid Accumulation. 
Diabetes, 65, 2862-75. 
DOERING, T. M., JENKINS, D. G., REABURN, P. R., BORGES, N. R., HOHMANN, 
E. & PHILLIPS, S. M. 2016. Lower Integrated Muscle Protein Synthesis in 
Masters Compared with Younger Athletes. Medicine and Science in Sports and 
Exercise, 48, 1613-1618. 
DOERING, T. M., REABURN, P. R., PHILLIPS, S. M. & JENKINS, D. G. 2015. Post-
Exercise Dietary Protein Strategies to Maximize Skeletal Muscle Repair and 
Remodeling in Masters Endurance Athletes: A Review. Int J Sport Nutr Exerc 
Metab. 
DOHERTY, T. J. 2003. Invited review: Aging and sarcopenia. J Appl Physiol (1985), 95, 
1717-27. 
DONATO, A. J., UBEROI, A., WRAY, D. W., NISHIYAMA, S., LAWRENSON, L. & 
RICHARDSON, R. S. 2006. Differential effects of aging on limb blood flow in 
humans. Am J Physiol Heart Circ Physiol, 290, H272-8. 
DREYER, H. C., BLANCO, C. E., SCHROEDER, E. T. & WISWELL, R. A. 2006. 
Satellite cell numbers in young and older men 24 hours after eccentric exercise. 
Muscle & Nerve, 33, 242-253. 
DREYER, H. C., DRUMMOND, M. J., PENNINGS, B., FUJITA, S., GLYNN, E. L., 
CHINKES, D. L., DHANANI, S., VOLPI, E. & RASMUSSEN, B. B. 2008. 
Leucine-enriched essential amino acid and carbohydrate ingestion following 
resistance exercise enhances mTOR signaling and protein synthesis in human 
muscle. Am J Physiol Endocrinol Metab, 294, E392-400. 
DRUMMOND, M. J., DICKINSON, J. M., FRY, C. S., WALKER, D. K., 
GUNDERMANN, D. M., REIDY, P. T., TIMMERMAN, K. L., MARKOFSKI, 
M. M., PADDON-JONES, D., RASMUSSEN, B. B. & VOLPI, E. 2012. Bed rest 
impairs skeletal muscle amino acid transporter expression, mTORC1 signaling, 
 
 175 
and protein synthesis in response to essential amino acids in older adults. Am J 
Physiol Endocrinol Metab, 302, E1113-22. 
DRUMMOND, M. J., DREYER, H. C., PENNINGS, B., FRY, C. S., DHANANI, S., 
DILLON, E. L., SHEFFIELD-MOORE, M., VOLPI, E. & RASMUSSEN, B. B. 
2008. Skeletal muscle protein anabolic response to resistance exercise and 
essential amino acids is delayed with aging. J Appl Physiol (1985), 104, 1452-61. 
DUBÉ, J. J., BROSKEY, N. T., DESPINES, A. A., STEFANOVIC-RACIC, M., 
TOLEDO, F. G. S., GOODPASTER, B. H. & AMATI, F. 2016. Muscle 
Characteristics and Substrate Energetics in Lifelong Endurance Athletes. Medicine 
& Science in Sports & Exercise, 48, 472-480. 
EGAN, B. & ZIERATH, J. R. 2013. Exercise metabolism and the molecular regulation of 
skeletal muscle adaptation. Cell Metab, 17, 162-84. 
EKELUND, U., BESSON, H., LUAN, J. A., MAY, A. M., SHARP, S. J., BRAGE, S., 
TRAVIER, N., AGUDO, A., SLIMANI, N., RINALDI, S., JENAB, M., NORAT, 
T., MOUW, T., ROHRMANN, S., KAAKS, R., BERGMANN, M. M., BOEING, 
H., CLAVEL-CHAPELON, F., BOUTRON-RUAULT, M. C., OVERVAD, K., 
JAKOBSEN, M. U., JOHNSEN, N. F., HALKJAER, J., GONZALEZ, C. A., 
RODRIGUEZ, L., SANCHEZ, M. J., ARRIOLA, L., BARRICARTE, A., 
NAVARRO, C., KEY, T. J., SPENCER, E. A., ORFANOS, P., NASKA, A., 
TRICHOPOULOU, A., MANJER, J., LUND, E., PALLI, D., PALA, V., VINEIS, 
P., MATTIELLO, A., TUMINO, R., BUENO-DE-MESQUITA, H. B., VAN DEN 
BERG, S. W., ODYSSEOS, A. D., RIBOLI, E., WAREHAM, N. J. & PEETERS, 
P. H. 2011. Physical activity and gain in abdominal adiposity and body weight: 
prospective cohort study in 288,498 men and women. American Journal of 
Clinical Nutrition, 93, 826-835. 
ESKURZA, I., DONATO, A. J., MOREAU, K. L., SEALS, D. R. & TANAKA, H. 2002. 
Changes in maximal aerobic capacity with age in endurance-trained women: 7-yr 
follow-up. Journal of Applied Physiology, 92, 2303-2308. 
ESLIGER, D. W., ROWLANDS, A. V., HURST, T. L., CATT, M., MURRAY, P. & 
ESTON, R. G. 2011. Validation of the GENEA Accelerometer. Med Sci Sports 
Exerc, 43, 1085-93. 
 
 176 
EVANS, W. J. & CAMPBELL, W. W. 1993. Sarcopenia and age-related changes in body 
composition and functional capacity. J Nutr, 123, 465-8. 
EVERMAN, S., FARRIS, J. W., BAY, R. C. & DANIELS, J. T. 2018. Elite Distance 
Runners: A 45-Year Follow-up. Medicine and Science in Sports and Exercise, 50, 
73-78. 
FARNFIELD, M. M., BREEN, L., CAREY, K. A., GARNHAM, A. & CAMERON-
SMITH, D. 2012. Activation of mTOR signalling in young and old human skeletal 
muscle in response to combined resistance exercise and whey protein ingestion. 
Appl Physiol Nutr Metab, 37, 21-30. 
FAULKNER, J. A., DAVIS, C. S., MENDIAS, C. L. & BROOKS, S. V. 2008. The aging 
of elite male athletes: age-related changes in performance and skeletal muscle 
structure and function. Clin J Sport Med, 18, 501-7. 
FELDMAN, H. A., LONGCOPE, C., DERBY, C. A., JOHANNES, C. B., ARAUJO, A. 
B., COVIELLO, A. D., BREMNER, W. J. & MCKINLAY, J. B. 2002. Age trends 
in the level of serum testosterone and other hormones in middle-aged men: 
longitudinal results from the Massachusetts male aging study. J Clin Endocrinol 
Metab, 87, 589-98. 
FERRANDO, A. A., SHEFFIELD-MOORE, M., YECKEL, C. W., GILKISON, C., 
JIANG, J., ACHACOSA, A., LIEBERMAN, S. A., TIPTON, K., WOLFE, R. R. 
& URBAN, R. J. 2002. Testosterone administration to older men improves muscle 
function: molecular and physiological mechanisms. American Journal of 
Physiology-Endocrinology and Metabolism, 282, E601-E607. 
FIATARONE, M. A., MARKS, E. C., RYAN, N. D., MEREDITH, C. N., LIPSITZ, L. A. 
& EVANS, W. J. 1990. High-intensity strength training in nonagenarians. Effects 
on skeletal muscle. JAMA, 263, 3029-34. 
FINCH, C. E. & TANZI, R. E. 1997. Genetics of aging. Science, 278, 407-411. 
FITZGERALD, M. D., TANAKA, H., TRAN, Z. V. & SEALS, D. R. 1997. Age-related 
declines in maximal aerobic capacity in regularly exercising vs. sedentary women: 
A meta-analysis. Journal of Applied Physiology, 83, 160-165. 
FRANZONI, F., GHIADONI, L., GALETTA, F., PLANTINGA, Y., LUBRANO, V., 
HUANG, Y., SALVETTI, G., REGOLI, F., TADDEI, S., SANTORO, G. & 
SALVETTI, A. 2005. Physical activity, plasma antioxidant capacity, and 
 
 177 
endothelium-dependent vasodilation in young and older men. American Journal of 
Hypertension, 18, 510-6. 
FRIES, J. F. 1980. Aging, natural death, and the compression of morbidity. N Engl J Med, 
303, 130-5. 
FRONTERA, W. R., HUGHES, V. A., FIELDING, R. A., FIATARONE, M. A., EVANS, 
W. J. & ROUBENOFF, R. 2000. Aging of skeletal muscle: a 12-yr longitudinal 
study. Journal of Applied Physiology, 88, 1321-1326. 
FRONTERA, W. R., MEREDITH, C. N., O'REILLY, K. P., KNUTTGEN, H. G. & 
EVANS, W. J. 1988. Strength conditioning in older men: skeletal muscle 
hypertrophy and improved function. J Appl Physiol (1985), 64, 1038-44. 
FRONTERA, W. R. & OCHALA, J. 2015. Skeletal muscle: a brief review of structure and 
function. Calcif Tissue Int, 96, 183-95. 
FRY, C. S., DRUMMOND, M. J., GLYNN, E. L., DICKINSON, J. M., 
GUNDERMANN, D. M., TIMMERMAN, K. L., WALKER, D. K., DHANANI, 
S., VOLPI, E. & RASMUSSEN, B. B. 2011. Aging impairs contraction-induced 
human skeletal muscle mTORC1 signaling and protein synthesis. Skeletal Muscle, 
1. 
FRY, C. S., NOEHREN, B., MULA, J., UBELE, M. F., WESTGATE, P. M., KERN, P. 
A. & PETERSON, C. A. 2014. Fibre type-specific satellite cell response to aerobic 
training in sedentary adults. The Journal of physiology, 592, 2625-2635. 
FUJITA, S., GLYNN, E. L., TIMMERMAN, K. L., RASMUSSEN, B. B. & VOLPI, E. 
2009. Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal 
muscle protein anabolism in older adults: evidence of a true age-related insulin 
resistance of muscle protein metabolism. Diabetologia, 52, 1889-1898. 
FUJITA, S. & VOLPI, E. 2004. Nutrition and sarcopenia of ageing. Nutrition research 
reviews, 17, 69-76. 
FUKUTANI, A. & KURIHARA, T. 2015. Comparison of the muscle fascicle length 
between resistance-trained and untrained individuals: cross-sectional observation. 
Springerplus, 4, 341. 
GALETTA, F., FRANZONI, F., FEMIA, F. R., ROCCELLA, N., PENTIMONE, F. & 
SANTORO, G. 2005. Lifelong physical training prevents the age-related 
 
 178 
impairment of heart rate variability and exercise capacity in elderly people. 
Journal of Sports Medicine & Physical Fitness, 45, 217-221. 
GALETTA, F., FRANZONI, F., PLANTINGA, Y., GHIADONI, L., ROSSI, M., 
PRATTICHIZZO, F., CARPI, A., TADDEI, S. & SANTORO, G. 2006. 
Ambulatory blood pressure monitoring and endothelium-dependent vasodilation in 
the elderly athletes. Biomedicine & Pharmacotherapy, 60, 443-7. 
GAVA, P., KERN, H. & CARRARO, U. 2015. Age-associated power decline from 
running, jumping, and throwing male masters world records. Experimental aging 
research, 41, 115-135. 
GAVIN, T. P., RUSTER, R. S., CARRITHERS, J. A., ZWETSLOOT, K. A., KRAUS, R. 
M., EVANS, C. A., KNAPP, D. J., DREW, J. L., MCCARTNEY, J. S. & 
GARRY, J. P. 2007. No difference in the skeletal muscle angiogenic response to 
aerobic exercise training between young and aged men. The Journal of physiology, 
585, 231-239. 
GENT, D. N. & NORTON, K. 2013. Aging has greater impact on anaerobic versus 
aerobic power in trained masters athletes. J Sports Sci, 31, 97-103. 
GLOVER, E. I., PHILLIPS, S. M., OATES, B. R., TANG, J. E., TARNOPOLSKY, M. 
A., SELBY, A., SMITH, K. & RENNIE, M. J. 2008. Immobilization induces 
anabolic resistance in human myofibrillar protein synthesis with low and high dose 
amino acid infusion. J Physiol, 586, 6049-61. 
GOODPASTER, B. H., PARK, S. W., HARRIS, T. B., KRITCHEVSKY, S. B., NEVITT, 
M., SCHWARTZ, A. V., SIMONSICK, E. M., TYLAVSKY, F. A., VISSER, M. 
& NEWMAN, A. B. 2006. The loss of skeletal muscle strength, mass, and quality 
in older adults: the health, aging and body composition study. J Gerontol A Biol 
Sci Med Sci, 61, 1059-64. 
GOODPASTER, B. H., THAETE, F. L. & KELLEY, D. E. 2000a. Composition of 
skeletal muscle evaluated with computed tomography. Annals of the New York 
Academy of Sciences, 904, 18-24. 
GOODPASTER, B. H., THERIAULT, R., WATKINS, S. C. & KELLEY, D. E. 2000b. 
Intramuscular lipid content is increased in obesity and decreased by weight loss. 
Metabolism, 49, 467-72. 
 
 179 
GOPALAKRISHNAN, R., GENC, K. O., RICE, A. J., LEE, S., EVANS, H. J., 
MAENDER, C. C., ILASLAN, H. & CAVANAGH, P. R. 2010. Muscle volume, 
strength, endurance, and exercise loads during 6-month missions in space. 
Aviation, space, and environmental medicine, 81, 91-104. 
GREIG, C. A., GRAY, C., RANKIN, D., YOUNG, A., MANN, V., NOBLE, B. & 
ATHERTON, P. J. 2011. Blunting of adaptive responses to resistance exercise 
training in women over 75 y. Experimental Gerontology, 46, 884-890. 
GRIES, K. J., RAUE, U., PERKINS, R. K., LAVIN, K. M., OVERSTREET, B. S., 
D'ACQUISTO, L. J., GRAHAM, B., FINCH, W. H., KAMINSKY, L. A., 
TRAPPE, T. A. & TRAPPE, S. 2018. Cardiovascular and skeletal muscle health 
with lifelong exercise. Journal of Applied Physiology, 125, 1636-1645. 
GRIMBY, G. & SALTIN, B. 1966. Physiological analysis of physically well-trained 
middle-aged and old athletes. Acta Med Scand, 179, 513-26. 
GROEN, B. B., HAMER, H. M., SNIJDERS, T., VAN KRANENBURG, J., FRIJNS, D., 
VINK, H. & VAN LOON, L. J. 2014. Skeletal muscle capillary density and 
microvascular function are compromised with aging and type 2 diabetes. J Appl 
Physiol (1985), 116, 998-1005. 
GUILLET, C., PROD'HOMME, M., BALAGE, M., GACHON, P., GIRAUDET, C., 
MORIN, L., GRIZARD, J. & BOIRIE, Y. 2004. Impaired anabolic response of 
muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. 
Faseb j, 18, 1586-7. 
GURALNIK, J. M., FRIED, L. P. & SALIVE, M. E. 1996. Disability as a public health 
outcome in the aging population. Annual Review of Public Health, 17, 25-46. 
GURALNIK, J. M., SIMONSICK, E. M., FERRUCCI, L., GLYNN, R. J., BERKMAN, 
L. F., BLAZER, D. G., SCHERR, P. A. & WALLACE, R. B. 1994. A short 
physical performance battery assessing lower extremity function: association with 
self-reported disability and prediction of mortality and nursing home admission. J 
Gerontol, 49, M85-94. 
HAGERMAN, F. C., WALSH, S. J., STARON, R. S., HIKIDA, R. S., GILDERS, R. M., 
MURRAY, T. F., TOMA, K. & RAGG, K. E. 2000. Effects of high-intensity 
resistance training on untrained older men. I. Strength, cardiovascular, and 
 
 180 
metabolic responses. Journals of Gerontology Series a-Biological Sciences and 
Medical Sciences, 55, B336-B346. 
HAIRI, N. N., CUMMING, R. G., NAGANATHAN, V., HANDELSMAN, D. J., LE 
COUTEUR, D. G., CREASEY, H., WAITE, L. M., SEIBEL, M. J. & 
SAMBROOK, P. N. 2010. Loss of muscle strength, mass (sarcopenia), and quality 
(specific force) and its relationship with functional limitation and physical 
disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc, 58, 
2055-62. 
HANNAM, K., DEERE, K., HARTLEY, A., CLARK, E., COULSON, J., IRELAND, A., 
MOSS, C., EDWARDS, M., DENNISON, E. & GAYSIN, T. 2017. A novel 
accelerometer-based method to describe day-to-day exposure to potentially 
osteogenic vertical impacts in older adults: findings from a multi-cohort study. 
Osteoporosis International, 28, 1001-1011. 
HANSEN, M. & KJAER, M. 2014. Influence of sex and estrogen on musculotendinous 
protein turnover at rest and after exercise. Exerc Sport Sci Rev, 42, 183-92. 
HARBER, M. P., KONOPKA, A. R., DOUGLASS, M. D., MINCHEV, K., KAMINSKY, 
L. A., TRAPPE, T. A. & TRAPPE, S. 2009. Aerobic exercise training improves 
whole muscle and single myofiber size and function in older women. American 
Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 297, 
R1452-R1459. 
HARBER, M. P., KONOPKA, A. R., UNDEM, M. K., HINKLEY, J. M., MINCHEV, K., 
KAMINSKY, L. A., TRAPPE, T. A. & TRAPPE, S. 2012. Aerobic exercise 
training induces skeletal muscle hypertrophy and age-dependent adaptations in 
myofiber function in young and older men. J Appl Physiol (1985), 113, 1495-504. 
HARPER, S. 2014. Economic and social implications of aging societies. Science, 346, 
587-91. 
HARRIDGE, S. D. & LAZARUS, N. R. 2017. Physical Activity, Aging, and 
Physiological Function. Physiology (Bethesda), 32, 152-161. 
HARRIS, J. A. & BENEDICT, F. G. 1919. A biometric study of basal metabolism in man, 
Carnegie institution of Washington. 
 
 181 
HAWKINS, S. A., MARCELL, T. J., JAQUE, S. V. & WISWELL, R. A. 2001. A 
longitudinal assessment of change in VO2max and maximal heart rate in master 
athletes. Medicine and Science in Sports and Exercise, 33, 1744-1750. 
HAYES, L. D., SCULTHORPE, N., HERBERT, P., BAKER, J. S., SPAGNA, R. & 
GRACE, F. M. 2015. Six weeks of conditioning exercise increases total, but not 
free testosterone in lifelong sedentary aging men. Aging Male, 18, 195-200. 
HEPPLE, R. T. 1997. A new measurement of tissue capillarity: the capillary-to-fibre 
perimeter exchange index. Can J Appl Physiol, 22, 11-22. 
HEPPLE, R. T., MACKINNON, S. L., GOODMAN, J. M., THOMAS, S. G. & PLYLEY, 
M. J. 1997a. Resistance and aerobic training in older men: effects on VO2peak and 
the capillary supply to skeletal muscle. J Appl Physiol (1985), 82, 1305-10. 
HEPPLE, R. T., MACKINNON, S. L. M., THOMAS, S. G., GOODMAN, J. M. & 
PLYLEY, M. J. 1997b. Quantitating the capillary supply and the response to 
resistance training in older men. Pflugers Archiv-European Journal of Physiology, 
433, 238-244. 
HERSKIND, A. M., MCGUE, M., HOLM, N. V., SORENSEN, T. I. A., HARVALD, B. 
& VAUPEL, J. W. 1996. The heritability of human longevity: A population-based 
study of 2872 Danish twin pairs born 1870-1900. Human Genetics, 97, 319-323. 
HJELMBORG, J. V., IACHINE, I., SKYTTHE, A., VAUPEL, J. W., MCGUE, M., 
KOSKENVUO, M., KAPRIO, J., PEDERSEN, N. L. & CHRISTENSEN, K. 
2006. Genetic influence on human lifespan and longevity. Human Genetics, 119, 
312-321. 
HOFFMAN, J. R., RATAMESS, N. A., TRANCHINA, C. P., RASHTI, S. L., KANG, J. 
& FAIGENBAUM, A. D. 2009. Effect of Protein-Supplement Timing on Strength, 
Power, and Body-Composition Changes in Resistance-Trained Men. International 
Journal of Sport Nutrition and Exercise Metabolism, 19, 172-185. 
HOLLAND, W. L., BIKMAN, B. T., WANG, L. P., YUGUANG, G., SARGENT, K. M., 
BULCHAND, S., KNOTTS, T. A., SHUI, G. H., CLEGG, D. J., WENK, M. R., 
PAGLIASSOTTI, M. J., SCHERER, P. E. & SUMMERS, S. A. 2011. Lipid-
induced insulin resistance mediated by the proinflammatory receptor TLR4 
requires saturated fatty acid-induced ceramide biosynthesis in mice. Journal of 
Clinical Investigation, 121, 1858-1870. 
 
 182 
HOLLOSZY, J. O. 2000. The biology of aging. Mayo Clin Proc, 75 Suppl, S3-8; 
discussion S8-9. 
HSIEH, A. 2012. mTOR: the master regulator. Cell, 149, 77. 
HUBAL, M. J., GORDISH-DRESSMAN, H., THOMPSON, P. D., PRICE, T. B., 
HOFFMAN, E. P., ANGELOPOULOS, T. J., GORDON, P. M., MOYNA, N. M., 
PESCATELLO, L. S., VISICH, P. S., ZOELLER, R. F., SEIP, R. L. & 
CLARKSON, P. M. 2005. Variability in muscle size and strength gain after 
unilateral resistance training. Med Sci Sports Exerc, 37, 964-72. 
HUGHES, V. A., FRONTERA, W. R., ROUBENOFF, R., EVANS, W. J. & SINGH, M. 
A. F. 2002. Longitudinal changes in body composition in older men and women: 
role of body weight change and physical activity. The American journal of clinical 
nutrition, 76, 473-481. 
HUGHES, V. A., FRONTERA, W. R., WOOD, M., EVANS, W. J., DALLAL, G. E., 
ROUBENOFF, R. & SINGH, M. A. F. 2001. Longitudinal muscle strength 
changes in older adults: Influence of muscle mass, physical activity, and health. 
Journals of Gerontology Series a-Biological Sciences and Medical Sciences, 56, 
B209-B217. 
HUNG, W. W., ROSS, J. S., BOOCKVAR, K. S. & SIU, A. L. 2011. Recent trends in 
chronic disease, impairment and disability among older adults in the United States. 
Bmc Geriatrics, 11. 
IBANEZ, J., IZQUIERDO, M., ARGUELLES, I., FORGA, L., LARRION, J. L., 
GARCIA-UNCITI, M., IDOATE, F. & GOROSTIAGA, E. M. 2005. Twice-
weekly progressive resistance training decreases abdominal fat and improves 
insulin sensitivity in older men with type 2 diabetes. Diabetes Care, 28, 662-7. 
IZQUIERDO, M., AGUADO, X., GONZALEZ, R., LÓPEZ, J. L. & HÄKKINEN, K. 
1999. Maximal and explosive force production capacity and balance performance 
in men of different ages. European Journal of Applied Physiology and 
Occupational Physiology, 79, 260-267. 
JANSSEN, I., HEYMSFIELD, S. B. & ROSS, R. 2002. Low relative skeletal muscle mass 
(sarcopenia) in older persons is associated with functional impairment and physical 
disability. J Am Geriatr Soc, 50, 889-96. 
 
 183 
JANSSEN, I., HEYMSFIELD, S. B., WANG, Z. M. & ROSS, R. 2000. Skeletal muscle 
mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 
(1985), 89, 81-8. 
JEFFERIS, B. J., SARTINI, C., LEE, I. M., CHOI, M., AMUZU, A., GUTIERREZ, C., 
CASAS, J. P., ASH, S., LENNNON, L. T., WANNAMETHEE, S. G. & 
WHINCUP, P. H. 2014. Adherence to physical activity guidelines in older adults, 
using objectively measured physical activity in a population-based study. Bmc 
Public Health, 14. 
JOANISSE, S., MCKAY, B. R., NEDERVEEN, J. P., SCRIBBANS, T. D., GURD, B. J., 
GILLEN, J. B., GIBALA, M. J., TARNOPOLSKY, M. & PARISE, G. 2015. 
Satellite cell activity, without expansion, after nonhypertrophic stimuli. Am J 
Physiol Regul Integr Comp Physiol, 309, R1101-11. 
KADI, F., CHARIFI, N., DENIS, C. & LEXELL, J. 2004. Satellite cells and myonuclei in 
young and elderly women and men. Muscle Nerve, 29, 120-7. 
KADI, F., CHARIFI, N., DENIS, C., LEXELL, J., ANDERSEN, J. L., SCHJERLING, P., 
OLSEN, S. & KJAER, M. 2005. The behaviour of satellite cells in response to 
exercise: what have we learned from human studies? Pflugers Archiv-European 
Journal of Physiology, 451, 319-327. 
KATZEL, L. I., FLEG, J. L., BUSBY-WHITEHEAD, M. J., SORKIN, J. D., BECKER, 
L. C., LAKATTA, E. G. & GOLDBERG, A. P. 1998. Exercise-induced silent 
myocardial ischemia in master athletes. American Journal of Cardiology, 81, 261-
5. 
KATZEL, L. I., SORKIN, J. D. & FLEG, J. L. 2001. A comparison of longitudinal 
changes in aerobic fitness in older endurance athletes and sedentary men. Journal 
of the American Geriatrics Society, 49, 1657-1664. 
KAWAKAMI, Y., ABE, T., KANEHISA, H. & FUKUNAGA, T. 2006. Human skeletal 
muscle size and architecture: Variability and interdependence. American Journal 
of Human Biology, 18, 845-848. 
KELLEY, G. A. & KELLEY, K. S. 2017. Is sarcopenia associated with an increased risk 
of all-cause mortality and functional disability? Exp Gerontol, 96, 100-103. 
 
 184 
KENT-BRAUN, J. A., NG, A. V. & YOUNG, K. 2000. Skeletal muscle contractile and 
noncontractile components in young and older women and men. J Appl Physiol 
(1985), 88, 662-8. 
KIM, I. Y., SUH, S. H., LEE, I. K. & WOLFE, R. R. 2016a. Applications of stable, 
nonradioactive isotope tracers in in vivo human metabolic research. Experimental 
and Molecular Medicine, 48. 
KIM, K. M., LIM, S., MOON, J. H., CHOI, S. H. & JANG, H. C. 2016b. Gender-Specific 
Associations between Muscle and Bone Losses in Longitudinal Changes of Muscle 
Mass and Strength, and Bone Mass. Osteoporosis International, 27, S384-S384. 
KIM, K. M., LIM, S., OH, T. J., MOON, J. H., CHOI, S. H., LIM, J. Y., KIM, K. W., 
PARK, K. S. & JANG, H. C. 2018. Longitudinal Changes in Muscle Mass and 
Strength, and Bone Mass in Older Adults: Gender-Specific Associations Between 
Muscle and Bone Losses. J Gerontol A Biol Sci Med Sci, 73, 1062-1069. 
KIM, P. L., STARON, R. S. & PHILLIPS, S. A. 2005. Fasted-state skeletal muscle 
protein synthesis after resistance exercise is altered with training. Journal of 
Physiology-London, 568, 283-290. 
KIM, S. Y., KO, J. B., FARTHING, J. P. & BUTCHER, S. J. 2015. Investigation of 
supraspinatus muscle architecture following concentric and eccentric training. 
Journal of science and medicine in sport, 18, 378-382. 
KIRKWOOD, T. B. L. 2005. Understanding the odd science of aging. Cell, 120, 437-447. 
KODAMA, S., SAITO, K., TANAKA, S. & ET AL. 2009. Cardiorespiratory fitness as a 
quantitative predictor of all-cause mortality and cardiovascular events in healthy 
men and women: A meta-analysis. JAMA, 301, 2024-2035. 
KONTIS, V., BENNETT, J. E., MATHERS, C. D., LI, G. Q., FOREMAN, K. & 
EZZATI, M. 2017. Future life expectancy in 35 industrialised countries: 
projections with a Bayesian model ensemble. Lancet, 389, 1323-1335. 
KOOPMAN, R., WALRAND, S., BEELEN, M., GIJSEN, A. P., KIES, A. K., BOIRIE, 
Y., SARIS, W. H. M. & VAN LOON, L. J. C. 2009. Dietary Protein Digestion and 
Absorption Rates and the Subsequent Postprandial Muscle Protein Synthetic 




KORHONEN, M. T., CRISTEA, A., ALEN, M., HAKKINEN, K., SIPILA, S., MERO, 
A., VIITASALO, J. T., LARSSON, L. & SUOMINEN, H. 2006. Aging, muscle 
fiber type, and contractile function in sprint-trained athletes. Journal of Applied 
Physiology, 101, 906-917. 
KORHONEN, M. T., HEINONEN, A., SIEKKINEN, J., ISOLEHTO, J., ALEN, M., 
KIVIRANTA, I. & SUOMINEN, H. 2012. Bone density, structure and strength, 
and their determinants in aging sprint athletes. Medicine and Science in Sports and 
Exercise, 44, 2340-2349. 
KOSEK, D. J., KIM, J. S., PETRELLA, J. K., CROSS, J. M. & BAMMAN, M. M. 2006. 
Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic 
mechanisms in young vs. older adults. J Appl Physiol (1985), 101, 531-44. 
KUBO, K., KANEHISA, H., AZUMA, K., ISHIZU, M., KUNO, S. Y., OKADA, M. & 
FUKUNAGA, T. 2003. Muscle architectural characteristics in young and elderly 
men and women. Int J Sports Med, 24, 125-30. 
KUK, J. L., KATZMARZYK, P. T., NICHAMAN, M. Z., CHURCH, T. S., BLAIR, S. N. 
& ROSS, R. 2006. Visceral fat is an independent predictor of all-cause mortality in 
men. Obesity, 14, 336-341. 
KUK, J. L., SAUNDERS, T. J., DAVIDSON, L. E. & ROSS, R. 2009. Age-related 
changes in total and regional fat distribution. Ageing Res Rev, 8, 339-48. 
KUMAGAI, K., ABE, T., BRECHUE, W. F., RYUSHI, T., TAKANO, S. & MIZUNO, 
M. 2000. Sprint performance is related to muscle fascicle length in male 100-m 
sprinters. Journal of Applied Physiology, 88, 811-816. 
KUMAR, V., SELBY, A., RANKIN, D., PATEL, R., ATHERTON, P., HILDEBRANDT, 
W., WILLIAMS, J., SMITH, K., SEYNNES, O., HISCOCK, N. & RENNIE, M. J. 
2009. Age-related differences in the dose-response relationship of muscle protein 
synthesis to resistance exercise in young and old men. Journal of Physiology-
London, 587, 211-217. 
KUSY, K. & ZIELINSKI, J. 2014. Aerobic capacity in speed-power athletes aged 20-90 
years vs endurance runners and untrained participants. Scandinavian Journal of 
Medicine & Science in Sports, 24, 68-79. 
LAMBERT, C. P. & EVANS, W. J. 2005. Adaptations to aerobic and resistance exercise 
in the elderly. Reviews in Endocrine & Metabolic Disorders, 6, 137-143. 
 
 186 
LAPLANTE, M. & SABATINI, D. M. 2012. mTOR signaling in growth control and 
disease. Cell, 149, 274-93. 
LARSSON, L., LI, X. P. & FRONTERA, W. R. 1997. Effects of aging on shortening 
velocity and myosin isoform composition in single human skeletal muscle cells. 
American Journal of Physiology-Cell Physiology, 272, C638-C649. 
LAZARUS, N. R. & HARRIDGE, S. D. 2007. Inherent ageing in humans: the case for 
studying master athletes. Scand J Med Sci Sports, 17, 461-3. 
LAZARUS, N. R. & HARRIDGE, S. D. R. 2010. Exercise, Physiological Function, and 
the Selection of Participants for Aging Research. Journals of Gerontology Series 
a-Biological Sciences and Medical Sciences, 65, 851-854. 
LAZARUS, N. R. & HARRIDGE, S. D. R. 2017. Declining performance of master 
athletes: silhouettes of the trajectory of healthy human ageing? Journal of 
Physiology-London, 595, 2941-2948. 
LEBLANC, E. S., WANG, P. Y., LEE, C. G., BARRETT-CONNOR, E., CAULEY, J. A., 
HOFFMAN, A. R., LAUGHLIN, G. A., MARSHALL, L. M. & ORWOLL, E. S. 
2011. Higher testosterone levels are associated with less loss of lean body mass in 
older men. The Journal of Clinical Endocrinology & Metabolism, 96, 3855-3863. 
LEE, D. C., ARTERO, E. G., SUI, X. & BLAIR, S. N. 2010. Mortality trends in the 
general population: the importance of cardiorespiratory fitness. J 
Psychopharmacol, 24, 27-35. 
LEE, D. C., SUI, X., ORTEGA, F. B., KIM, Y. S., CHURCH, T. S., WINETT, R. A., 
EKELUND, U., KATZMARZYK, P. T. & BLAIR, S. N. 2011. Comparisons of 
leisure-time physical activity and cardiorespiratory fitness as predictors of all-
cause mortality in men and women. Br J Sports Med, 45, 504-10. 
LEE, I. M., SHIROMA, E. J., LOBELO, F., PUSKA, P., BLAIR, S. N., KATZMARZYK, 
P. T. & WORKIN, L. P. A. S. 2012. Effect of physical inactivity on major non-
communicable diseases worldwide: an analysis of burden of disease and life 
expectancy. Lancet, 380, 219-229. 
LEXELL, J. 1995. Human aging, muscle mass, and fiber type composition. J Gerontol A 
Biol Sci Med Sci, 50 Spec No, 11-6. 
 
 187 
LEXELL, J., DOWNHAM, D. & SJOSTROM, M. 1986. Distribution of different fibre 
types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from 
three groups of healthy men between 15 and 83 years. J Neurol Sci, 72, 211-22. 
LEXELL, J., TAYLOR, C. C. & SJÖSTRÖM, M. 1988. What is the cause of the ageing 
atrophy?: Total number, size and proportion of different fiber types studied in 
whole vastus lateralis muscle from 15-to 83-year-old men. Journal of the 
neurological sciences, 84, 275-294. 
LI, R., XIA, J., ZHANG, X., GUO, J. J. & SONG, Y. Q. 2017. Associations of Sarcopenia 
and Low Muscular Strength With All-ause Mortality Among US Older Adults: 
The National Health and Nutrition Examination Surveys 1999-2002. Circulation, 
135. 
LIEBER, R. L. & FRIDEN, J. 2000. Functional and clinical significance of skeletal 
muscle architecture. Muscle Nerve, 23, 1647-66. 
LJUNGQUIST, B., BERG, S., LANKE, J., MCCLEARN, G. E. & PEDERSEN, N. L. 
1998. The effect of genetic factors for longevity: A comparison of identical and 
fraternal twins in the Swedish twin registry. Journals of Gerontology Series a-
Biological Sciences and Medical Sciences, 53, M441-M446. 
LOE, H., ROGNMO, O., SALTIN, B. & WISLOFF, U. 2013. Aerobic capacity reference 
data in 3816 healthy men and women 20-90 years. PLoS One, 8, e64319. 
LU, C.-W., YANG, K.-C., CHANG, H.-H., LEE, L.-T., CHEN, C.-Y. & HUANG, K.-C. 
2013. Sarcopenic obesity is closely associated with metabolic syndrome. Obesity 
research & clinical practice, 7, e301-e307. 
MACDONALD, A. J., GREIG, C. A. & BARACOS, V. 2011. The advantages and 
limitations of cross-sectional body composition analysis. Curr Opin Support 
Palliat Care, 5, 342-9. 
MACKEY, A., ESMARCK, B., KADI, F., KOSKINEN, S., KONGSGAARD, M., 
SYLVESTERSEN, A., HANSEN, J., LARSEN, G. & KJAER, M. 2007. Enhanced 
satellite cell proliferation with resistance training in elderly men and women. 
Scandinavian journal of medicine & science in sports, 17, 34-42. 
MACKEY, A. L., KARLSEN, A., COUPPÉ, C., MIKKELSEN, U. R., NIELSEN, R. H., 
MAGNUSSON, S. P. & KJAER, M. 2014. Differential satellite cell density of 
 
 188 
type I and II fibres with lifelong endurance running in old men. Acta Physiologica, 
210, 612-627. 
MAFFULLI, N., TESTA, V. & CAPASSO, G. 1994. Anaerobic Threshold Determination 
in Master Endurance Runners. Journal of Sports Medicine and Physical Fitness, 
34, 242-249. 
MALBUT, K. E., DINAN, S. & YOUNG, A. 2002. Aerobic training in the 'oldest old': the 
effect of 24 weeks of training. Age Ageing, 31, 255-60. 
MANINI, T. M. & CLARK, B. C. 2012. Dynapenia and Aging: An Update. Journals of 
Gerontology Series a-Biological Sciences and Medical Sciences, 67, 28-40. 
MARCELL, T. J., HAWKINS, S. A., TARPENNING, K. M., HYSLOP, D. M. & 
WISWELL, R. A. 2003. Longitudinal analysis of lactate threshold in male and 
female master athletes. Medicine and Science in Sports and Exercise, 35, 810-817. 
MARCELL, T. J., HAWKINS, S. A. & WISWELL, R. A. 2014. Leg strength declines 
with advancing age despite habitual endurance exercise in active older adults. 
Journal of Strength & Conditioning Research, 28, 504-13. 
MATELOT, D., SCHNELL, F., KERVIO, G., RIDARD, C., THILLAYE DU 
BOULLAY, N., WILSON, M. & CARRE, F. 2016. Cardiovascular Benefits of 
Endurance Training in Seniors: 40 is not too Late to Start. International Journal of 
Sports Medicine, 37, 625-632. 
MATTHEWS, D. R., HOSKER, J. P., RUDENSKI, A. S., NAYLOR, B. A., 
TREACHER, D. F. & TURNER, R. C. 1985. Homeostasis model assessment: 
insulin resistance and beta-cell function from fasting plasma glucose and insulin 
concentrations in man. Diabetologia, 28, 412-9. 
MAUGHAN, R. 1984. Relationship between muscle strength and muscle cross-sectional 
area implications for training. Sports medicine, 1, 263-269. 
MAYHEW, J. L., BALL, T. E., ARNOLD, M. D. & BOWEN, J. C. 1992. Relative 
Muscular Endurance Performance as a Predictor of Bench Press Strength in 
College Men and Women. The Journal of Strength & Conditioning Research, 6, 
200-206. 
MCCALL, G. E., BYRNES, W. C., DICKINSON, A., PATTANY, P. M. & FLECK, S. J. 
1996. Muscle fiber hypertrophy: Hyperplasia, and capillary density in college men 
after resistance training. Journal of Applied Physiology, 81, 2004-2012. 
 
 189 
MCGLORY, C., VON ALLMEN, M. T., STOKES, T., MORTON, R. W., HECTOR, A. 
J., LAGO, B. A., RAPHENYA, A. R., SMITH, B. K., MCARTHUR, A. G., 
STEINBERG, G. R., BAKER, S. K. & PHILLIPS, S. M. 2018. Failed Recovery of 
Glycemic Control and Myofibrillar Protein Synthesis With 2 wk of Physical 
Inactivity in Overweight, Prediabetic Older Adults. Journals of Gerontology Series 
a-Biological Sciences and Medical Sciences, 73, 1070-1077. 
MCKAY, B. R., DE LISIO, M., JOHNSTON, A. P., O'REILLY, C. E., PHILLIPS, S. M., 
TARNOPOLSKY, M. A. & PARISE, G. 2009. Association of interleukin-6 
signalling with the muscle stem cell response following muscle-lengthening 
contractions in humans. PLoS One, 4, e6027. 
MCKENDRY, J., BREEN, L., SHAD, B. J. & GREIG, C. A. 2018. Muscle morphology 
and performance in master athletes: A systematic review and meta-analyses. 
Ageing Res Rev, 45, 62-82. 
MCKENDRY, J., PEREZ-LOPEZ, A., MCLEOD, M., LUO, D., DENT, J. R., 
SMEUNINX, B., YU, J., TAYLOR, A. E., PHILP, A. & BREEN, L. 2016. Short 
inter-set rest blunts resistance exercise-induced increases in myofibrillar protein 
synthesis and intracellular signalling in young males. Exp Physiol, 101, 866-82. 
MCPHEE, J. S., CAMERON, J., MADEN-WILKINSON, T., PIASECKI, M., YAP, M. 
H., JONES, D. A. & DEGENS, H. 2018. The Contributions of Fiber Atrophy, 
Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in 
Sarcopenia. J Gerontol A Biol Sci Med Sci, 73, 1287-1294. 
MENEILLY, G. S., ELLIOT, T., BRYERASH, M. & FLORAS, J. S. 1995. Insulin-
Mediated Increase in Blood-Flow Is Impaired in the Elderly. Journal of Clinical 
Endocrinology & Metabolism, 80, 1899-1903. 
MESSIER, V., RABASA-LHORET, R., BARBAT-ARTIGAS, S., ELISHA, B., 
KARELIS, A. D. & AUBERTIN-LEHEUDRE, M. 2011. Menopause and 
sarcopenia: a potential role for sex hormones. Maturitas, 68, 331-336. 
MIKKELSEN, U. R., COUPPE, C., KARLSEN, A., GROSSET, J. F., SCHJERLING, P., 
MACKEY, A. L., KLAUSEN, H. H., MAGNUSSON, S. P. & KJAER, M. 2013. 
Life-long endurance exercise in humans: Circulating levels of inflammatory 




MITCHELL, C. J., CHURCHWARD-VENNE, T. A., BELLAMY, L., PARISE, G., 
BAKER, S. K. & PHILLIPS, S. M. 2013. Muscular and Systemic Correlates of 
Resistance Training-Induced Muscle Hypertrophy. Plos One, 8. 
MITCHELL, C. J., CHURCHWARD-VENNE, T. A., PARISE, G., BELLAMY, L., 
BAKER, S. K., SMITH, K., ATHERTON, P. J. & PHILLIPS, S. M. 2014. Acute 
post-exercise myofibrillar protein synthesis is not correlated with resistance 
training-induced muscle hypertrophy in young men. PloS one, 9, e89431. 
MITCHELL, C. J., CHURCHWARD-VENNE, T. A., WEST, D. W. D., BURD, N. A., 
BREEN, L., BAKER, S. K. & PHILLIPS, S. M. 2012a. Resistance exercise load 
does not determine training-mediated hypertrophic gains in young men. Journal of 
Applied Physiology, 113, 71-77. 
MITCHELL, W. K., WILLIAMS, J., ATHERTON, P., LARVIN, M., LUND, J. & 
NARICI, M. 2012b. Sarcopenia, dynapenia, and the impact of advancing age on 
human skeletal muscle size and strength; a quantitative review. Frontiers in 
Physiology, 3. 
MOHER, D., LIBERATI, A., TETZLAFF, J., ALTMAN, D. G. & GROUP, P. 2009. 
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA 
statement. PLoS Med, 6, e1000097. 
MOLMEN, H. E., WISLOFF, U., AAMOT, I. L., STOYLEN, A. & INGUL, C. B. 2012. 
Aerobic interval training compensates age related decline in cardiac function. 
Scandinavian Cardiovascular Journal, 46, 163-171. 
MOORE, D. R., CHURCHWARD-VENNE, T. A., WITARD, O., BREEN, L., BURD, N. 
A., TIPTON, K. D. & PHILLIPS, S. M. 2014. Protein ingestion to stimulate 
myofibrillar protein synthesis requires greater relative protein intakes in healthy 
older versus younger men. Journals of Gerontology Series A: Biomedical Sciences 
and Medical Sciences, 70, 57-62. 
MOORE, D. R., ROBINSON, M. J., FRY, J. L., TANG, J. E., GLOVER, E. I., 
WILKINSON, S. B., PRIOR, T., TARNOPOLSKY, M. A. & PHILLIPS, S. M. 
2009a. Ingested protein dose response of muscle and albumin protein synthesis 




MOORE, D. R., TANG, J. E., BURD, N. A., RERECICH, T., TARNOPOLSKY, M. A. & 
PHILLIPS, S. M. 2009b. Differential stimulation of myofibrillar and sarcoplasmic 
protein synthesis with protein ingestion at rest and after resistance exercise. 
Journal of Physiology-London, 587, 897-904. 
MORLEY, J. E. 2008. Sarcopenia: Diagnosis and treatment. Journal of Nutrition Health 
& Aging, 12, 452-456. 
MORLEY, J. E., THOMAS, D. R. & WILSON, M. M. G. 2006. Cachexia: 
pathophysiology and clinical relevance. American Journal of Clinical Nutrition, 
83, 735-743. 
MORTENSEN, S. P., NYBERG, M., WINDING, K. & SALTIN, B. 2012. Lifelong 
physical activity preserves functional sympatholysis and purinergic signalling in 
the ageing human leg. Journal of Physiology-London, 590, 6227-6236. 
MORTON, R. W., MURPHY, K. T., MCKELLAR, S. R., SCHOENFELD, B. J., 
HENSELMANS, M., HELMS, E., ARAGON, A. A., DEVRIES, M. C., 
BANFIELD, L., KRIEGER, J. W. & PHILLIPS, S. M. 2018. A systematic review, 
meta-analysis and meta-regression of the effect of protein supplementation on 
resistance training-induced gains in muscle mass and strength in healthy adults. 
British Journal of Sports Medicine, 52, 376-+. 
MOSOLE, S., CARRARO, U., KERN, H., LOEFLER, S., FRUHMANN, H., 
VOGELAUER, M., BURGGRAF, S., MAYR, W., KRENN, M., 
PATERNOSTRO-SLUGA, T., HAMAR, D., CVECKA, J., SEDLIAK, M., 
TIRPAKOVA, V., SARABON, N., MUSARO, A., SANDRI, M., PROTASI, F., 
NORI, A., POND, A. & ZAMPIERI, S. 2014. Long-Term High-Level Exercise 
Promotes Muscle Reinnervation With Age. Journal of Neuropathology and 
Experimental Neurology, 73, 284-294. 
MUCCI, P., ANSELME-POUJOL, F., CAILLAUD, C., COURET, I., ROSSI, M. & 
PREFAUT, C. 1999. Basophil releasability in young highly trained and older 
athletes. Medicine & Science in Sports & Exercise, 31, 507-513 7p. 
MURACH, K. A., WALTON, R. G., FRY, C. S., MICHAELIS, S. L., GROSHONG, J. S., 
FINLIN, B. S., KERN, P. A. & PETERSON, C. A. 2016. Cycle training modulates 
satellite cell and transcriptional responses to a bout of resistance exercise. 
Physiological reports, 4. 
 
 192 
MURTON, A. & GREENHAFF, P. 2013. Resistance exercise and the mechanisms of 
muscle mass regulation in humans: acute effects on muscle protein turnover and 
the gaps in our understanding of chronic resistance exercise training adaptation. 
The international journal of biochemistry & cell biology, 45, 2209-2214. 
MURTON, A. J., MARIMUTHU, K., MALLINSON, J. E., SELBY, A. L., SMITH, K., 
RENNIE, M. J. & GREENHAFF, P. L. 2015. Obesity Appears to Be Associated 
With Altered Muscle Protein Synthetic and Breakdown Responses to Increased 
Nutrient Delivery in Older Men, but Not Reduced Muscle Mass or Contractile 
Function. Diabetes, 64, 3160-3171. 
NARICI, M. V. & MAFFULLI, N. 2010. Sarcopenia: characteristics, mechanisms and 
functional significance. Br Med Bull, 95, 139-59. 
NARICI, M. V., MAGANARIS, C. N., REEVES, N. D. & CAPODAGLIO, P. 2003. 
Effect of aging on human muscle architecture. J Appl Physiol (1985), 95, 2229-34. 
NEDERVEEN, J. P., JOANISSE, S., SNIJDERS, T., IVANKOVIC, V., BAKER, S. K., 
PHILLIPS, S. M. & PARISE, G. 2016. Skeletal muscle satellite cells are located at 
a closer proximity to capillaries in healthy young compared with older men. J 
Cachexia Sarcopenia Muscle, 7, 547-554. 
NETO, W. K., GAMA, E. F., ROCHA, L. Y., RAMOS, C. C., TAETS, W., SCAPINI, K. 
B., FERREIRA, J. B., RODRIGUES, B. & CAPERUTO, É. 2015. Effects of 
testosterone on lean mass gain in elderly men: systematic review with meta-
analysis of controlled and randomized studies. AGE, 37, 5. 
NEWMAN, A. B., KUPELIAN, V., VISSER, M., SIMONSICK, E. M., GOODPASTER, 
B. H., KRITCHEVSKY, S. B., TYLAVSKY, F. A., RUBIN, S. M. & HARRIS, T. 
B. 2006. Strength, but not muscle mass, is associated with mortality in the health, 
aging and body composition study cohort. The Journals of Gerontology Series A: 
Biological Sciences and Medical Sciences, 61, 72-77. 
NEWTON, R. U., HAKKINEN, K., HAKKINEN, A., MCCORMICK, M., VOLEK, J. & 
KRAEMER, W. J. 2002. Mixed-methods resistance training increases power and 
strength of young and older men. Med Sci Sports Exerc, 34, 1367-75. 
NICCOLI, T. & PARTRIDGE, L. 2012. Ageing as a Risk Factor for Disease. Current 
Biology, 22, R741-R752. 
 
 193 
NILWIK, R., SNIJDERS, T., LEENDERS, M., GROEN, B. B., VAN KRANENBURG, 
J., VERDIJK, L. B. & VAN LOON, L. J. 2013. The decline in skeletal muscle 
mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp 
Gerontol, 48, 492-8. 
NYBERG, M., BLACKWELL, J. R., DAMSGAARD, R., JONES, A. M., HELLSTEN, 
Y. & MORTENSEN, S. P. 2012. Lifelong physical activity prevents an age-related 
reduction in arterial and skeletal muscle nitric oxide bioavailability in humans. 
Journal of Physiology-London, 590, 5361-5370. 
OJANEN, T., RAUHALA, T. & HÄKKINEN, K. 2007. Strength and power profiles of 
the lower and upper extremities in master throwers at different ages. Journal of 
Strength & Conditioning Research (Allen Press Publishing Services Inc.), 21, 216-
222 7p. 
ORTEGA, F. B., LAVIE, C. J. & BLAIR, S. N. 2016. Obesity and Cardiovascular 
Disease. Circulation Research, 118, 1752-1770. 
ORTEGA, F. B., SILVENTOINEN, K., TYNELIUS, P. & RASMUSSEN, F. 2012. 
Muscular strength in male adolescents and premature death: cohort study of one 
million participants. BMJ, 345, e7279. 
PADDON-JONES, D., SHEFFIELD-MOORE, M., ZHANG, X. J., VOLPI, E., WOLF, S. 
E., AARSLAND, A. & WOLFE, R. R. 2004. Amino acid ingestion improves 
muscle protein synthesis in the young and elderly. American Journal of 
Physiology-Endocrinology and Metabolism, 286, E321-E328. 
PAN, D. A., LILLIOJA, S., KRIKETOS, A. D., MILNER, M. R., BAUR, L. A., 
BOGARDUS, C., JENKINS, A. B. & STORLIEN, L. H. 1997. Skeletal muscle 
triglyceride levels are inversely related to insulin action. Diabetes, 46, 983-8. 
PARIZKOVA, J., EISELT, E., SPRYNAROVA, S. & WACHTLOVA, M. 1971. Body 
composition, aerobic capacity, and density of muscle capillaries in young and old 
men. J Appl Physiol, 31, 323-5. 
PEARSON, S. J., YOUNG, A., MACALUSO, A., DEVITO, G., NIMMO, M. A., 
COBBOLD, M. & HARRIDGE, S. D. 2002. Muscle function in elite master 
weightlifters. Med Sci Sports Exerc, 34, 1199-206. 
PENNINGS, B., KOOPMAN, R., BEELEN, M., SENDEN, J. M. G., SARIS, W. H. M. & 
VAN LOON, L. J. C. 2011. Exercising before protein intake allows for greater use 
 
 194 
of dietary protein-derived amino acids for de novo muscle protein synthesis in both 
young and elderly men. American Journal of Clinical Nutrition, 93, 322-331. 
PEREIRA, F. B., LEITE, A. F. & DE PAULA, A. P. 2015. Relationship between pre-
sarcopenia, sarcopenia and bone mineral density in elderly men. Arquivos 
Brasileiros De Endocrinologia E Metabologia, 59, 59-65. 
PETERSON, M. D., RHEA, M. R., SEN, A. & GORDON, P. M. 2010. Resistance 
exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev, 9, 
226-37. 
PETERSON, M. D., SEN, A. & GORDON, P. M. 2011. Influence of resistance exercise 
on lean body mass in aging adults: a meta-analysis. Med Sci Sports Exerc, 43, 249-
58. 
PHILLIPS, B. E., ATHERTON, P. J., VARADHAN, K., LIMB, M. C., WILKINSON, D. 
J., SJØBERG, K. A., SMITH, K. & WILLIAMS, J. P. 2015. The effects of 
resistance exercise training upon macro and micro-circulatory responses to feeding 
and skeletal muscle protein anabolism, in older men. The Journal of Physiology, 
n/a-n/a. 
PHILLIPS, S. M. 2004. Protein requirements and supplementation in strength sports. 
Nutrition, 20, 689-695. 
PHILLIPS, S. M., TIPTON, K. D., AARSLAND, A., WOLF, S. E. & WOLFE, R. R. 
1997. Mixed muscle protein synthesis and breakdown after resistance exercise in 
humans. Am J Physiol, 273, E99-107. 
PIASECKI, M., IRELAND, A., COULSON, J., STASHUK, D. W., HAMILTON-
WRIGHT, A., SWIECICKA, A., RUTTER, M. K., MCPHEE, J. S. & JONES, D. 
A. 2016a. Motor unit number estimates and neuromuscular transmission in the 
tibialis anterior of master athletes: evidence that athletic older people are not 
spared from age-related motor unit remodeling. Physiol Rep, 4. 
PIASECKI, M., IRELAND, A., JONES, D. A. & MCPHEE, J. S. 2016b. Age-dependent 
motor unit remodelling in human limb muscles. Biogerontology, 17, 485-96. 
PIASECKI, M., IRELAND, A., PIASECKI, J., STASHUK, D. W., SWIECICKA, A., 
RUTTER, M. K., JONES, D. A. & MCPHEE, J. S. 2018. Failure to expand the 
motor unit size to compensate for declining motor unit numbers distinguishes 
sarcopenic from non-sarcopenic older men. J Physiol, 596, 1627-1637. 
 
 195 
PIASECKI, M., IRELAND, A., STASHUK, D., HAMILTON-WRIGHT, A., JONES, D. 
A. & MCPHEE, J. S. 2016c. Age-related neuromuscular changes affecting human 
vastus lateralis. Journal of Physiology-London, 594, 4525-4536. 
PIERCY, K. L., TROIANO, R. P., BALLARD, R. M., CARLSON, S. A., FULTON, J. E., 
GALUSKA, D. A., GEORGE, S. M. & OLSON, R. D. 2018. The Physical 
Activity Guidelines for Americans. Jama-Journal of the American Medical 
Association, 320, 2020-2028. 
PINEDO-VILLANUEVA, R., WESTBURY, L. D., SYDDALL, H. E., SANCHEZ-
SANTOS, M. T., DENNISON, E. M., ROBINSON, S. M. & COOPER, C. 2019. 
Health Care Costs Associated With Muscle Weakness: A UK Population-Based 
Estimate. Calcif Tissue Int, 104, 137-144. 
POLLOCK, M. L., FOSTER, C., KNAPP, D., ROD, J. L. & SCHMIDT, D. H. 1987. 
Effect of age and training on aerobic capacity and body composition of master 
athletes. J Appl Physiol (1985), 62, 725-31. 
POLLOCK, R. D., CARTER, S., VELLOSO, C. P., DUGGAL, N. A., LORD, J. M., 
LAZARUS, N. R. & HARRIDGE, S. D. R. 2015. An investigation into the 
relationship between age and physiological function in highly active older adults. 
Journal of Physiology-London, 593, 657-680. 
POLLOCK, R. D., O'BRIEN, K. A., DANIELS, L. J., NIELSEN, K. B., ROWLERSON, 
A., DUGGAL, N. A., LAZARUS, N. R., LORD, J. M., PHILP, A. & HARRIDGE, 
S. D. R. 2018. Properties of the vastus lateralis muscle in relation to age and 
physiological function in master cyclists aged 55-79years. Aging Cell, 17. 
POWER, G. A., DALTON, B. H., BEHM, D. G., DOHERTY, T. J., VANDERVOORT, 
A. A. & RICE, C. L. 2012. Motor Unit Survival in Lifelong Runners Is Muscle 
Dependent. Medicine and Science in Sports and Exercise, 44, 1235-1242. 
POWER, G. A., DALTON, B. H., BEHM, D. G., VANDERVOORT, A. A., DOHERTY, 
T. J. & RICE, C. L. 2010. Motor Unit Number Estimates in Masters Runners: Use 
It or Lose It? Medicine and Science in Sports and Exercise, 42, 1644-1650. 
PRASAD, A., POPOVIC, Z. B., ARBAB-ZADEH, A., FU, Q., PALMER, D., DIJK, E., 
GREENBERG, N. L., GARCIA, M. J., THOMAS, J. D. & LEVINE, B. D. 2007. 
The Effects of Aging and Physical Activity on Doppler Measures of Diastolic 
Function. American Journal of Cardiology, 99, 1629-1636. 
 
 196 
PREFAUT, C., ANSELME, F., CAILLAUD, C. & MASSE-BIRON, J. 1994. Exercise-
induced hypoxemia in older athletes. Journal of Applied Physiology, 76, 120-6. 
PROCTOR, D. N. & JOYNER, M. J. 1997. Skeletal muscle mass and the reduction of 
VO2max in trained older subjects. Journal of Applied Physiology, 82, 1411-1415. 
PROCTOR, D. N., SINNING, W. E., WALRO, J. M., SIECK, G. C. & LEMON, P. W. 
1995. Oxidative capacity of human muscle fiber types: effects of age and training 
status. J Appl Physiol (1985), 78, 2033-8. 
RANTALAINEN, T., DUCKHAM, R. L., SUOMINEN, H., HEINONEN, A., ALEN, M. 
& KORHONEN, M. T. 2014. Tibial and fibular mid-shaft bone traits in young and 
older sprinters and non-athletic men. Calcified Tissue International, 95, 132-140. 
RASMUSSEN, B. B., FUJITA, S., WOLFE, R. R., MITTENDORFER, B., ROY, M., 
ROWE, V. L. & VOLPI, E. 2006. Insulin resistance of muscle protein metabolism 
in aging. Faseb Journal, 20, 768-+. 
REEVES, N. D., NARICI, M. V. & MAGANARIS, C. N. 2004a. Effect of resistance 
training on skeletal muscle-specific force in elderly humans. J Appl Physiol 
(1985), 96, 885-92. 
REEVES, N. D., NARICI, M. V. & MAGANARIS, C. N. 2004b. In vivo human muscle 
structure and function: adaptations to resistance training in old age. Experimental 
physiology, 89, 675-689. 
RIEU, I., MAGNE, H., SAVARY-AUZELOUX, I., AVEROUS, J., BOS, C., PEYRON, 
M.-A., COMBARET, L. & DARDEVET, D. 2009. Reduction of low grade 
inflammation restores blunting of postprandial muscle anabolism and limits 
sarcopenia in old rats. The Journal of physiology, 587, 5483-5492. 
RITTWEGER, J., DI PRAMPERO, P. E., MAFFULLI, N. & NARICI, M. V. 2009. Sprint 
and endurance power and ageing: an analysis of master athletic world records. 
Proc Biol Sci, 276, 683-9. 
RIVAS, D. A., MORRIS, E. P., HARAN, P. H., PASHA, E. P., MORAIS MDA, S., 
DOLNIKOWSKI, G. G., PHILLIPS, E. M. & FIELDING, R. A. 2012. Increased 
ceramide content and NFkappaB signaling may contribute to the attenuation of 




RIVIER, A., PENE, J., CHANEZ, P., ANSELME, F., CAILLAUD, C., PREFAUT, C., 
GODARD, P. & BOUSQUET, J. 1994. Release of cytokines by blood monocytes 
during strenuous exercise. International Journal of Sports Medicine, 15, 192-8. 
RODEHEFFER, R. J., GERSTENBLITH, G., BECKER, L. C., FLEG, J. L., 
WEISFELDT, M. L. & LAKATTA, E. G. 1984. Exercise Cardiac-Output Is 
Maintained with Advancing Age in Healthy-Human Subjects - Cardiac Dilatation 
and Increased Stroke Volume Compensate for a Diminished Heart-Rate. 
Circulation, 69, 203-213. 
ROGERS, M. A., HAGBERG, J. M., MARTIN, W. H., 3RD, EHSANI, A. A. & 
HOLLOSZY, J. O. 1990. Decline in VO2max with aging in master athletes and 
sedentary men. J Appl Physiol (1985), 68, 2195-9. 
ROSENBERG, I. H. 1989. Epidemiologic and Methodologic Problems in Determining 
Nutritional-Status of Older Persons - Proceedings of a Conference Held in 
Albuquerque, New Mexico, October 19-21, 1988 - Summary Comments. 
American Journal of Clinical Nutrition, 50, 1231-1233. 
ROTH, S. M., MARTEL, G. F., IVEY, F. M., LEMMER, J. T., METTER, E. J., 
HURLEY, B. F. & ROGERS, M. A. 2000. Skeletal muscle satellite cell 
populations in healthy young and older men and women. Anat Rec, 260, 351-8. 
RUIZ, J. R., SUI, X., LOBELO, F., MORROW, J. R., JACKSON, A. W., SJÖSTRÖM, 
M. & BLAIR, S. N. 2008. Association between muscular strength and mortality in 
men: prospective cohort study. BMJ, 337. 
SALLINEN, J., OJANEN, T., KARAVIRTA, L., AHTIAINEN, J. P. & HAKKINEN, K. 
2008. Muscle mass and strength, body composition and dietary intake in master 
strength athletes vs untrained men of different ages. Journal of Sports Medicine 
and Physical Fitness, 48, 190-196. 
SANADA, K., MIYACHI, M., TABATA, I., SUZUKI, K., YAMAMOTO, K., 
KAWANO, H., USUI, C. & HIGUCHI, M. 2009. Differences in body composition 
and risk of lifestyle-related diseases between young and older male rowers and 
sedentary controls. Journal of Sports Sciences, 27, 1027-1034. 
SCHINDELIN, J., ARGANDA-CARRERAS, I., FRISE, E., KAYNIG, V., LONGAIR, 
M., PIETZSCH, T., PREIBISCH, S., RUEDEN, C., SAALFELD, S., SCHMID, 
B., TINEVEZ, J. Y., WHITE, D. J., HARTENSTEIN, V., ELICEIRI, K., 
 
 198 
TOMANCAK, P. & CARDONA, A. 2012. Fiji: an open-source platform for 
biological-image analysis. Nat Methods, 9, 676-82. 
SCHMIDT, J. F., ANDERSEN, T. R., ANDERSEN, L. J., RANDERS, M. B., 
HORNSTRUP, T., HANSEN, P. R., BANGSBO, J. & KRUSTRUP, P. 2015. 
Cardiovascular function is better in veteran football players than age-matched 
untrained elderly healthy men. Scandinavian Journal of Medicine & Science in 
Sports, 25, 61-69. 
SCHOENFELD, B. J., PETERSON, M. D., OGBORN, D., CONTRERAS, B. & 
SONMEZ, G. T. 2015. Effects of low-vs. high-load resistance training on muscle 
strength and hypertrophy in well-trained men. The Journal of Strength & 
Conditioning Research, 29, 2954-2963. 
SEALS, D. R., JUSTICE, J. N. & LAROCCA, T. J. 2016. Physiological geroscience: 
targeting function to increase healthspan and achieve optimal longevity. J Physiol, 
594, 2001-24. 
SHAD, B. J., THOMPSON, J. L. & BREEN, L. 2016. Does the muscle protein synthetic 
response to exercise and amino acid-based nutrition diminish with advancing age? 
A systematic review. American Journal of Physiology-Endocrinology and 
Metabolism, 311, E803-E817. 
SHIBATA, S. & LEVINE, B. D. 2012. Effect of exercise training on biologic vascular age 
in healthy seniors. American Journal of Physiology - Heart & Circulatory 
Physiology, 302, H1340-6. 
SHORT, K. R., VITTONE, J. L., BIGELOW, M. L., PROCTOR, D. N. & NAIR, K. S. 
2004a. Age and aerobic exercise training effects on whole body and muscle protein 
metabolism. American Journal of Physiology-Endocrinology and Metabolism. 
SHORT, K. R., VITTONE, J. L., BIGELOW, M. L., PROCTOR, D. N. & NAIR, K. S. 
2004b. Age and aerobic exercise training effects on whole body and muscle 
protein metabolism. Am J Physiol Endocrinol Metab, 286, E92-101. 
SINCLAIR, D. A. & GUARENTE, L. 2006. Unlocking the secrets of longevity genes. 
Scientific American, 294, 48-+. 
SIPILA, S. & SUOMINEN, H. 1991. Ultrasound imaging of the quadriceps muscle in 
elderly athletes and untrained men. Muscle & Nerve, 14, 527-33. 
 
 199 
SKELTON, D. A., GREIG, C. A., DAVIES, J. M. & YOUNG, A. 1994. Strength, power 
and related functional ability of healthy people aged 65–89 years. Age and ageing, 
23, 371-377. 
SKILTON, M. R., LAI, N. T., GRIFFITHS, K. A., MOLYNEAUX, L. M., YUE, D. K., 
SULLIVAN, D. R. & CELERMAJER, D. S. 2005. Meal-related increases in 
vascular reactivity are impaired in older and diabetic adults: insights into roles of 
aging and insulin in vascular flow. Am J Physiol Heart Circ Physiol, 288, H1404-
10. 
SLENTZ, C. A., DUSCHA, B. D., JOHNSON, J. L., KETCHUM, K., AIKEN, L. B., 
SAMSA, G. P., HOUMARD, J. A., BALES, C. W. & KRAUS, W. E. 2004. 
Effects of the amount of exercise on body weight, body composition, and measures 
of central obesity: STRRIDE--a randomized controlled study. Arch Intern Med, 
164, 31-9. 
SMEUNINX, B., MCKENDRY, J., WILSON, D., MARTIN, U. & BREEN, L. 2017. 
Age-Related Anabolic Resistance of Myofibrillar Protein Synthesis Is Exacerbated 
in Obese Inactive Individuals. J Clin Endocrinol Metab, 102, 3535-3545. 
SMEUNINX, B., NISHIMURA, Y., MCKENDRY, J., LIMB, M., SMITH, K., 
ATHERTON, P. J. & BREEN, L. 2018. The effect of acute oral phosphatidic acid 
ingestion on myofibrillar protein synthesis and intracellular signaling in older 
males. Clin Nutr. 
SMITH, G. I., ATHERTON, P., VILLAREAL, D. T., FRIMEL, T. N., RANKIN, D., 
RENNIE, M. J. & MITTENDORFER, B. 2008. Differences in Muscle Protein 
Synthesis and Anabolic Signaling in the Postabsorptive State and in Response to 
Food in 65-80 Year Old Men and Women. Plos One, 3. 
SNIJDERS, T., NEDERVEEN, J. P., JOANISSE, S., LEENDERS, M., VERDIJK, L. B., 
VAN LOON, L. J. & PARISE, G. 2017. Muscle fibre capillarization is a critical 
factor in muscle fibre hypertrophy during resistance exercise training in older men. 
J Cachexia Sarcopenia Muscle, 8, 267-276. 
SNIJDERS, T., NEDERVEEN, J. P., MCKAY, B. R., JOANISSE, S., VERDIJK, L. B., 
VAN LOON, L. J. & PARISE, G. 2015. Satellite cells in human skeletal muscle 
plasticity. Front Physiol, 6, 283. 
 
 200 
SNIJDERS, T., SMEETS, J. S., VAN KRANENBURG, J., KIES, A. K., VAN LOON, L. 
J. & VERDIJK, L. B. 2016. Changes in myonuclear domain size do not precede 
muscle hypertrophy during prolonged resistance-type exercise training. Acta 
Physiol (Oxf), 216, 231-9. 
SNIJDERS, T., VERDIJK, L. B., SMEETS, J. S., MCKAY, B. R., SENDEN, J. M., 
HARTGENS, F., PARISE, G., GREENHAFF, P. & VAN LOON, L. J. 2014. The 
skeletal muscle satellite cell response to a single bout of resistance-type exercise is 
delayed with aging in men. Age (Dordr), 36, 9699. 
SNIJDERS, T., VERDIJK, L. B. & VAN LOON, L. J. C. 2009. The impact of sarcopenia 
and exercise training on skeletal muscle satellite cells. Ageing Research Reviews, 
8, 328-338. 
SNYDER, P. J., PEACHEY, H., HANNOUSH, P., BERLIN, J. A., LOH, L., LENROW, 
D. A., HOLMES, J. H., DLEWATI, A., SANTANNA, J. & ROSEN, C. J. 1999. 
Effect of testosterone treatment on body composition and muscle strength in men 
over 65 years of age. The Journal of Clinical Endocrinology & Metabolism, 84, 
2647-2653. 
SONN, U. 1996. Longitudinal studies of dependence in daily life activities among elderly 
persons - Methodological development, use of assistive devices and relation to 
impairments and functional limitations. Scandinavian Journal of Rehabilitation 
Medicine, 1-35. 
SOUSA, A. S., GUERRA, R. S., FONSECA, I., PICHEL, F., FERREIRA, S. & 
AMARAL, T. F. 2016. Financial impact of sarcopenia on hospitalization costs. 
Eur J Clin Nutr, 70, 1046-51. 
SRIKANTHAN, P. & KARLAMANGLA, A. S. 2014. Muscle Mass Index As a Predictor 
of Longevity in Older Adults. American Journal of Medicine, 127, 547-553. 
ST-JEAN-PELLETIER, F., PION, C. H., LEDUC-GAUDET, J. P., SGARIOTO, N., 
ZOVILÉ, I., BARBAT-ARTIGAS, S., REYNAUD, O., ALKATERJI, F., 
LEMIEUX, F. C. & GRENON, A. 2017. The impact of ageing, physical activity, 
and pre-frailty on skeletal muscle phenotype, mitochondrial content, and 




STARON, R. S., KARAPONDO, D. L., KRAEMER, W. J., FRY, A. C., GORDON, S. E., 
FALKEL, J. E., HAGERMAN, F. C. & HIKIDA, R. S. 1994. Skeletal muscle 
adaptations during early phase of heavy-resistance training in men and women. J 
Appl Physiol (1985), 76, 1247-55. 
STARON, R. S., MALICKY, E. S., LEONARDI, M. J., FALKEL, J. E., HAGERMAN, F. 
C. & DUDLEY, G. A. 1990. Muscle hypertrophy and fast fiber type conversions in 
heavy resistance-trained women. Eur J Appl Physiol Occup Physiol, 60, 71-9. 
STENROTH, L., CRONIN, N. J., PELTONEN, J., KORHONEN, M. T., SIPILA, S. & 
FINNI, T. 2016. Triceps surae muscle-tendon properties in older endurance- and 
sprint-trained athletes. Journal of Applied Physiology, 120, 63-69. 
STEPHENS, F. B., CHEE, C., WALL, B. T., MURTON, A. J., SHANNON, C. E., VAN 
LOON, L. J. C. & TSINTZAS, K. 2015. Lipid-Induced Insulin Resistance Is 
Associated With an Impaired Skeletal Muscle Protein Synthetic Response to 
Amino Acid Ingestion in Healthy Young Men. Diabetes, 64, 1615-1620. 
STRASSER, E. M., DRASKOVITS, T., PRASCHAK, M., QUITTAN, M. & GRAF, A. 
2013. Association between ultrasound measurements of muscle thickness, 
pennation angle, echogenicity and skeletal muscle strength in the elderly. Age, 35, 
2377-2388. 
SUETTA, C., ANDERSEN, J. L., DALGAS, U., BERGET, J., KOSKINEN, S. O., 
AAGAARD, P., MAGNUSSON, S. P. & KJAER, M. 2008. Resistance training 
induces qualitative changes in muscle morphology, muscle architecture and muscle 
function in elderly postoperative patients. Journal of applied physiology. 
SUNDSTRUP, E., JAKOBSEN, M. D., ANDERSEN, J. L., RANDERS, M. B., 
PETERSEN, J., SUETTA, C., AAGAARD, P. & KRUSTRUP, P. 2010. Muscle 
function and postural balance in lifelong trained male footballers compared with 
sedentary elderly men and youngsters. Scandinavian Journal of Medicine & 
Science in Sports, 20, 90-97. 
SUOMINEN, H. & RAHKILA, P. 1991. Bone mineral density of the calcaneus in 70- to 
81-yr-old male athletes and a population sample.[Erratum appears in Med Sci 




SYMONS, T. B., SHEFFIELD-MOORE, M., MAMEROW, M. M., WOLFE, R. R. & 
PADDON-JONES, D. 2011. The anabolic response to resistance exercise and a 
protein-rich meal is not diminished by age. Journal of Nutrition Health & Aging, 
15, 376-381. 
TAAFFE, D. R., HENWOOD, T. R., NALLS, M. A., WALKER, D. G., LANG, T. F. & 
HARRIS, T. B. 2009. Alterations in Muscle Attenuation following Detraining and 
Retraining in Resistance-Trained Older Adults. Gerontology, 55, 217-223. 
TANAKA, H., DESOUZA, C. A., JONES, P. P., STEVENSON, E. T., DAVY, K. P. & 
SEALS, D. R. 1997. Greater rate of decline in maximal aerobic capacity with age 
in physically active vs. sedentary healthy women. Journal of Applied Physiology, 
83, 1947-1953. 
TANAKA, H. & SEALS, D. R. 2003. Invited Review: Dynamic exercise performance in 
Masters athletes: insight into the effects of primary human aging on physiological 
functional capacity. J Appl Physiol (1985), 95, 2152-62. 
TANAKA, H. & SEALS, D. R. 2008. Endurance exercise performance in Masters 
athletes: age-associated changes and underlying physiological mechanisms. J 
Physiol, 586, 55-63. 
TANG, J. E., MOORE, D. R., KUJBIDA, G. W., TARNOPOLSKY, M. A. & PHILLIPS, 
S. M. 2009. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects 
on mixed muscle protein synthesis at rest and following resistance exercise in 
young men. J Appl Physiol (1985), 107, 987-92. 
TANG, J. E., PERCO, J. G., MOORE, D. R., WILKINSON, S. B. & PHILLIPS, S. M. 
2008. Resistance training alters the response of fed state mixed muscle protein 
synthesis in young men. American Journal of Physiology-Regulatory, Integrative 
and Comparative Physiology, 294, R172-R178. 
TANNER, R. E., BRUNKER, L. B., AGERGAARD, J., BARROWS, K. M., BRIGGS, R. 
A., KWON, O. S., YOUNG, L. M., HOPKINS, P. N., VOLPI, E. & MARCUS, R. 
L. 2015. Age-related differences in lean mass, protein synthesis and skeletal 
muscle markers of proteolysis after bed rest and exercise rehabilitation. The 
Journal of physiology, 593, 4259-4273. 
 
 203 
TARPENNING, K. M., HAMILTON-WESSLER, M., WISWELL, R. A. & HAWKINS, 
S. A. 2004. Endurance training delays age of decline in leg strength and muscle 
morphology. Medicine & Science in Sports & Exercise, 36, 74-78 5p. 
THOM, J. M., MORSE, C. I., BIRCH, K. M. & NARICI, M. V. 2007. Influence of muscle 
architecture on the torque and power-velocity characteristics of young and elderly 
men. European Journal of Applied Physiology, 100, 613-619. 
THOMAS, B. P., YEZHUVATH, U. S., TSENG, B. Y., LIU, P., LEVINE, B. D., 
ZHANG, R. & LU, H. 2013. Life-long aerobic exercise preserved baseline cerebral 
blood flow but reduced vascular reactivity to CO2. Journal of Magnetic Resonance 
Imaging, 38, 1177-83. 
THORNELL, L. E., LINDSTROM, M., RENAULT, V., MOULY, V. & BUTLER-
BROWNE, G. S. 2003. Satellite cells and training in the elderly. Scandinavian 
Journal of Medicine & Science in Sports, 13, 48-55. 
TIMMERMAN, K. L., DHANANI, S., GLYNN, E. L., FRY, C. S., DRUMMOND, M. J., 
JENNINGS, K., RASMUSSEN, B. B. & VOLPI, E. 2012. A moderate acute 
increase in physical activity enhances nutritive flow and the muscle protein 
anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr, 95, 
1403-12. 
TIMMERMAN, K. L., LEE, J. L., FUJITA, S., DHANANI, S., DREYER, H. C., FRY, C. 
S., DRUMMOND, M. J., SHEFFIELD-MOORE, M., RASMUSSEN, B. B. & 
VOLPI, E. 2010. Pharmacological vasodilation improves insulin-stimulated 
muscle protein anabolism but not glucose utilization in older adults. Diabetes. 
TIPTON, K. D., HAMILTON, D. L. & GALLAGHER, I. J. 2018. Assessing the Role of 
Muscle Protein Breakdown in Response to Nutrition and Exercise in Humans. 
Sports Med, 48, 53-64. 
TOMLINSON, B. & IRVING, D. 1977. The numbers of limb motor neurons in the human 
lumbosacral cord throughout life. Journal of the neurological sciences, 34, 213-
219. 
TRAPPE, S., HAYES, E., GALPIN, A., KAMINSKY, L., JEMIOLO, B., FINK, W., 
TRAPPE, T., JANSSON, A., GUSTAFSSON, T. & TESCH, P. 2013. New records 
in aerobic power among octogenarian lifelong endurance athletes. Journal of 
Applied Physiology, 114, 3-10. 
 
 204 
TRAPPE, T., WILLIAMS, R., CARRITHERS, J., RAUE, U., ESMARCK, B., KJAER, 
M. & HICKNER, R. 2004. Influence of age and resistance exercise on human 
skeletal muscle proteolysis: a microdialysis approach. Journal of Physiology-
London, 554, 803-813. 
VERDIJK, L. B., KOOPMAN, R., SCHAART, G., MEIJER, K., SAVELBERG, H. H. & 
VAN LOON, L. J. 2007. Satellite cell content is specifically reduced in type II 
skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab, 292, E151-7. 
VERDIJK, L. B., SNIJDERS, T., BEELEN, M., SAVELBERG, H. H., MEIJER, K., 
KUIPERS, H. & VAN LOON, L. J. 2010. Characteristics of muscle fiber type are 
predictive of skeletal muscle mass and strength in elderly men. J Am Geriatr Soc, 
58, 2069-75. 
VERDIJK, L. B., SNIJDERS, T., DROST, M., DELHAAS, T., KADI, F. & VAN LOON, 
L. J. 2014. Satellite cells in human skeletal muscle; from birth to old age. Age 
(Dordr), 36, 545-7. 
VISSER, M., GOODPASTER, B. H., KRITCHEVSKY, S. B., NEWMAN, A. B., 
NEVITT, M., RUBIN, S. M., SIMONSICK, E. M. & HARRIS, T. B. 2005. 
Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident 
mobility limitations in well-functioning older persons. The Journals of 
Gerontology Series A: Biological Sciences and Medical Sciences, 60, 324-333. 
VOLPI, E., SHEFFIELD-MOORE, M., RASMUSSEN, B. B. & WOLFE, R. R. 2001. 
Basal muscle amino acid kinetics and protein synthesis in healthy young and older 
men. Jama, 286, 1206-1212. 
VON HAEHLING, S., MORLEY, J. E. & ANKER, S. D. 2010. An overview of 
sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia 
Sarcopenia Muscle, 1, 129-133. 
WACKERHAGE, H. & RATKEVICIUS, A. 2008. Signal transduction pathways that 
regulate muscle growth. Drugs and Ergogenic Aids to Improve Sport Performance, 
44, 99-108. 
WADA, K. I., TAKAHASHI, H., KATSUTA, S. & SOYA, H. 2002. No decrease in 
myonuclear number after long-term denervation in mature mice. American Journal 
of Physiology-Cell Physiology, 283, C484-C488. 
 
 205 
WÅHLIN-LARSSON, B., WILKINSON, D. J., STRANDBERG, E., HOSFORD-
DONOVAN, A., ATHERTON, P. J. & KADI, F. 2017. Mechanistic Links 
Underlying the Impact of C-Reactive Protein on Muscle Mass in Elderly. Cellular 
Physiology and Biochemistry, 44, 267-278. 
WALL, B. T., DIRKS, M. L., SNIJDERS, T., VAN DIJK, J. W., FRITSCH, M., 
VERDIJK, L. B. & VAN LOON, L. J. 2016. Short-term muscle disuse lowers 
myofibrillar protein synthesis rates and induces anabolic resistance to protein 
ingestion. Am J Physiol Endocrinol Metab, 310, E137-47. 
WALL, B. T., SNIJDERS, T., SENDEN, J. M. G., OTTENBROS, C. L. P., GIJSEN, A. 
P., VERDIJK, L. B. & VAN LOON, L. J. C. 2013. Disuse Impairs the Muscle 
Protein Synthetic Response to Protein Ingestion in Healthy Men. Journal of 
Clinical Endocrinology & Metabolism, 98, 4872-4881. 
WELLE, S., THORNTON, C., JOZEFOWICZ, R. & STATT, M. 1993. Myofibrillar 
Protein-Synthesis in Young and Old Men. American Journal of Physiology, 264, 
E693-E698. 
WEST, D. W. D. & PHILLIPS, S. M. 2012. Associations of exercise-induced hormone 
profiles and gains in strength and hypertrophy in a large cohort after weight 
training. European Journal of Applied Physiology, 112, 2693-2702. 
WILKINSON, D. J. 2018. Historical and contemporary stable isotope tracer approaches to 
studying mammalian protein metabolism. Mass spectrometry reviews, 37, 57-80. 
WILKINSON, D. J., FRANCHI, M. V., BROOK, M. S., NARICI, M. V., WILLIAMS, J. 
P., MITCHELL, W. K., SZEWCZYK, N. J., GREENHAFF, P. L., ATHERTON, 
P. J. & SMITH, K. 2014. A validation of the application of D(2)O stable isotope 
tracer techniques for monitoring day-to-day changes in muscle protein subfraction 
synthesis in humans. Am J Physiol Endocrinol Metab, 306, E571-9. 
WILKINSON, S. B., PHILLIPS, S. M., ATHERTON, P. J., PATEL, R., YARASHESKI, 
K. E., TARNOPOLSKY, M. A. & RENNIE, M. J. 2008a. Differential effects of 
resistance and endurance exercise in the fed state on signalling molecule 
phosphorylation and protein synthesis in human muscle. Journal of Physiology-
London, 586, 3701-3717. 
WILKINSON, S. B., PHILLIPS, S. M., ATHERTON, P. J., PATEL, R., YARASHESKI, 
K. E., TARNOPOLSKY, M. A. & RENNIE, M. J. 2008b. Differential effects of 
 
 206 
resistance and endurance exercise in the fed state on signalling molecule 
phosphorylation and protein synthesis in human muscle. J Physiol, 586, 3701-17. 
WILLIS, L. H., SLENTZ, C. A., BATEMAN, L. A., SHIELDS, A. T., PINER, L. W., 
BALES, C. W., HOUMARD, J. A. & KRAUS, W. E. 2012. Effects of aerobic 
and/or resistance training on body mass and fat mass in overweight or obese adults. 
American Journal of Physiology-Heart and Circulatory Physiology. 
WILSON, T. M. & TANAKA, H. 2000. Meta-analysis of the age-associated decline in 
maximal aerobic capacity in men: relation to training status. American Journal of 
Physiology-Heart and Circulatory Physiology, 278, H829-H834. 
WITARD, O. C., JACKMAN, S. R., BREEN, L., SMITH, K., SELBY, A. & TIPTON, K. 
D. 2014. Myofibrillar muscle protein synthesis rates subsequent to a meal in 
response to increasing doses of whey protein at rest and after resistance exercise. 
Am J Clin Nutr, 99, 86-95. 
WITKOWSKI, S., LOCKARD, M. M., JENKINS, N. T., OBISESAN, T. O., 
SPANGENBURG, E. E. & HAGBERG, J. M. 2010. Relationship between 
circulating progenitor cells, vascular function and oxidative stress with long-term 
training and short-term detraining in older men. Clinical Science, 118, 303-11. 
WOLFE, R. R. & CHINKES, D. L. 2005. Isotope tracers in metabolic research: 
principles and practice of kinetic analysis, John Wiley & Sons. 
WROBLEWSKI, A. P., AMATI, F., SMILEY, M. A., GOODPASTER, B. & WRIGHT, 
V. 2011. Chronic exercise preserves lean muscle mass in masters athletes. Phys 
Sportsmed, 39, 172-8. 
YANG, Y., BREEN, L., BURD, N. A., HECTOR, A. J., CHURCHWARD-VENNE, T. 
A., JOSSE, A. R., TARNOPOLSKY, M. A. & PHILLIPS, S. M. 2012. Resistance 
exercise enhances myofibrillar protein synthesis with graded intakes of whey 
protein in older men. Br J Nutr, 108, 1780-8. 
YARASHESKI, K. E., PAK-LODUCA, J., HASTEN, D. L., OBERT, K. A., BROWN, 
M. B. & SINACORE, D. R. 1999. Resistance exercise training increases mixed 




YARASHESKI, K. E., ZACHWIEJA, J. J. & BIER, D. M. 1993. Acute Effects of 
Resistance Exercise on Muscle Protein-Synthesis Rate in Young and Elderly Men 
and Women. American Journal of Physiology, 265, E210-E214. 
YATACO, A. R., BUSBY-WHITEHEAD, J., DRINKWATER, D. T. & KATZEL, L. I. 
1997. Relationship of body composition and cardiovascular fitness to lipoprotein 
lipid profiles in master athletes and sedentary men. Aging-Clinical & Experimental 
Research, 9, 88-94. 
YOUNG, A., STOKES, M. & CROWE, M. 1984. Size and Strength of the Quadriceps 
Muscles of Old and Young-Women. European Journal of Clinical Investigation, 
14, 282-287. 
YUKI, A., OTSUKA, R., KOZAKAI, R., KITAMURA, I., OKURA, T., ANDO, F. & 
SHIMOKATA, H. 2013. Relationship between low free testosterone levels and 
loss of muscle mass. Scientific reports, 3, 1818. 
ZAMPIERI, S., PIETRANGELO, L., LOEFLER, S., FRUHMANN, H., VOGELAUER, 
M., BURGGRAF, S., POND, A., GRIM-STIEGER, M., CVECKA, J., SEDLIAK, 
M., TIRPAKOVA, V., MAYR, W., SARABON, N., ROSSINI, K., BARBERI, L., 
DE ROSSI, M., ROMANELLO, V., BONCOMPAGNI, S., MUSARO, A., 
SANDRI, M., PROTASI, F., CARRARO, U. & KERN, H. 2015. Lifelong 
Physical Exercise Delays Age-Associated Skeletal Muscle Decline. Journals of 




















8. (physical adj (exercise* or exertion* or endurance* or therap* or activit* or conditioning 
or fitness or train*)) 
9. (exercise adj (train* or intervention* or protocol* or program* or therap* or regim* or 
activit* or chronic)) 
10. (fitness adj (train* or intervention* or protocol* or program* or therap* or activit* or 
regim*)) 
11. ((training or conditioning) adj (intervention* protocol* or program* or activit* or regim*)) 
12. ((endurance or aerobic or cardio*) adj (fitness or train* or intervention* or protocol* or 
program* or therap* or activit* or regim*)) 
13. ((weight or strength* or resistance) adj (train* or condition* or exercise* or lift* or 
program*)) 
14. ((isometric or isotonic or isokinetic or dynamic or eccentric or concentric or pleiometric or 
plyometric) adj (action* or contraction* or exercis* or train* or intervention or protocol or 
condition*)) 
Age 





17. Skeletal muscle 
18. (Musc* adj (mass or size or strength or thick* or growth or enlarge* or area or volume or 
hypertrophy or function* or morphology or architecture or cross sectional area or CSA or 
fib* or protein*)) 
19. (Body adj (composition or fat or mass or weight or size)) 
20. Sarcopenia or atrophy or muscle loss  
Function 
21. ((isometric or isotonic or isokinetic or dynamic or eccentric or concentric or pleiometric or 
plyometric or peak or maximum) adj (one rep* max* or 1RM or MVC or torque or power 
or strength or handgrip or velocity)) 
22. ((endurance or aerobic or cardio*) adj (performance or capacity or fitness)) 
23. Function* 
Exercise Duration 
24. (Master* adj (athlete*) 
25. ((Life* or all-time or highly or largely or hugely or extremely or exceptionally or very) adj 
(active)) 
Final Search  
26. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14  
27. 16 or 17 or 18 or 19 or 20  
28. 21 or 22 or 23 
29. 24 or 25  




6.2. Isolation of myofibrillar proteins for FSR 
 
For 30-50mg tissue with single bead homogenization 
Overview of procedure: 
1. Weigh muscle samples, chip if necessary. 
2. Homogenize and separate muscle sub-fractions (sarcoplasmic, myofibrillar). 
3. Purify myofibrillar fraction and hydrolyse proteins. 
4. Column and reconstitute. 
5. Derivatize. 
6. Run on mass spectrometer. 
 
STEP 2: Homogenization with single bead homogenizer 
Before beginning:  
• For each sample, label 2 tubes: a 2ml MYO Eppendorf and a 1.5ml SARC 
Eppendorf.  You can also label a third 1.5ml Eppendorf BCA if you need to run a 
protein content assay for western blots. 
• Make up enough 25mM Tris buffer (can be made in advance and stored for up to a 
month) and homogenization buffer (must be made fresh the morning of) for the 
number of samples you plan on running today. 
• Take the blocks and beads out of the -20 freezer and allow to warm up for ~10 min 
(otherwise buffer will freeze). 
• Turn on centrifuge and let cool down to 4ºC. 
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Recipe for 50ml of 25mM Tris buffer, pH 7.2 
1. In a 50ml Falcon tube, mix Tris-HCl (175.5mg) and Trizma Base (16.75mg) in 
25ml of Milli-Q H2O. 
2. Bring to pH to 7.2. using 0.1M HCl. 
3. Bring total volume 50ml with H2O. 
4. Store Tris Buffer at 4ºC for up to 1 month. 
 
Recipe for 10ml of homogenization buffer  
1. 8 ml of 25mM Tris buffer from above, pH 7.2. 
2. 1 PhosStop Tablet, Roche (4ºC fridge). 
3. 100µl TritonX-100 (final 0.5%) (room temperature). 
4. 1 complete mini (Roche) protease inhibitor tab (kept in door of 4ºC fridge). 
5. Bring to pH to 7.2 on ice, with a stir bar in to be sure it is mixing. The pH will 
change fast, so use 0.1M HCl and wait 30 seconds between drops.  
6. Bring volume to 10 ml with 25mM Tris buffer. 
 
To homogenize: 
1. Collect samples from freezer, keep on liquid nitrogen until transferred to buffer. 
2. Place 500µl homogenization buffer in the 2ml MYO Eppendorf on ice.  Be sure to 
use the flatter bottomed 2mL Eppendorfs (vs. conical 1.5mL Eppendorfs) or the 
bead won’t reach the bottom of the tube. 
3. Place a single bead in the Eppendorf.  
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4. Place the muscle in the Eppendorf.   
5. Place the Eppendorf in the cold blocks and lock it place in the (mixing chamber). 
6. Set the gauges to 40 seconds at 20/s frequency (ensuring the muscle is well 
homogenized). 
7. Carefully take the Eppendorf out by pushing from the bottom with a pen. 
8. Carefully remove bead. Bead can be washed thoroughly in 70% EtOH, dried and 
reused. 
 
To separate myofibrillar and sarcoplasmic fractions: 
9. Centrifuge the homogenate at 4500 rpm for 10 min at 4°C. 
10. Remove supernatant, leaving a little left with the pellet to ensure the pellet is not 
disturbed, and place it in the Eppendorf labelled SARC for westerns. The pellet 
contains the myofibrillar fraction - do not disturb this.  
11. Place 10µl of the sarcoplasmic fraction and 90µl of Milli-Q H2O the Eppendorf 
labelled BCA if you are going to run a protein content assay. 
12. Store all samples at -80ºC.  Can stop here and continue another day. 




STEP 3: Purification and hydrolysis of myofibrillar amino acids 
Before beginning:  
• Turn on centrifuge and let cool to 4°C.  Ensure correct rotor is in place (you 
need the one that fits Eppendorf tubes).   
• Set heating block to 50°C (there is a notch that indicates 50°C on the dial on 
the heating block in the fume hood).   
• Set oven to 110°C.  Tell the other labs that the oven needs to stay plugged in.  
Sometimes others will unplug the oven to use the autoclave. 
• Label 1 4mL glass screw-top vial per sample. 
To purify: 
1. Open Eppendorfs containing myofibrillar pellets and place tubes on ice. 
2. To the frozen pellet add 500µl Milli-Q H20. 
3. Vortex 5 seconds. 
4. Spin for 10min at 1500rpm at 4°C. 
5. Replace tubes on ice.  Remove supernatant and discard. 
6. To the pellet add 1ml 0.3M NaOH.  
7. Vortex 5 seconds. 
8. Put in heating block at 50°C for 30min, vortex 5 seconds every 10 min. 
9. Spin at 10,000rpm for 5min at 4°C.  Collagen is not soluble in NaOH and will 
collect in a pellet.  Note that the collagen “pellet” looks more like a smear, and that 
for some samples you may not get much, if any at all.  
10. Assemble your glass screw-top tubes in a rack with foil at the base to prevent the 
tubes from falling through.  Remove caps. 
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11. Remove supernatant (which now contains the myofibrillar fraction) and place in 
4ml glass screw-top tubes.   
12.  Add 1ml 0.3M NaOH to pellet.  
13.  Vortex 5 seconds. 
14.  Spin for 5 min at 10,000 rpm at 4°C. 
15.  Remove supernatant and combine with the 1ml of the previous supernatant in the 
screw tops. 
16.  Place collagen pellet in fridge if measuring collagen FSR or discard.  
17.  Add 1ml 1M PCA to screw top (containing myofibrillar fraction).  Note: must 
have cloudy-looking precipitate. *Do not vortex* 
18.  Spin 10min at 2500rpm at 4°C. 
19.  Remove supernatant and discard. 
20.  Add 1ml 70% ethanol to myofibrillar fraction. *Do not vortex* 
21.  Spin 10 min at 2500 rpm at 4°C. 
22.  Remove ethanol and discard (ensure no fluid is in glass tubes).  
23.  Add 1ml of Dowex (make sure your Dowex has been cleaned and mixed with 
0.5M HCL prior to use) and 1ml of 1M HCL. 
24. Vortex thoroughly.  The white “pancake” of precipitate will float.  Try your best to 




To hydrolyse:  
25. Place rack of tubes in oven at 110°C for 72 hrs, vortex well every 24hrs.  Use 
paper towel to grip vials when vortexing samples that have just come out of oven 
or you will burn your fingers. 
26. Remove from oven.  Samples will have denatured so they can sit at room 
temperature for a few days/weeks until you are ready to column. 
 
STEP 4: Dowex column clean-up and reconstituting    
Reagents needed  
• 2M NH4OH 
• 1M HCL 
• Dowex (50wx8-200 ion exchange resin)  
• pH paper 
Equipment needed  
• Repeater pipette 
• 3ml syringes 
• Glass wool 
• Styrofoam ice-box and sample rack 
• Culture tubes 
• Rotor-evaporator 
Before beginning:  
• Label 1 culture tube per sample.  Set aside. 
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• Set up one column per sample.  To make a column, stuff a 3mL syringe with 
small amount of cotton/glass wool.  Fill syringe up to 0.5mL: you want 
enough cotton to trap the Dowex but enough room to add solutions.  Do not 
pack too tightly. 
• Add a bit of water to the bottom of the Styrofoam container to prevent 
smoking when the acids/bases run through the columns. 
• Place rack on top of Styrofoam container and suspend columns from rack. 
To column: 
1. Add 1.2ml of Dowex resin to all columns  
2. Add 2-4ml H2O to neutralize the HCl that is in the resin.  Check with pH paper. 
3. Add 2ml of 2M NH4OH (elutes contaminants) 
4. Add H2O until neutral, 10-15mL or ~ 4 rounds (check with pH paper.) 
5. Add 4ml of 1M of HCl (ensure pH of 1) 
6. Add samples to each column using a transfer pipette and stirring the sample as you 
draw it up (the charged/acidic column will retain samples) 
7. Add H2O until neutral, 8-10mL for myo’s - check often with pH paper.  A slight 
ring of red is ok.   
8. Place the columns on top of culture tubes in order to collect eluent 
9.  Elute with 4.5mL 2M NH4OH.  Add 2mL at a time because 4.5mL won’t fit in the 
column at once.   
10. Gently push a plunger into the tops of the syringes to squeeze out 2-3 more drops.  
Do not push the plunger in the whole way, or you may push out some Dowex. 
11.  Dry samples in rotor evaporator: 
12. Place samples in roto-vac, ensuring they are balanced. 
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13. There are 2 switches on the front of the machine: turn the left-hand switch ON, do 
not touch the right-hand switch. 
14. Connect hose to tap.  Turn tap on full blast.  
15. The top of the roto-vac should develop a seal.  This may take a few minutes, but 
make sure you cannot shift or lift the lid before leaving the room.  You should also 
hear a humming from the machine once it gets going. 
16. Place hot pack on lid to prevent condensation from collecting. 
17. The more samples you have, the longer they will take to dry.  It takes ~30 samples 
about 6-12 hours to dry.  Check them regularly, and do not leave the roto-vac on 
overnight.  If you need to leave and the samples are not fully dry, you can remove 
the tubes and cover them with parafilm or tin foil (do not use saran wrap) and place 
in fridge, and continue the following day. 
To clean up, pour water on used syringes to neutralize them.  They can then be thrown out.  
Glass vials should go in the glass waste.  Liquid in the Styrofoam container should go 
down the sink with lots of water. 
To reconstitute: 
Once samples are dry you can reconstitute right away or cover the tubes with parafilm or 
tin foil and leave in the fridge.  To do this: 
• add 500µl of 0.1M HCl to hydrolysed samples, vortex, and place in an Eppendorf 
tube.  
Derivatize according to samples’ needs. 
NOTE: If you are shipping to metabolic solutions, add 200µl of reconstituted sample to a 
crimp top tube.  Dry sample under N2 gas, seal with crimp top, and ship.  
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6.3.  Western Blot Protocol  
Gel Preparation (day 1): 
1. Clean plates by spraying with 70% ethanol and drying with a towel. 
2. Make plate sandwich and align in clamp (thumbnail shouldn’t catch). 
3. Make separating gel cocktail containing the proper amounts of (see table–each amount 
makes ~2 gels): 
 
Final acrylamide % 5% 7.5% 8% 8.5% 10% 12.5% 15% 
H2O (mL) 5.75 4.9 4.73 4.56 4 3.2 2.4 
4X Tris-SDS pH 8.8 
(mL) 
2.5 2.5 2.5 2.5 2.5 2.5 2.5 
30% Acrylamide 
solution (mL) 
1.65 2.5 2.66 2.83 3.33 4.2 5 
10% APS (μL) 100 100 100 100 100 100 100 
TEMED (μL) 10-16 10-16 10-16 10-16 10-16 10-16 10-16 
• Add ≈3.4 mL of gel to each mini gel with 0.75 mm spacers.  
4. Overlay with 100 µL of 70% ethanol. 
5. Allow to polymerize ≈20 min. 
6. Aspirate the ethanol and wash 2X with water.  
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7. Make 5% stacking gel: 
 
Final acrylamide % 5% 
H2O (mL) 4.67 
4X Tris-SDS pH 6.8 (mL) 2 
30% Acrylamide solution (mL) 1.33 
10% APS (μL) 65 
8. Place the combs (15 well or 10 well) in the gel at an angle. 
9. Add 10-16 µL TEMED. 
10. Pour 1 mL (or enough to fill) at the corner under the comb. 
11. Push the comb down at an angle making sure not to trap any bubbles. 
12. Allow the gel to polymerize for ≈20 minutes. 
 
Gel Run (day 1): 
1. Take out and defrost samples and pre-stained protein marker (STD; from –20oC 
freezer). 
2. Put gels in the gel core unit so that the smaller plate is facing inward. 
3. Press the gels down and then the core unit and close the clamps. 
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4. Pour 1X Running Buffer (RB) until it reaches the level of the top of the gaskets. 
5. Remove the combs carefully and straight up as to not alter the lanes. 
6. Rinse out the lanes with the 1X RB. 
7. Add 4 µL (10 well) or 2.5 µL (15 well) STD and 2-20 µL of sample to the lanes 
(vortexing before adding; return STD and samples to freezer when finished).  
8. Now place the gel core into the gel tank. 
9. Fill 1X RB up to halfway up the clamps on the front of the gel core. 
10. Put on electrode top (make sure black-black and red-red). 
11. Using Power Pac 300 plug in electrodes (black-black and red-red). 
12. Run at constant amperage at 23 mA/gel and variable voltage until front leaves the gel.  
Transfer (day 1): 
1. Approximately 5-10 minutes before gel running is complete, take out tub, four filter 
papers, two membranes, two black/white cartridges, tray and transfer Buffer (TB). 
2. Label both membranes (don’t touch with hands!) on upper left hand corner 
3. Wet membranes TB. 




5. Remove the gels from the core. 
6. Using the gel wedge, separate the two plates from each other and press the gel down 
onto the smaller plate. 
7. After the 2 plates are separated and gel is on the smaller plate, cut off the lanes. 
8. Open 1 black/white cartridge and put in tray with TB.  
9. Lay first sponge on the black side of the cartridge. 
10. Lay one filter paper on the gel (on small plate), and transfer the gel to the filter paper 
using the gel wedge. 
11. Lay the filter paper plus the gel on the sponge (with the filter paper first on sponge). 
12. Lay membrane on the gel, face down (as it is sitting in the transfer buffer) and center 
first. 
13. Lay other filter paper on the membrane. 
14. Hold one hand on filter (corners) paper and roll out any bubbles with a pipette in the 
other hand. 
15. Lay other sponge on the filter paper. 
16. Close up the black/white cartridge and place in the black and red gel transfer unit, so 
that the black side of cartridge faces black connection of red and black gel transfer unit. 
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17. Take 2nd gel from gel core unit and repeat steps 6-16 for other gel so that both 
black/white cartridges are in the black and red gel transfer unit. 
18. Place red and black gel transfer unit into the gel tank. 
19. Put in small stir bar and place an ice block behind black and red gel transfer unit. 
20. Fill gel tank to rim with TB, using all TB that is in tray and tub (return extra TB to 
fridge). 
21. Put on top (make sure black-black and red-red). 
22. Place gel tank on stirring plate and stir at a high velocity. 
23. Using Power Pac 200 (or 300), plug in electrodes (black-black and red-red), set 
constant voltage to 100 V and run for 60 min, amperage should be around 300 mA. 
24. While transferring, make 5% milk using 2.5 g dry milk and 50 mL TTBS.   
Blocking (day 1): 
1. When transfer is finished, turn off Power Pac 200 and take off the top.  
2. Return ice block (now liquid) to freezer. 
3. Take out black and red gel transfer unit and remove and open both cartridges. 
4. Discard the filter papers and gel and place each membrane face up into a small 
container Ponceau – and image.  
5. Return the Ponceau to falcon tube and wash the membrane ~5X with water.   
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6. Place each membrane face up into a small container with 25 mL of 3% milk solution. 
7. Rock slowly for 30-60 min. 
8. While rocking, return TB to the fridge, return the stir bar, rinse out the gel tank with 
water, rinse the sponges and dry flat, and rinse the red and black cartridge. 
9. After rocking for 30-60 min, take out milk and rinse with TTBS.  
10. Dump out TTBS, add new TTBS, and shake for 5 min. 
Primary Antibodies (day 1): 
1. Make primary antibody solutions in TTBS, 3% milk in TTBS or 3% BSA in TTBS.  
2. Take membranes from small container, set on piece of paper (or plastic) and cut 
membranes according to molecular weight. 
3. Put membrane, protein side up, into a 6 well plastic gel container filled with ≈6-10 mL 
TTBS – rinse 2x and then wash 3 x 5 min in TTBS. 
4. Dump TTBS from 6 well plastic gel container and quickly add enough primary 
antibody to cover (6-10 mL) for each targeted protein. 






Secondary Antibodies (day 2): 
1. Pipette out primary antibodies and return to respective tube and immediately put in 
TTBS. 
2. When all wells have been cleared of their primary antibodies and are filled with TTBS, 
dump out TTBS, and pour new TTBS in. 
3. Shake for 5 min, dump TTBS, then add new TTBS. 
4. Repeat step 3 twice more (for a total of 15 min of washing in TTBS). 
5. While washing, make secondary antibodies in 3% milk solution as before or TTBS and 
add appropriate secondary antibody for each targeted protein.  
6. After the wash is complete, dump out TTBS from each well, and add 6-10 mL of 
secondary antibody and rock slowly for 60 min at RT.  
7. After 60 min, dump secondary antibodies, and repeat steps 3-4 for a total of 15 minutes 
of washing with TTBS again. 
8. Make up Chemi (~ approx. 2ML of each solution, totally 4ml) (1:1)), apply to 
membrane, dry membrane, cover with sheet and image.  




• www.fmblab.com  
